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ABSTRACT 
Background: The retail sector is an important channel for increasing access to 
adequate treatment of fevers in Africa. The objectives of the thesis were to assess the 
performance of three malaria control programmes targeting private medicine retailers 
(PMRs) by addressing coverage, utilisation, impact on PMRs' knowledge, practices 
and implementation processes in Kisii central, Kwale and Bungoma districts of Kenya. 
Methods: The thesis used mixed methods including retail audits, surrogate client 
surveys based on post intervention cross sectional surveys in intervention and controls 
and mapping of outlets in intervention areas. Qualitative methods including record 
reviews, in-depth interviews and focus group discussions with programme 
stakeholders were analysed using thematic framework and policy analysis. 
Results: There was a significant impact on PMR knowledge and practice of an NGO- 
led participatory training programme in Kisii-central district with 60.5% of trained 
PMRs selling AQ medicines adequately compared to 2.8% in the untrained ones (OR; 
53.5: 95% CI 6.7,428.3). There was some evidence of a limited impact for the Moll- 
led participatory training programme in the Kwale district, where 18.8% of trained 
PMRs sold AQ medicines adequately compared to 2.3% of control PMRs (OR; 9.4: 
95% CI 1.1,83.7). This study was unable to show evidence of impact in the social 
marketing programme in Bungoma district. In terms of coverage, Kisii central covered 
27.1% of all outlets in the study sites, compared to 14.1% and 16.7% in Kwalc and 
Bungoma districts, respectively. Policy analysis indicated that, deliberate and careful 
management of the implementation process, actors involved and establishing a 
transparent management system with a flexible decision-making processes, is key to 
successftil uptake and impact at retailer level. 
2 
Conclusions: PMR interventions operationalised through various institutions in the 
district level settings at moderate scale are likely to impact on PMR knowledge and 
practices and lead to increased coverage of appropriate treatment to target populations. 
Implementation management play a major role in determining programme impact, and 
should be areas of focus in planning and managing public health programmes. 
ACKNOWLEDGEMENTS 
The success of this PhD was made possible by the cooperation of many people. I am 
grateful to my supervisors and mentors, Dr. Vicki Marsh for her constant support and 
advice and Prof Lucy Gilson and Bob Snow for their guidance. My gratitude goes to 
my colleagues within the Kenya Medical Research Institute (KEMRI)/Wellcome Trust 
Research Programme. Thanks to Yvonne Rowa, Francis Kombe, Karisa Baya and 
Richard Rimba and the entire field teams for supporting data collection. I am also 
grateftil to the district health managers in, Kisii, Bungoma, and Kwale, districts for 
their support. Thanks to Metrine Saisi, Whilma Mbeyu and Chrisbel Kanini for data 
entry. Thanks to Greg Fegan for his guidance in statistical analysis, Victor Alegana 
and Abdisalan Noor for their assistance with the spatial analysis and Amin Abdinasir, 
for his advice. 
I am also grateful to Drs Mike English, Sassy Molyneux and Penny Holding, members 
of my Scientific Advisory Committee for their support. Thanks to members of staff at 
the Centre for Health Policy University of Witswatersrand and Health Economics Unit 
of the University of Cape Town where I spend time analysing qualitative data. I am 
grateful for the financial support received from The Wellcome Trust/ KEMRI- 
CGMRC programme Kilifi. My gratitude also to Prof Kevin Marsh and Dr. Norbert 
Peshu for providing a conducive environment for my PhD. 
Finally, I am grateful to my Wife, Veena and sons Shawn and Trevor for their love, 
support and patience as I spend time away while pursuing my studies. I am forever 
thankful to my parents and family members for their love and support. Also 
remembered are my friends David Katana, Moremi Nkonsi for their hospitality. 
4 
DEDICATION 
To my wife Veena 
List of Contents 
ABSTRACT 2 
ACKNOWLEDGEMENTS ................................................................................................. 4 
DEDICATION ...................................................................................................................... 5 
LIST OF CONTENTS ......................................................................................................... 6 
LIST OF TABLES ............................................................................................................. 10 
LIST OF FIGURES ........................................................................................................... 11 
LIST OF ACRONYMS AND ABBREVIATIONS ......................................................... 13 
CHAPTERl: ...................................................................................................................... is 
INTRODUCTION AND LITERATURE REVIEW ....................................................... 15 
1.1 INTRODUCTION ............................................................................................................ 16 1.2 MALARIA CONTROL STRATEGIES 
................................................................................ . 17 1.2.1 Historical overview of global control efforts ..................................................... . 17 1.2.2 Roll Back Malaria initiative ............................................................................... . 19 1.3 CARE SEEKING FOR FEVERS AND MALARIA IN SUB-SAHARAN AFRICA 
....................... . 21 1.3.1 Literature review for care seeking behaviour ..................................................... . 21 1.3.2 Studies reviewed and variables of interest ......................................................... . 24 1.3.3 Descriptive summary of the review ................................................................... . 25 1.3.4 Use of PMRs for treatment of fevers and malarial illnesses .............................. . 31 1.4 HOME MANAGEMENT OF MALARIA ........................................................................... . 34 1.4.1 Historical overview of HMM ............................................................................. . 34 1.4.2 Objectives and strategic components of HMM .................................................. . 35 1.4.3 Interventions to improve HMM using PMRs in SSA ......................................... 36 1.4.4 Nature of interventions involving PMRs ............................................................ 38 1.4.5 Impact of interventions on PMR knowledge and practices ................................ 46 1.4.6 Summary of PMR interventions .......................................................................... 48 1.5 STUDY OBJECTIVES 
..................................................................................................... 51 1.5.1 General objective ................................................................................................ 52 1.5.2 Specific objectives .............................................................................................. 52 1.6 EVALUATION OF PUBLIC HEALTH INTERVENTIONS ....................................................... 52 
1.6.1 Framework for evaluating public health interventions ....................................... 53 1.6.2 Evaluation design for public health interventions ............................................... 55 1.6.3 Retail audit and surrogate client survey .............................................................. 59 1.6.4 Assessing coverage and utilisation ...................................................................... 60 1.6.5 Assessing implementation process of PMR interventions .................................. 63 1.6.5.1 Theoretical concepts and policy analysis frameworks ................................. 64 1.6.5.2 Policy analysis studies in low and middle income countries ....................... 66 1.7 SCOPE AND ROLE OF THESIS ......................................................................................... 70 
CHAPTER 2: ............................... ....................................................................................... 72 
THE KENYAN HEALTH SYSTEM, BACKGROUND TO THESIS AND STUDY 
METHODS ......................................................................................................................... 72 
2.1 INTRODUCTION ......................... ................................................................................... 73 2.2 GEOGRAPHICAL LOCATION AND BASIC INDICATORS FOR KENYA ................................. 73 2.3 KENYAN HEALTH CARE SYSTEM .................................................................................. 76 2.3.1 Kenyan Health Policy Framework: An overview ............................................... 76 2.3.2 Structure of the Kenyan health care system ............................................ ............ 76 2.4 MALARIA CONTROL EFFORTS IN KENYA ...................................................................... 79 
2.4.1 Role of DoMC in malaria control ....................................................................... 80 2.4.2 The role of retailer programmes in the HMM in Kenya ................................... .. 83 2.4.2.1 The Kilifi shopkeeper training programme ................................................ .. 83 2.4.2.2 The Bungoma-AMREF programme .......................................................... .. 83 2.4.2.3 Cry for the World Foundation programme ................................................ .. 85 2.4.2.4 Assembling experiences of PMR interventions in Kenya ......................... .. 85 2.4.3. Influence of drug policy change in the implementation of HMM in Kenya .... .. 86 2.5 APPROACH TO PROGRAMME EVALUATION IN THIS THESIS ......................................... .. 88 
2.5.1 Overview of programmes evaluated ................................................................. .. 88 2.5.1.1 Bungoma-AMREF programme .................................................................. .. 90 2.5.1.2 Kisii-Merlin PMR training programme ..................................................... .. 94 2.5.1.3. Kwale-MoH PMR training programme .................................................... .. 97 2.6 CONCEPTUAL FRAMEWORK ....................................................................................... 103 2.6.1 Indicators for assessing retailer's knowledge and practices ............................. 104 2.6.2 Indicators for estimating population coverage and utilisation of programme.. 105 
2.6.3 Assessing implementation and factors influencing process .............................. 105 2.7 GEOGRAPHICAL LOCATION AND CHARACTERISTICS OF STUDY DISTRICTS ................. 106 2.7.1 Bungoma district ............................................................................................... 106 2.7.2 Kisii Central district .......................................................................................... 107 2.7.3 Kwale district .................................................................................................... 107 2.8 STUDY DESIGN AND SELECTION OF STUDY SITES ....................................................... 108 
2.9 STUDY METHODS ....................................................................................................... 112 2.9.1 Quantitative studies ........................................................................................... 112 2.9.1.1 Sampling for Retail Audit and Surrogate Client Survey ............................ 112 2.9.1.2 Planning and preparation of surveys .......................................................... 113 2.9.1.3 Surrogate Client Survey method ................................................................ 113 2.9.1.4 Retail audit method .................................................................................... 114 2.9.1.5 Generating coordinates for assessing coverage .......................................... 114 2.9.2 Quantitative data management .......................................................................... 115 2.9.2.1 Storage and analysis of the surrogate client survey and retail audit data .. 115 2.9.2.2 Generating maps ......................................................................................... 115 2.9.2.3 Developing models for assessing utilisation .............................................. 115 2.9.3 Qualitative study and policy analysis ................................................................ 117 2.9.3.1 Sampling technique for the qualitative study ............................................. 119 
2.9.3.2 Desk review of programme activity ........................................................... 120 2.9.3.3 Focus group discussions ............................................................................. 
120 
2.9.3.4 Interviews and informal discussions .......................................................... 121 2.9.3.5 Use of diaries .............................................................................................. 122 2.9.4 Managing qualitative data ................................................................................. 122 2.9.5 Ethical considerations ................................................................................... 124 
CHAPTER 3: .................................................................................................................... 126 
QUANTITATIVE ASSESSMENT OF THE IMPACT OF PMR PROGRAMMES 
ON RETAILER KNOWLEDGE, PRACTICES, COVERAGE AND POTENTIAL 
UTILISATION ................................................................................................................. 126 
3.1 INTRODUCTION .......................................................................................................... 127 3.2 MEASURES OF COVERAGE AND POTENTIAL UTILISATION ........................................... 128 
3.2.1 Spatial distribution of retail outlets in the three sites ........................................ 128 3.2.2 Provider-population ratios of retail outlets ....................................................... 135 3.2.3 Threshold distance for using retail sector services . .......................................... 136 3.2.4 Potential under five users and average distance to access retail outlets ........... 137 3.3 DESCRIPTION OF OUTLETS AND PMRS ACROSS SITES ................................................ 141 3.3.1 Distribution of IEC materials in the three sites ................................................. 141 
7 
3.3.2 Number and status of retail outlets visited ........................................................ 145 3.3.3 Characteristics of retail outlets .......................................................................... 147 3.3.4: Patterns of medicines stocked in the retail outlets ........................................... 149 3.3.5: Storage conditions and expiry dates of anti-malarial medicines ...................... 153 3.3.6 Sources of SP and AQ medicines ..................................................................... 154 3.3.7 Price of SP and AQ medicines .......................................................................... 156 3.4 IMPACT OF PROGRAMME ON PMR KNOWLEDGE AND PRACTICES ............................... 158 
3.4.1 PMR's ability to identify simple febrile events ................................................ 158 3.4.2 Sale of medicines in the retail outlets ............................................................... 160 3.4.3 Type of anti-malarial medicines sold and adequacy of advice given on dosages 
.................................................................................................................................... 163 3.4.4 PMR knowledge on OTC drug types ................................................................ 165 3.4.5: PMR's knowledge on dosing anti-malarial medicines .................................... 167 3.5 DiscussioN ............................................................................................................... 169 3.5.1 Summary of quantitative outcomes across the three sites ................................. 169 3.5.2 Study limitations ............................................................................................... 
172 
3.5.2.1 Limitations of methods used to measure coverage .................................... 172 3.5.2.2 Limitations in assessing impact on PMR knowledge and practices .......... 173 3.5.2.3 Specific limitations for the Bungoma-AMREF site ................................... 178 3.5.2.4 Contextual factors influencing interpretations ........................................... 181 3.5.2.5 Generalizability of findings ........................................................................ 
183 
3.6 SummARY ................................................................................................................. 
186 
CHAPTER 4: .................................................................................................................... 188 
QUALITATIVE ASSESSMENT AND POLICY ANALYSIS OF 
IMPLEMENTATION PROCESS .................................................................................. 188 
4.1 INTRODUCTION 
.......................................................................................................... 
189 
4.2 OVERVIEW OF THE FRAMEWORKS USED .................................................................... 
190 
4.3 IMPLEMENTATION EXPERIENCES OF EVALUATED INTERVENTIONS ............................. 
197 
4.3.1 INTERVENTION DESIGN ........................................................................................... 
198 
4.3.2 Management model of the innovations ............................................................. 200 4.3.3 Roles of actors ................................................................................................... 
201 
4.3.4 Actors' interests and influence over programme implementation .................... 212 4.4 EXPLANATORY FACTORS INFLUENCING IMPLEMENTATION PROCESS AND OUTCOME. 223 
4.4.1 Explanatory factors influencing implementation process and outcome in the 
Kisii-Merlin experience ............................................................................................. 224 4.4.1.1 The innovation and its attributes in the Kisii-Merlin site .......................... 224 4.4.1.2 The resource team and its attributes in Kisii-Merlin site ........................... 227 4.4.1.3 The attributes of the user organisation in the Kisii-Merlin site ................. 232 4.4.1.4 Scaling up strategy in the Kisii-Merlin site ............................................... 234 4.4.1.5 Managing wider context in the Kisii-Merlin site ....................................... 234 4.4.2 Explanatory factors influencing implementation process and outcome in the 
Kwale-MoH and Bungoma-AMREF sites ................................................................. 239 4.4.2.1 The innovation in the Kwale-MoH and Bungoma-AMREF sites .............. 239 4.4.2.2. The attributes of the resource team in the Kwale-MoH and Bungoma, 
AMREF sites .......................................................................................................... 242 4.4.2.3 The attributes of the user organisation in the Kwale-MoH and Bungoma- 
AMREF sites .......................................................................................................... 246 4.4.2.4 The scaling up strategy in the Kwale-MoH and Bungoma-AMREF sites. 254 
4.4.2.5 Managing wider context in the Kwale-MoH and Bungoma-AMREF sites 
................................................................................................................................ 255 4.5 SUMMARY ................................................................................................................. 263 
CHAPTER 5: .................................................................................................................... 266 
POLICY IMPLICATIONS AND CONCLUSIONS ..................................................... 266 
5.1 INTRODUCTION .......................................................................................................... 
267 
5.2 SUMMARY OF KEY FINDINGS ..................................................................................... 
270 
5.3 CONTRIBUTION TO KNOWLEDGE ON RETAIL SECTOR INTERVENTIONS ....................... 275 
5.3.1 Impact of PMR programmes ............................................................................. 
275 
5.3.2 Insights on the importance of management processes in implementing 
innovative PMR programmes .................................................................................... 
275 
5.3.3 Importance of context on implementation process ............................................ 283 5.4 RECOMMENDATIONS ON STRENGTHENING THE INTRODUCTION AND IMPLEMENTATION 
OF PMR PROGRAMMES ................................................................................................... 
286 
5.4.1 General recommendations ................................................................................. 
286 
5.4.2 Recommendations on the challenges of new drug policy for PMR interventions 
291 
5.5. IMPLICATIONS FOR FUTURE EVALUATIONS ............................................................... 
294 
5.6 CONCLUSIONS ........................................................................................................... 
296 
REFERENCES ................................................................................................................. 298 
APPENDICES .................................................................................................................. 
316 
9 
List of Tables 
TABLE 1.1: CARE SEEKING PATTERNS FOR FEVERS AND MALARIA IN SUB-SAHARAN AFRICAN 
COUNTRIES .................................................................................................................... 27 
TABLE 1.2: PMR. INTERVENTIONS TO IMPROVE MALARIA RELATED ACTIVITIES IN SSA ........ 
40 
TABLE 2-1 SUMMARY CHARACTERISTICS OF THE KENYAN DEMOGRAPHIC INDICES .............. 
75 
TABLE 2-2 REGISTERED MEDICAL PERSONNEL AND PROVIDER POPULATION RATIO FOR 
KENYA 
.......................................................................................................................... 79 
TABLE 2-3 SUMMARY OF THE ELEMENTS OF THE INTERVENTION ACROSS ALL SITES ............. 
89 
TABLE 2-4 DEMOGRAPHIC, AND MALARIOMETRIC INDICES OF THE STUDY DISTRICTS ......... 
108 
TABLE 2.5: TYPES AND NUMBER OF QUALITATIVE INTERVIEWS AND DISCUSSIONS ............. 
122 
TABLE 3-1 RETAIL SECTOR SERVICE INDICES ACROSS THE PROGRAMME SITES .................... 
131 
TABLE 3-2 DISTRIBUTION OF IEC MATERIALS .................................................................... 
142 
TABLE 3-3: NUM13ER AND STATUS OF RETAIL OUTLETS VISITED .......................................... 
146 
TABLE 3-4 CHARACTERISTICS OF RETAIL OUTLETS AND PMRs .......................................... 
148 
TABLE 3-5: STOCKS OF COMMON OTC MEDICINES AVAILABLE .......................................... 
150 
TABLE 3-6 FREQUENCY OF AQ BRANDS OF MEDICINES ....................................................... 
152 
TABLE 3-7 FREQUENCY OF SP BRANDS OF MEDICINES . ....................................................... 
152 
TABLE 3-8 FREQUENCY FOR PMR. ASKING QUESTIONS ABOUT USERS AND THEIR SYMPTOMS 
BEFORE SELLING MEDICINES ........................................................................................ 
159 
TABLE 3-9 SALE OF OTC MEDICINES AND REASONS GIVEN BY PMRS FOR NOT SELLING 
MEDICINES .................................................................................................................. 
162 
TABLE 3-10 PMR's PRACTICES WHILE SELLING MEDICINES FOR A THREE YEAR OLD FEBRILE 
CHILD .......................................................................................................................... 
164 
TABLE 3-11 PMR'S KNOWLEDGE ON RECOMMENDATION FOR FEBRILE ILLNESSES ............. 
166 
TABLE 3-12 PMR'S KNOWLEDGE ON DOSING SP AND AQ MEDICINES ................................ 
168 
TABLE 3-13 SUMMARY OF QUANTITATIVE FINDINGS ACROSS SITES .................................... 
171 
TABLE 4.1 ACTOR'S INTERESTS, POSITION AND INFLUENCES ON IMPLEMENTATION PROCESS IN 
THE Kisll-MERLIN SITE ............................................................................................... 
203 
TABLE 4.2 ACTOR'S INTERESTS, POSITION AND INFLUENCES ON PROCESS AND OUTCOME IN 
THE KWALE-MOH SITE ............................................................................................... 
205 
TABLE 4-3: ACTOR'S INTERESTS, POSITION AND INFLUENCES ON PROCESS AND OUTCOME IN 
THE BUNGOMA-AMREF SITE ..................................................................................... 
207 
TABLE 4.4 SUMMARY OF KEY INDICATORS MEASURED ACROSS SITES ................................. 
224 
TABLE 5.1 SUMMARY OF KEY FINDINGS ACROSS SITES ........................................................ 
273 
10 
List of figures 
FIGURE 1.1 UNIVERSE OF PRIVATE MEDICINE SELLERS; SOURCE: (WHO/RBM, 2005) ......... 
24 
FIGURE 1.2 STRATEGIC COMPONENTS OF HMM (WHO, 2005A) .......................................... 
36 
TABLE 1.2: PMR INTERVENTIONS TO IMPROVE MALARIA RELATED ACTIVITIES IN SSA 
ADAPTED FROM (GOODMAN ET AL., 2007A) .................................................................. 40 FIGURE 1.3 RESEARCH GAPS IN STUDIES EVALUATING HMM USING PMRS AND OTHER 
COMMUNITY LEVEL PROVIDERS (GOODMAN ET AL., 2007A; HOPKINS ET AL., 2007) .... 50 FIGURE 1.4 EVALUATION DESIGN ISSUES OF PUBLIC HEALTH INTERVENTIONS 
...................... 57 FIGURE 1.5: POLICY ANALYSIS TRIANGLE: SOURCE: (WALT AND GILSON, 1994) .................. 65 FIGURE 2.1: MAP OF AFRICA SHOWING THE LOCATION OF KENYA 
........................................ 74 FIGURE 2-1 ORGANOGRAM SHOWING THE ADMINISTRATIVE AND ORGANISATIONAL 
STRUCTURE OF THE KENYAN MINISTRY OF HEALTH (NCAPD, 2004) .......................... 77 FIGURE 2-2 LEVELS OF HEALTH CARE DELIVERY WITHIN THE KENYA ESSENTIAL PACKAGE 
FOR HEALTH (KEHP) .................................................................................................... 78 FIGURE 2.4 IMPLEMENTATION MILESTONES TOWARDS ACHIEVING INTENDED OUTCOME IN 
THE BUNGOMA-AMREF INTERVENTION ....................................................................... 93 FIGURE 2.5 IMPLEMENTATION MILESTONES TOWARDS ACHIEVING THE INTENDED OUTCOME 
IN THE KiSII-MERLIN INTERVENTION 
............................................................................ 96 FIGURE 2.6 IMPLEMENTATION MILESTONES TOWARDS ACHIEVING T'HE INTENDED OUTCOMES 
IN THE KWALE-MOH INTERVENTION .......................................................................... 
100 
FIGURE 2.7 SUMMARY OF TIME LINE OF ACTIVITIES ACROSS THE THREE SITES .................... 
102 
FIGURE 2.8: CONCEPTUAL FRAMEWORK FOR ASSESSING PROGRAMME PERFORMANCE ....... 
103 
FIGURE 2.9 GEOGRAPHIC LOCATION OF THE STUDY DISTRICTS IN KENYA ........................... 
106 
FIGURE 2.10 MAP SHOWING GEOGRAPHICAL LOCATION OF SELECTED STUDY SITES IN EACH 
DISTRICT ..................................................................................................................... 
III 
FIGURE 2.11: RESEARCH STRATEGY FOR THE QUALITATIVE AND POLICY ANALYSIS STUDY 119 
FIGURE 3.1: (A-C) MAPS OF STUDY SITES SHOWING GIS DATA ON POPULATION DISTRIBUTION, 
RETAIL OUTLETS, HEALTH FACILITIES AND TRANSPORT NETWORKS ............................ 132 
A) KlAmOKAMA DIVISION OF THE KISII-MERLIN SITE ......................................................... 132 FIGURE 3.2: GRAPH SHOWING UTILIZATION RATES OF RETAIL SECTOR SERVICES FOR 
TREATMENT OF 
............................................................................................................. 137 FEVERS IN THE Kisil-MERLIN SITE 
....................................................................................... 137 FIGURE 3.3 A-C MAPS SHOWING SURFACE POINTS AS INPUTS, THIESSEN POLYGONS AND 
DISTRIBUTION OF UNDER FIVE POPULATION AS OUTPUTS ............................................. 
138 
FIGURE 3.4 DISTRIBUTION OF IEC MATERIALS IN THE INTERVENTION AREAS ..................... 
143 
FIGURE 3.5: IMAGE OF DRUG DOSAGE CHARTS USED IN THE KWALE-MoH SITE ................. 
144 
FIGURE 3-6: IMAGES OF JOB AIDS AND POSTERS USED IN THE KWALE-MoH SITE ................ 
144 
FIGURE 3.7 PROPORTION OF OUTLETS WITH ANTI-MALARIAL MEDICINES THAT STOCKED AQ 
-i. -i .......................................................................................................................... 151 FIG . IMAGES OF COMMON BRANDS OF AQ AND SP MEDICINES ENCOUNTERED 
....... 153 FIGURE 3.9 SOURCES OF AQ MEDICINES ............................................................................. 155 FIGURE 3.10 SOURCES OF SP MEDICINES 
............................................................................ 156 FIGURE 3.11 WHOLESALE AND THE RETAIL PRICES OF SP AND AQ CLASSES OF MEDICINES 157 
FIGURE 4.3 FRAMEWORK FOR SCALING UP INNOVATIONS IN HEALTH SERVICE DELIVERY 
(SIMMONS & SHIFFMAN, 2006) ................................................................................... 192 FIGURE 4.4 SIMPLIFIED FRAMEWORK FOR CONSIDERING DETERMINANTS OF DIFFUSION, 
DISSEMINATION AND IMPLEMENTATION OF INNOVATIONS (GREENHALGH ET AL., 2004) 
-*-*********'***********- .... *"****'***"*****'************'**'********'*"****'*'***********"******'*'**"*' 193 FIGURE 4.3 DISTRICT LEVEL FORCE FIELD ANALYSIS OF THE ACTOR'S INFLUENCE OF THE 
INNOVATION IN THE KiSII-MERLIN SITE 
...................................................................... 216 
11 
FIGURE 4.4 DISTRICT LEVEL FORCE FIELD ANALYSIS OF THE ACTOR'S INFLUENCE OF THE 
INNOVATION DURING THE SET UP PHASE IN THE KWALE-MOH SITE ............................ 
217 
FIGURE 4.5 DISTRICT LEVEL FORCE FIELD ANALYSIS OF THE ACTOR'S INFLUENCE OF 
INNOVATION DURING THE CONTINUATION PHASE OF THE KWALE-MOH SITE .............. 
218 
FIGURE 4.6: DISTRICT LEVEL FORCE FIELD ANALYSIS OF THE ACTOR'S INFLUENCE ON THE 
BUNGomA-AMUF INNOVATION DURING THE SET UP PHASE ..................................... 
219 
FIGURE 4.7 DISTRICT LEVEL FORCE FIELD ANALYSIS OF THE ACTOR'S INFLUENCE IN THE 
BUNGomA-AMUF INNOVATION DURING THE CONTINUATION PHASE ....................... 
220 
FIGURE 4.8 FUNDING MECHANISM OF THE KiSII-MERLIN SITE ............................................ 
228 
FIGURE 4.9 NETWORKS AND ITS CONSEQUENCES IN THE KiSII-MERLIN SITE ....................... 
231 
FIGURE 4.10: MANAGING DRUG POLICY CHANGES IN THE Kisll-MERLIN SITE ..................... 
235 
FIGURE 4.11 FRAMEWORK FOR UNDERSTANDING FACTORS INFLUENCING IMPLEMENTATION 
OF INNOVATION TO INFLUENCE IMPACTS IN THE Kisll-MERLIN SITE ............................ 
238 
FIGURE 4.12: FUNDING PROCESS OF THE BUNGOMA-AMREF SITE ..................................... 
245 
FIGURE 4.13: FUNDING PROCESS OF THE MoH-KWALE SITE ............................................... 
251 
FIGURE 4.14: NETWORKS AND ITS CONSEQUENCES IN THE KWALE-MOH SITE ................... 
252 
FIGURE 4.15: NETWORKS AND ITS CONSEQUENCES IN THE BUNGOMA-AMREF SITE .......... 
253 
FIGURE 4.16: MANAGING DRUG POLICY CHANGES IN THE KWALE-MOH SITE ..................... 
256 
FIGURE 4.17: MANAGING DRUG POLICY CHANGES IN THE BUNGOMA-AMREF SITE ........... 
257 
FIGURE 4.18 FRAMEWORK FOR UNDERSTANDING FACTORS INFLUENCING IMPLEMENTATION 
OF INNOVATION TO INFLUENCE IMPACTS IN THE KWALE-MoH SITE ........................... 
261 
FIGURE 4.19 FRAMEWORK FOR UNDERSTANDING FACTORS UNDERLYING IMPLEMENTATION 
OF INNOVATION TO INFLUENCE IMPACTS IN THE BUNGomA-AMREF INNOVATION .... 
262 
FIGURE 4.20 SUMMARY OF KEY FACTORS ENABLING SUCCESSFUL IMPLEMENTATION OF PMR 
INTERVENTION ............................................................................................................ 
265 
12 
List of acronyms and abbreviations 
AQ Amodiaquine 
AIE Authority to Incur Expenditure 
ACT Arternesinin based Combination Therapy 
ADDO Accredited Drug Dispensing Drug Outlets 
AFRO African Regional Office 
AL Artemether Lumefantrine 
AMREF African Medical Research Foundation 
BDMI Bungoma District Malaria Initiative 
CBO Community Based Organisations 
CBS Central Bureau of Statistics 
CHW Community Health Workers 
CFW Cry for the World Foundation 
CCM Country Coordinating Committee 
CQ Chloroquine 
CDC Centre for Disease Control 
CORPS Community Owned Resource Persons 
CI Confidence Interval 
DDP District Demonstration Programme 
DHMT District Health Management Team 
DHMB District Health Management Board 
DN District Nutritonist 
DVBD Division of Vector Borne Diseases 
DDT Dichloro-Diphenyl-Trichlorocthane 
DoMC Division of Malaria Control 
DFID Department for International Development 
DMOH District Medical Officer of Health 
DPHO District Public Health Officer 
DHEO District Health Education Officer 
EA Enumeration areas 
FGD Focus Group Discussions 
GFTAM Global Fund to Fight AIDS, TB and Malaria 
GLLAMM Generalised Linear Latent and Mixed Model 
GoK Government of Kenya 
GPS Global Positioning Systems 
GIS Geographical Information systems 
HMM Home Management of Malaria 
HIV/AIDS Human Immuno Virus/Acquired Immunity Deficiency Syndrome 
IMCI Integrated Management of Childhood Illnesses 
IEC Information Education and Communication 
ITN Insecticide Treated Nets 
IQR Inter Quartile Range 
ICIPE International Centre for Insect Physiology 
JKJ Jirani Kwa Jirani 
KNMS Kenya National Malaria Strategy 
KES Kenya Shillings 
KEHP Kenya Essential Health Package 
KeNAAM Kenya NGO Alliance Against Malaria 
KEMRI-CGM RC Kenya Medical Research Institute/Centre for Geographic 
Medicine Research Coast 
KPMG Klynveld Peat Marwick and Goerdeler 
KHPF Kenya Health Policy Framework 
13 
LMIC Low and Middle Income Countries 
MDG Millennium Development Goals 
MoH Ministry of Health 
M&E Monitoring and Evaluation 
Mou Memorandum of Understanding 
Merlin Medical Emergency Relief International 
MSW Medical Social Worker 
MRO Medical Records Officer 
NHSSP National Health Sector Strategic Plan 
NMCP National Malaria Control Programme 
NGO Non Governmental Organisations 
OR Odds Ratio 
OTC Over the Counter 
PSI Population Services International 
PHO Public Health Officers 
PHT Public Health Technician 
PC Project Coordinator 
PM Project Manager 
PO Project Officer 
PO-M&E Project officer Monitoring and Evaluation 
PT Pharmaceutical Technologist 
PMR Private Medicine retailers 
PMV Private Medicine Vendors 
QAP Quality Assurance Project 
RBM Roll Back Malaria 
SPO Senior Project Officer 
SP Sulphadoxine-Pyrimethamine 
SSA Sub Saharan Africa 
TB Tuberculosis 
TP Thiessen Polygons 
TBA Traditional Birth Attendants 
TDR Tropical Diseases Research 
UNDP United Nations Development Programme 
UNICEF United Nations Children's Fund 
us United States 
USAID United States Agency for International Development 
USD United States Dollars 
UR Utilisation rate 
VHM Village Health Monitors 
VTV Vendor to Vendor 
WHO World Health Organisation 
14 
CHAPTER 1: 
Introduction and Literature Review 
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1.1 Introduction 
Malaria remains a major public health challenge worldwide with most malaria 
illnesses and deaths caused by the Plasmodiumfalciparum parasite (Greenwood et al., 
2008). Malaria has been estimated to account for 515 (range 300-660) million clinical 
attacks, with about 2.2 billion people exposed to the threat of Plasmodiumfalciparum 
malaria (Snow et al., 2005). Recent estimates using spatial analysis of populations at 
risk indicate similar estimates with 2.37 billion people being at risk of P. falciparum in 
2007.26% live in the World Health Organization (WHO) African region and 62% in 
the combined South East Asia region and Western Pacific region (Guerra et al., 2008). 
The burden of malaria is greatest among children under five and pregnant women. For 
example, in 2000, there were about 116 million malaria episodes in children under five 
years of age, with 545000 children being admitted with severe malaria and 3.6 per 
1000 per annum. episodes of severe malarial anaemia (Roca-Fletrer et al., 2008). 
Against this background, the study described in this thesis set out to evaluate three 
malaria control interventions in Kenya, all based on addressing the role of the private 
retail sector in optimising malaria home care. Based on a conceptual framework drawn 
from the literature on evaluating public health interventions, the study used mixed 
methodologies to evaluate three key areas of programme performance: retailer 
knowledge and practices; programme utilisation and coverage; and implementation 
processes. 
This chapter presents an introduction to this thesis. It begins by describing current 
global malaria control strategies and aims at situating retail sector interventions within 
broader malaria control efforts (section 1.2). Thereafter, drawing on literature reviews, 
the current understanding of care seeking practices for fever and malaria in Sub- 
Saharan Africa (SSA) is presented to illustrate the importance of retail sector in the 
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treatment of fevers and malaria (section 1.3). Based on the evidence from care seeking 
studies, the development of the concept of Home Management of Malaria (HMM) as a 
control strategy is presented in section 1.4. Section 1.5 outlines the objectives of the 
study while section 1.6 provides a description of the conceptual approaches to 
evaluating public health interventions and the way they have been used to inform the 
conceptual framework for this study. This framework is further developed in the 
second half of chapter 2. Section 1.6 also provides background information on the 
methods used in this study. This chapter ends with the aims and scope of the thesis 
(1.7). 
1.2 Malaria control strategies 
1.2.1 Historical overview of global control efforts 
Historically, malaria control efforts have led to success in some parts of the world. For 
example, malaria occurred in the United States (US) and Westem Europe until it was 
eliminated in the US between 1947-1951 due to economic development and public 
health measures (Greenwood et al., 2008). In 1955 the Global Malaria Eradication 
Campaign based on indoor and outdoor spraying with dichloro-diphenyl- 
trichloroethane (DDT) and use of choloroquine (CQ) medicines was launched focusing 
on malarious regions of the world but not the majority of SSA countries (Trigg and 
Kondrachine, 1998). Global eradication efforts were not pursued in SSA countries due 
to transport problems, water shortages, different habits of populations in Africa, lack 
of a well developed public health-oriented infrastructure, the emergence of resistance 
to DDT and CQ, and lack of political will (Trigg and Kondrachine, 1998; Greenwood 
ct al., 2008). The development of primary health care renewed optimism for malaria 
control efforts in the 1980s. But problems of interpretation of the primary health care 
strategy and reluctance to move away from practices used in the eradication era led to 
increased malaria burden in the 1980s and 1990s (Trigg and Kondrachine, 1998). 
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Since the late 1990s, there has been progress on expanded programmes, funding, 
technology and advocacy for malaria (Bates and Herrington, 2007). Coordinated 
malaria control efforts gave rise to initiatives such as Roll Back Malaria (RBM) 
launched by WHO, the United Nations Children's fund (UNICEF) and the United 
Nations Development Fund (UNDP) in 1998 (Teklehaimanot et al., 2001; Bates and 
Herrington, 2007). There has also been increased funding and commitment by 
governments and other private organisations towards malaria and other diseases such 
as Tuberculosis (TB) and Human Immunodeficiency Virus-Acquired Immune 
Deficiency Syndrome (HIV-AIDS). In 2002 the Global Fund to Fight AIDS, TB and 
Malaria (GFTAM) was formed to attract and manage funds for the three diseases 
(Bates and Herrington, 2007; Glass and Fauci, 2007; Snow et al., 2008). Initiatives 
such as the Multilateral Initiative on Malaria started in 1997 have enhanced scientific 
and research capacity for malaria (Teklehaimanot et al., 2001; Glass and Fauci, 2007). 
Other initiatives include the Malaria Vaccine Initiative under the Bill and Melinda 
Gates Foundation, the World Bank's Malaria Global Strategy and Booster programme 
(World Bank, 2007), and the US President's Malaria Initiative, working with the 
United States Agency for International Aid (USAID) and the Centres for Disease 
Control (CDC) among other agencies (President Malaria Initiative, 2008). 
Such a wide range of contributors and efforts has led to recent calls for the re-adoption 
of global eradication of malaria, although this has been presented as a long-term vision 
rather than a near-terni goal (Roberts and Enserink, 2007; Feachem and Sabot, 2008). 
Calls for eradication are partly due to reductions in malaria morbidity and mortality in 
some countries and progress in the development of new drugs (Bhattarai et al., 2007; 
Fegan et al., 2007). Although the debate on its feasibility continues, contemporary 
approaches to malaria control under the RBM initiative remain key to the reduction of 
malaria mortality and morbidity in SSA. 
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1.2.2 Roll Back Malaria initiative 
RBM's global strategic plans 2005-2015 are in line with the Millennium Development 
Goals (MDGs) and continue to guide malaria control efforts in Africa (RBM, 2005). In 
2000 world leaders committed to a global partnership to reduce extreme poverty, 
hunger, disease and lack of adequate shelter, and promote gender equality, education 
and environmental sustainability. They set out a series of time-bound targets known as 
the MDGs with eight goals, 18 targets and a deadline of 2015. The sixth goal focuses 
on control of HIV/AIDS, malaria and other diseases. The target for malaria disease is 
"to have halted by 2015 and begun to reverse the incidence of malaria and other major 
diseases"(http: //www. urunillenniumproject. org/goals/gti. htm). To ensure that MDGs 
related goals are achieved, RBM's strategic plan aims to reduce malaria morbidity and 
mortality by 75% by the year 2015 and ensure universal and equitable coverage of 
effective interventions (RBM, 2005). 
To attain this target, four core strategic approaches have been identified: rapid, 
effective treatment of persons with malaria as close to home as possible within the first 
24 hours of illness onset; increased use of insecticide treated nets (ITNs) to limit 
human-mosquito contact; prevention of malaria in pregnancy; and better epidemic 
preparedness and appropriate response to epidemics (http: //www. rbm. who. int/). The 
first strategic approach is relevant in this thesis since retail sector interventions aim to 
improve case management of malaria and fevers at home as part of HMM strategy. 
Most national malaria control programmes have adopted RBM's strategic approaches 
and developed a plan of action and targets. For example a meeting of African Heads of 
State in 2002 ratified an action-oriented document named the Abuja Declaration which 
set targets to halve malaria mortality for Africa's people by 2010. The leaders resolved 
that by 2005: 
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* 60% of those with malaria have prompt and effective treatment of malaria 
within 24 hours of onset of symptoms 
0 60% of under five and pregnant women have access to protective measures 
such as ITNs 
0 60% of pregnant women at risk of malaria have access to chemoprophylaxis 
(RBM, 2003). 
Although many SSA countries have not attained these targets (Amin et al., 2003; 
Monasch et al., 2004; Nsungwa-Sabiiti et al., 2005; Ahorlu et al., 2006; Oresanya et 
al., 2008), malaria control efforts remain a priority. 
Access to appropriate and effective treatment for malaria in endemic regions remains 
important for positive outcomes since there is evidence that many deaths occur within 
48 hours of onset of illness (Greenwood et al., 1987). Effective case management 
depends on correct diagnosis, prescription and availability of effective treatment (Font 
et al., 2001). However, case management in most SSA countries is characterised by 
several challenges. First, most rural populations in many endemic countries live far 
from health facilities, limiting physical access to treatment (Atting and Egwu, 1991; 
Diop et al., 1998; Baume et al., 2000; Bour, 2003; Dzator and Asafu-Adjaye, 2004; 
Mbagaya et al., 2005). Secondly, health facility level factors such as the availability of 
drugs and equipment, poor staff attitudes, cost and opening hours limit access to 
adequate care (Williams and Jones, 2004). Thirdly, the symptoms of malaria are 
difficult to distinguish from other illnesses or may co-exist with other illnesses 
(Greenwood, 1997; Berkley et al., 1999; Kallander et al., 2004), making it difficult to 
diagnose. Even in cases where diagnostic facilities are available, malaria test results 
are sometimes not used by clinicians. There are also potential inaccuracies of test 
results due to capacity and equipment constraints (Reyburn et al., 2004; Zurovae et al., 
2006; Greenwood et al., 2008). 
20 
A fourth challenge associated with case management is the spread of P. falciparum 
resistance to former first line drugs such as CQ and sulphadoxine-pyrimethamine (SP) 
medicines (White, 2004; Greenwood et al., 2008). This has led to the development and 
deployment of new drugs with emphasis on Artemesinin-based combination therapies 
(ACT) due to their high cure rates, potential to decrease transmission and the limited 
resistance of malaria parasites to these drugs (Greenwood and Mutabingwa, 2002; 
White, 2004; Bosman and Mendis, 2007; Rosenthal, 2008). Although use of ACT is 
likely to reduce the global burden of malaria (Greenwood et al., 2008), deployment, 
access, implementing costs, and rational use of the drug remain a challenge (Malenga 
et al., 2005; Zurovac et al., 2005; Bosman and Mendis, 2007; Gitonga et al., 2008; 
Njau et al., 2008; Wasunna et al., 2008; Zurovac et al., 2008). 
In the light of all these challenges, clinical diagnosis in malaria endemic areas, 
although imprecise, remains the basis of treatment for most febrile patients 
(Wongsrichanalai et al., 2007). International guidelines recommend that fevers in 
children under five years in endemic countries be treated presumptively as malaria 
()WHO, 2000a). The next section reviews the existing evidence on fever and malaria 
treatment practices in SSA, and points to the rationale for developing and 
implementing retail sector interventions. 
1.3 Care seeking for fevers and malaria in Sub-Saharan Africa 
1.3.1 Literature review for care seeking behaviour 
There are two recent systematic reviews that have summarised care seeking for fevers 
and malaria. McCombie's paper, published in 2002, builds on an earlier WHO review 
on malaria care seeking behaviour. This earlier review examined published and 
unpublished literature between 1985 and 1993. It aimed at identifying potential 
determinants of care seeking patterns and assessing what was known about adequacy 
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of the treatments used (McCombie, 1996). The later review updated the evidence to 
April 2002, with a focus on methodological issues around the classification, definition 
and treatment of illnesses (McCombie, 2002). 
The second review used is that by Williams and Jones, published in 2004 (Williams 
and Jones, 2004). This summarised behavioural issue related to malaria control, 
building from McCombie's 1996 review, and attempted to see whether methodological 
rigour had increased or knowledge from the 1996 review had been applied 
programmatically. The review considered both published and unpublished work 
between 1994 to 2002 (Williams and Jones, 2004). 
This section draws on these reviews to illustrate the main features of care seeking 
patterns for fevers and malarial illness in both adults and children, with emphasis on 
the role of the retail sector. In addition to directly reviewing the published articles cited 
in these articles, a separate search was made in PubMed to identify more recent 
relevant publications. Three sets of search words were used: care seeking, malaria or 
fever and Sub-Saharan Africa; treatment seeking, malaria or fever and sub Saharan 
Africa; and self-treatment, malaria or fever and Sub Saharan Africa. The inclusion 
criteria were papers that: describe care seeking patterns qualitatively or 
quantitatively; were conducted in SSA between 1978-2008; reported on childhood 
illnesses/fever, malarial or acute illnesses in adults or children; and were either a 
descriptive study or part of ongoing or planned intervention. 
Before summarising the outcome of this process, limitations, methodological 
challenges and operational definitions of terms are discussed. The review in this 
chapter has two main caveats. First, no grey literature was used to update the published 
reviews. Secondly, research published in other languages other than English were 
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difficult to access and extract information. Methodological challenges included 
differences between studies in the type of questions asked (for example, the use of 
hypothetical versus actual illness episodes), the classification of sources of care, 
analysis and presentation of data. In addition, there were variations in the use of terms 
such as "home" management or self treatment, reported time to treatment, and the 
extent to which switching patterns of care were reported (McCombie, 2002; 
Nyamongo, 2002; Williams and Jones, 2004). These factors made a quantitative 
summary on resort to care difficult to extract. 
In terms of operational definitions, the term "home" in this context is used to refer to 
any action taken without contact with formal health practitioners (government/mission, 
non-governmental organisation (NGOs) or private health facilities). It includes use of 
drugs kept at home (left over medicines from previous episodes), purchase of 
medicines from any kind of medicine sellers, use of herbal remedies and consultation 
with traditional healers. 
There are considerable variations in the type of medicine sellers described in different 
settings and the laws that regulate them, with each country having its own procedures 
and categories of licenses across SSA (Goodman et al., 2007a). Medicine sellers 
operate from specialist drug shops, general retail outlets, kiosks and market stalls, or as 
itinerant hawkers. In some of these situations, they may also sell a variety of other 
household goods (Goodman et al., 2004). Under national legislation, there are 
categories of medicines that can be sold over the counter (OTC) from general outlets, 
and these vary from country to country. OTC medicines often include aspirin, 
paracetamol, cough medicines and, in some countries, anti-malarial medicines. Other 
medicines are restricted to sales with a prescription and are sold through outlets 
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registered as pharmacies. However, PMRs have been reported to sell prescription 
medicines, such as antibiotics (WHO/RBM, 2005; Goodman et al., 2007a). 
Similarly the terms used to describe medicine sellers varies, including drug sellers, 
shopkeepers, chemical sellers or patent medicine vendors (PMVs). An RBM technical 
advisory group recommended use of the term "medicine sellers" to capture the 
disparate groups of providers available in many settings. They used the term "universe 
of private sector provide&' illustrated in figure 1.1 which includes a wide range of 
providers (WHO/RBM, 2005). The group of sellers who commercially retail medicines 
to communities with or without a prescription are referred to as private medicine 
retailers (PMRs) throughout this thesis. 
Figure 1.1 Universe of private medicine sellers; Source: (VMO/RBM, 2005) 
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13.2 Studies reviewed and variables of interest 
From the combination of the search strategy described earlier, III articles and three 
reviews were found relevant. Of these 102 full text articles and 12 abstracts were 
obtained and reviewed. Information extracted included country, location and year of 
24 
study, objectives and design, methods, setting (health facility or community based, 
urban or rural), recall period, type of illness, malaria transmission patterns and age of 
participants. Other variables included the proportion treated through PMRs or health 
facilities, given anti-malarial at home and given adequate malaria medicines by PMRs. 
Relevant data was used to construct table I. I. The table contains 93 studies where 
quanitiatve outcomes of interest as well as qualitative information on care sekeing 
patterns of the above variables were provided. The proportion of illnesses first treated 
through PMRs refers to cases where use of PMR was reported. The proportion treated 
through health facilities includes where the first actions reported were the use of 
public, private, NGO or mission facilities. The proportion using any type of anti- 
malarial medicines at home includes those that were either purchased from PMRs or 
were kept at home, (including drugs sourced from health facilities from previous 
visits). The proportion that used anti-malarial medicines adequately from PMRs 
includes studies that reported use of anti-malarial medicines. Adequacy is based on a 
definition of each study. 
1.3.3 Descriptive summary of the review 
This section describes the geographical distribution, study design, methods, setting, 
transmission patterns, and types of illnesses, recall periods and the age groups included 
for all studies reviewed. The studies represented all the regions of Africa except North 
Africa. Only 16 studies from French speaking countries were reviewed, illustrating a 
potential limitation of generalising findings to the African region. Overall, 52 studies 
were based in West Africa, 48 in East Africa, 10 from South Africa and three from 
Central Africa. One study used demographic health survey data from 23 SSA 
countries. 
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Most studies (99/114) were descriptive cross-sectional surveys. Seven studies were 
longitudinal, three were retrospective, and two used demographic health survey data 
and ethnographic methods, respectively. 67/114 studies used quantitative data 
collection techniques, 12 were qualitative and 29 used both methods. Six studies 
involved blood sampling. Most studies were community based (95/114), 17 were 
based at a health facility while two included both. A majority (77) were conducted in 
rural areas, 15 were urban and another 15 compared urban and rural patterns of care 
seeking. This information was not available in 12 studies. Care seeking studies for 
fever or malaria have been conducted in almost all types of malaria transmission 
settings. Of those that reported transmission settings (62), 23 were conducted in 
endemic areas, nine each in holo-endemic and seasonal transmission areas, six in 
meso-endemic, three in epidemic type settings and four compared areas with different 
transmissions patterns. 
Many studies focussed on febrile illnesses alone or as a proxy for malaria. For those 
that mentioned malaria (3 1), many of them did not define it. 28 studies described care 
seeking for acute illnesses. One study in Tanzania focussed on fatal illnesses (de 
Savigny et al., 2004). In addition to the type of illnesses, studies either reported 
treatment of actual illness or hypothetical situations, or both. For studies that focussed 
on actual episodes, information on recall periods was available in 62 studies. 35/62 
studies used a two week recall period, 12 studies reported a one week period, while 3 
studies reported a three week period. Three studies used three months, five used one 
month while two studies used 6 months and 5 years recall periods, respectively. These 
variations make inferences on the variables of interest difficult. Finally, most studies 
focussed on study participants below five years of age (56/114). 28 studies included 
adults and children, five studies considered pregnant women and four studies 
considered adults only. 
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1.3.4 Use of PMRs for treatment of fevers and malarial illnesses 
The literature on care seeking for fevers and malaria illustrates that the types and 
sources of care available vary between countries and with urban/rural areas. Care 
seeking occurs in a pluralistic health system with complex patterns involved. Both 
quantitative and qualitative evidence exist to show the importance of PMRs as a first 
source of treatment for childhood and adult illness before visiting a health facility, and 
as a major source of anti-malarial medicines (Williams and Jones, 2004). This section 
reviews evidence on patterns of use of PMRs compared to health facilities, reasons 
behind their popularity and the quality of care given. 
Patterns of use of PMRs are drawn from the use of PMRs in table 1.1 and the 
conclusions of the authors in the reviews used. Regardless of type of illnesses, age, 
urban or rural settings or malaria transmission patterns, use of PMRs is common in 
many parts of SSA. The proportion using PMRs before visiting a health facility ranged 
from 4.8% in an area of low transmission in Kenya (Munguti, 1998) to 87.7% in heath 
facility-based survey among children in an endemic area of Nigeria (Ajayi and Falade, 
2006). A high proportion of use (87.3%) was also reported in a field-based survey 
among pregnant women in Uganda (Ndyomugyenyi et al., 1998a). The proportion of 
illnesses treated through PMRs as a first action did not vary with studies conducted 
among children or adults recall periods, health facility or community based surveys. 
However, it appeared to vary with urban or rural settings. Seven studies reported use of 
PMRs in urban areas and 29 in rural settings. One study reported similar proportions of 
use amongst urban and rural residents (Molyneux et al., 1999; Chuma et al., 2006). 
Also one study showed that most poor respondents used PMRs, traditional healers and 
community health workers (CHWs) more often than other treatment options, while the 
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least poor used private clinics (Uzochukwu and Onwujekwe, 2004). But overall, PMRs 
are used by all socio-economic groups. 
Use of PMRs as a source of care is often done promptly after symptoms arc recognised 
(Deming et al., 1989; Molyneux et al., 1999; Amin et al., 2003; Holtz et al., 2003; 
Ahorlu et al., 2006; Gitonga et al., 2008). PMRs are patronised for a variety of reasons 
including physical proximity compared to health facilities (Glik et al., 1989; Yeneah et 
al., 1993; Mwenesi et al., 1995; Baume et al., 2000; Muller et al., 2003). PMRs are 
also used if carers perceive the illness to be less severe or because outlets are thought 
to have a reliable drug supply (Mwenesi et al., 1995; Afolabi ct al., 2004; Ibeh et al., 
2005). Other reasons include their ability to respond to community pressures by selling 
drugs in accordance to clients needs (Okeke et al., 2006), they are friendly, offer credit 
to clients, and are often cheaper than health facilities (Glik et al., 1989). 
Despite their popularity, there are concerns on the quality of care given, especially on 
the type of medicines and the way they are administered. Most studies do not report 
clearly the proportion that obtained anti-malarials from PMRs for fever or malaria 
(McCombie, 2002). For studies that reported types of drugs sourced from PMRs, the 
most frequently reported drugs bought were anti-pyretics (Agyepong, 1992; Snow et 
al., 1992; Agyepong and Manderson, 1994; Slutsker et al., 1994; Mwenesi et al., 1995; 
Baume et al., 2000; Tarimo et al., 2000; Thera et al., 2000; Amin et al., 2003; Ajayi 
and Falade, 2006). Given that many fevers in malarious areas may be due to malaria 
(Kachur et al., 2006), and since WHO recommends presumptive treatment of 
childhood fevers as malaria in endemic settings, this common use of anti-pyretics for 
childhood fevers is likely to contribute to perceived burden of disease. 
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A few studies reporting on the use of anti-malarials purchased from PMRs included 
information on dosage patterns (Krause and Sauerborn, 2000; Them et al., 2000; Holtz 
et al., 2003; Marsh et al., 2004; Ajayi and Falade, 2006; Senbanjo et al., 2006; Abuya 
et al., 2007). From table 1.1 only six studies had information on dosing with anti- 
malarial medicines sourced from PMRs. Measures of adequacy varied between studies, 
influencing interpretation of the summary statistic and making it difficult to compare 
across studies (McCombie, 1996; McCombie, 2002). The highest proportion (61.1%) 
was recorded in a hospital based study in Uganda (Kemble et al., 2006) and the lowest 
(4.9%) in a community survey in Malawi (Holtz et al., 2003). 
In summary, key lessons learned from this review include: 
9 Many fevers are first treated at home with OTC medicines in the majority of 
sites where this has been studied. This occurs in both rural and urban areas, and 
where use of OTC anti-malarials at home is common (Williams and Jones, 
2004). It also illustrates that this occurs in different malaria transmission 
settings. 
* There are numerous descriptive studies on care seeking patterns for fever or 
malaria covering almost all regions of Africa. However, differences in the 
methods used make comparisons across studies difficult. There is therefore 
need for improved methodological rigour, including defining terminologies, to 
allow for cross site comparison (McCombie, 2002; Williams and Jones, 2004). 
e The evidence around the use of PMRs as a source of care generates an 
understanding of the importance of strategies to improve management of fevers 
and malaria at home. 
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The next section describes interventions that sought to address the problems of quality 
of care given for febrile or malarial illnesses at home. 
1.4 Home Management of Malaria 
1.4.1 Historical overview of HMM 
HMM is an integral part of malaria case management within the RBM strategy and 
includes services offered by the community and the formal and informal private health 
sectors. It aims to ensure effective care for non-immune persons such as young 
children (under five years) and pregnant women. It may be applicable to both adults 
and children in low to moderate transmission areas (WHO, 2005a). WHO defines 
HMM, as "... early recognition of and prompt and appropriate response (treatment) to 
malarial illness in children under 5 years of age outside the health facility setting 
within the home or community" 
(http: //www. who. int/malaria/homemanagement. html accessed 24 July 2008). 
The history of HMM can be traced back to recognition of the need for interventions to 
improve care sought outside formal health care settings (section 1.3). Although 
community based approaches to malaria and other illness control existed, renewed 
efforts to fight malaria through community involvement gained momentum in 1997 
through a meeting of Heads of State from the then Organization of African Unity. An 
outcome of this meeting was the formation of Africa Initiative for Malaria in April 
1998, which later merged with the RBM initiative to advance malaria control efforts 
for the African region. 
Meanwhile, in early 2000, a working group in the WHO-African Regional Office 
ki &A fA FRO) was formed to develop strategies for community-based interventions. In April 
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2000, a meeting brought in several WHO-AFRO departments, including RBM, and the 
Integrated Management of Childhood illnesses (IMCI), to develop a framework for 
community based interventions. In August 2000, a draft document on the framework 
was developed (WHO, 2000b). This was followed by two regional workshops, which 
marked the first steps towards scaling up experiences on the role of communities in thp 
implementation of curative and preventive malaria activities. These meetings brought 
together participants working with communities to share experiences and develop 
country specific action plans for the promotion of community-based interventions for 
malaria control. 
In the global arena, RBM continued to develop the HMM strategy. In 2000 WHO set 
up a task force on HMM to make an assessment of priorities and needs, and to update 
the HMM research agenda. The research agenda was presented in the Tropical Disease 
Research (TDR) division of WHO to shape the work plans for 2001 (WHO/TDR, 
2000). Based on these efforts and given the evidence on the importance of the 
approach, a workshop was held in Geneva in 2002 to develop a framework for scaling 
up HMM, and an action plan to support HMM in African countries (WHO, 2004a). In 
2004, a WHO technical team on HMM met in Zimbabwe to develop a generic strategy 
of HMM, defined the key components and set goals and objectives (WHO, 2005a). 
WHO adopted the HMM strategy which was subsequently included in the national 
control strategies of more than 22 African countries (WHO, 2004a; WHO, 2004b; 
WHO, 2005b). The implementation of HMM in Kenya is presented in chapter two. 
1.4.2 Objectives and strategic components of HMM 
The main objective of the HMM strategy is to reduce severe malaria morbidity and 
mortality among children under five. Specifically, the strategy seeks to increase the 
capacity of caregivers to recognize malaria illness promptly and take early appropriate 
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action; to empower service providers by imparting adequate knowledge, skills and 
capacity to respond to malaria illness appropriately; and to create an enabling 
environment for implementation (WHO, 2005a). The strategic components of HMM 
are presented in figure 1.2. National control programmes are encouraged to implement 
HMM as a package to achieve the strategy's main objectives. This thesis aimed to 
contribute to the current understanding of the strategic component that focuses on 
imparting skills and knowledge to PMRs (WHO, 2005a). 
Figure 1.2 Strategic components of HMM (WHO, 2005al 
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1.43 Interventions to improve HMM using PMRs in SSA 
Based on the strategic approaches for HMM (figure 1.2), this section describes 
interventions aimed at improving PMRs knowledge as part of 11MM in SSA (VMO, 
2004a; VMO, 2005a). A recent review on medicine sellers in SSA was used to 
surnmarise existing evidence on these interventions (Goodman et al., 2007a). This 
review was updated by a further search in PubMed using the following search terms: 
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medicine sellers, drug shops, retail sector, chemical sellers, general shops, patent 
medicines vendors, with Sub Saharan Africa and malaria. In addition, websites, of 
organisations included in Goodman's review with projects focusing on PMRs and 
malaria control were accessed for any recent reports on PMR interventions. These sites 
included Population Services International (PSI), the Clinton Foundation, VMO/TDR 
and Cry for the Word Foundation (CFWTm). Other contacts or actors involved in 
developing or supporting HMM initiatives in SSA were also consulted for information 
on ongoing PMR activities. 
From the search strategy, 66 articles were identified. 61 articles had information on 
PMRs describing the role, characteristics of retail sector, regulatory mechanisms, and 
behaviour of PMRs and patterns of use of the sector by community members in 
different geographical settings. Five described PMR interventions in SSA. By 
accessing the websites described above, three reports describing on-going 
interventions were identified. One publication reporting outcomes of PMR 
interventions to improve access to ACT medicines in Tanzania was identified through 
contacts. A summary of these studies is presented in table 1.2. The table was adapted 
from Goodman's review by restructuring and adding one column to describe key 
outcomes and evaluation methods. 
There were 19 interventions identified that aimed to improve treatment of malaria 
through PMRs in SSA. Geographically, five were based in Nigeria, six in Kenya, two 
each in Uganda, Ghana and Tanzania, and one each in Madagascar and Zambia. Some 
studies in Kenya and Uganda were implemented as part of scaling up PMR 
interventions within a national IIMM strategy. The interventions were implemented in 
areas of different malaria transmission areas ranging from holo-endemic, seasonal 
transmission and epidemic type settings, mostly in rural areas. The number and type of 
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PMRs involved in the interventions varied as did their distribution, the size of the 
interventions and their regulatory frameworks. 
1.4.4 Nature of interventions involving PMRs 
All the interventions involved some form of training, demand generation or consumer 
information. Three studies used franchise or accreditation networks, and almost all 
interventions (except one) involved working with existing PMRs (Goodman et al., 
2007a). In addition, all interventions except one (piloting use of ACT in Tanzania), 
involved improving knowledge in the use of SP, CQ or AQ anti-malarial medicines. 
The major intervention components identified were training or capacity building, 
demand generation, quality assurance, and creating an enabling environment 
(Goodman et al., 2007a). Training was through 2 to 4 day participatory workshops or 
peer education at the shop (PSI Nigeria; Health communication project, 2003; Kaona 
and Tuba, 2003; Tavrow et al., 2003). Training content covered malaria causes and 
treatment, drug use, communication, referral, safety, regulatory law, management 
skills, and franchising principles (Goodman et al., 2007a). One intervention in Uganda 
used negotiation sessions to identify achievable behaviour changes targets (Tawfik et 
al., 2006). 
Demand generation was accomplished through mass media or public information 
activities (PSI Madagscar; PSI Nigeria; Muturi, 2001; Brieger et al., 2002; Health 
communication project, 2003; Ndomondo-Sigonda et al., 2003; Tavrow et al., 2003; 
Marsh et al., 2004; ACCESS Programme, 2005). Messages on product information and 
malaria treatment were communicated using channels such as television, radio, mobile 
video units, posters, billboards, leaflets, flyers, point of sale stickers, promotional 
material, and special events (Goodman et al., 2007a). Other projects trained 
community volunteers to promote appropriate medicines and use of trained PMRs 
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(Brieger and Ogulande, 2001; Brieger et al., 2002; Kaona and Tuba, 2003; Tavrow et 
al., 2003; Marsh et al., 2004). Subsidies on pre-packaged anti-malarial drugs were 
promoted in programmes in Tanzania and Nigeria (PSI Madagscar; The steadman 
Group, 2007). 
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Goodman and colleagues (2007) further identify ways in which quality assurance was 
implemented, namely, franchising or accreditation, consumer accountability, engaging 
a medicine seller association, or monitoring and supervision (Goodman et al., 2007a). 
Franchising or accreditation entailed specific recognition of trained outlets through 
painted logos, posters, or stickers that identified them as programme outlets. The 
networks were publicised through identifiable names, brands, and logos. Franchising 
or accreditation was key in three projects, CFWshopSTM in Kenya, ADDOs in 
Tanzania, and CARE shops in Ghana (ACCESS Programme, 2005; Mensah, 2005; 
Ombogo, 2005) and in one study pre-packaged anti-malarial drugs were promoted 
(Greer et al., 2004). 
Finally, only five studies addressed creation of an enabling enviromnent through drug 
policies and regulations (PSI Nigeria; Greer et al., 2004; ACCESS Programme, 2005; 
Mensah, 2005; Tawfik et al., 2006). Interventions which utilised franchising principles 
also provided credit facilities to PMRs (http: //www. cfwshops. org; Ndomondo-Sigonda. 
et al., 2003; Mensah, 2005). In Tanzania the pilot project on improving access of ACT 
worked with the national drug board to deregulate ACT use in the programme areas 
(The steadman Group, 2007). The development of PMR interventions implemented in 
Kenya and those evaluated in this thesis are described in chapter two. 
1.4.5 Impact of interventions on PMR knowledge and practices 
Fourteen PMR interventions were evaluated and documented improvements in 
knowledge and practices of PMRs. Most studies relied on methods such as retail 
audits, exit surveys, surrogate client surveys and in some cases record reviews to 
examine an impact on PMR knowledge or practices. Evaluation designs were generally 
weak, with most relying on pre and post data without a control group (Goodman et al., 
2007a). 
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All the studies evaluated PMR knowledge through a retail audit or by presenting a 
series of test questions to PMRs. There were variations in reported improvements on 
PMRs knowledge. For example, in Nigeria, PMRs' scores in a test of appropriate 
treatment of malaria medicines rose from 46 to 70% (Oshiname and Brieger, 1992). In 
Kenya, by reviewing PMRs records, there was an increase from 0 to 59% of PMRs 
with correct knowledge of CQ (Muturi, 2001). Evaluation of a social marketing 
intervention showed that PMRs receiving job aids from mobile vendors had 
significantly higher knowledge scores than those receiving job aids from wholesale 
attendants (Tavrow et al., 2003). Through test questions, the proportion of franchised 
shops scoring more than 60% in managing simple ailments increased from 35% to 
82% in Ghana (Mensah, 2005). 
Provider practices were evaluated through surrogate client surveys, with all 
interventions reporting improvements in PMR practices. Some studies examined drug 
stocking patterns, while others examined PMR practices while selling medicines 
including asking questions about the user. In Tanzania, following a subsidized ACT 
programme, 55% of all intervention outlets stocked ACTs (The steadman Group, 
2007). In Kenya, the proportion of sellers stocking recommended anti-malarial drugs 
was 62% in outlets that had received job aids compared to 23% in controls (Tavrow et 
al., 2003). In Tanzania, the proportion of drug stores stocking unregistered medicines 
was 2% in accredited stores compared with 10% in controls (ACCESS Programme, 
2005). The proportion of PMRs asking for danger signs (vomiting, diarrhoea and 
difficulty in breathing) while selling medicines was also measured. Although in some 
settings asking for danger signs was higher in intervention outlets compared to controls 
(26% versus 0%) (Marsh et al., 2004), this remained low in other studies (Tavrov et 
al., 2002; Greer et al., 2004). 
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There was an indication of the impact of the intervention on PMRs practices while 
selling anti-malarial medicines. After the intervention, the proportion giving 
appropriate drugs for uncomplicated malaria increased from 2% to 73% in Luwero, 
Uganda (Tawfik et al., 2006). In Kilifi, Kenya, training of PMRs led to significant 
changes in the proportion of OTC anti-malarial drug users receiving an adequate dose 
from 8% to 33% between 1998 and 1999 in the early implementation area and rose to 
64% across the early and late implementation areas with use of SP medicines in 2001 
(Marsh et al., 2004). In Nigeria, the proportion of sellers recommending or giving a 
correct anti-malarial dose also increased from 9% to 53% after training and 
introduction of pre-packed anti-malarial drugs (Greer et al., 2004). 
Studies that evaluated the impact of interventions on educating the community 
demonstrated increase in caregiver knowledge (Goodman et al., 2007a). In Zambia, 
training and community mobilization enabled caretakers to identify simple and severe 
malaria in 32% and 51% respectively (Kaona and Tuba, 2003). Rates of appropriate 
treatment at community level were examined in Kenya and Nigeria (Goodman et al., 
2007a). In rural Nigeria, promotion of pre-packaged anti-malarial drugs through 
community distributors led to an increase in anti-malarial drug use for reported fevers 
from 38% to 50% (Brieger et al., 2002). In Kilifi, Kenya, there was an increase in the 
proportion of shop treated childhood fevers receiving an adequate amount of a 
recommended anti-malarial drug from 2% to 15% within 24 hours after training on CQ 
and to 30% after subsequent training on SP (Marsh et al., 2004). 
1.4.6 Summary of PMR interventions 
In summary, PMR interventions lead to greater knowledge, improved practices of 
PMRs and a higher rate of appropriate treatment of malaria and other childhood 
illnesses among communities (Goodman et al., 2007a). However, most of the PMR 
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interventions were implemented as pilot studies while others were conducted as part of 
scaling up interventions within the national malaria control programmes. There are 
plans to scale up these interventions in some countries using ACT. For example, ACT 
is being introduced in the HMM programme in northern districts of Uganda. A 
community-based trial of ACT is currently on-going in Burkina Faso (Hopkins et al., 
2007). In Kenya, use of ACT is also being piloted with the support of PSI in some 
Kenyan districts (Goodman -personal communication). Overall, there is a push to 
piloting ways of delivering ACTs through global subsidies (Institute of Medicine, 
2004; Gelband and Seiter, 2007). A draft proposal on piloting subsidised ACT delivery 
through PMRs has been approved by the WHO/TDR task force (Affordable 
Medicines-Facility Malaria, 2007). On the basis of this strategy, ACT subsidies have 
been planned or put in practice in 12 countries in SSA and Asia (Sabot et al., 2008). 
On the basis of the existing literature on interventions focussing on increasing 
knowledge of community level providers, several research gaps have been identified 
(figure 1.3). This study aimed to address some of these gaps through a comparative 
analysis of three different PMR programmes in Kenya. Both reviews emphasise an 
underlying theme of limited evidence on use of ACTs and PMRs in the HMM and 
sustainability of the programmes discussed in subsequent paragraphs. 
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Figure 13 Research gaps in studies evaluating HMM using PMRs and other 
community level providers (Goodman et al., 2007a; Hopkins et al., 2007) 
" Limited evidence on the distribution of benefits of interventions across 
socio-economic groups 
" Limited evidence of sustained impact and capacity to operate at scale 
" Need for evaluation of interventions at scale to include indicators 
directly related to health outcomes, costs, cost effectiveness including 
deploying ACTs in HMM 
" Need to assess the impact of widespread presumptive use of ACTs in 
IIMM programmes on the development of drug resistance 
" Limited understanding of the impact of community-bascd treatment on 
malaria-associated morbidity and mortality in different epidemiologic; 
settings, particularly areas with perennial malaria transmission 
" Insufficient evidence on whether any approach of working with PMRs 
is superior in improving malaria treatment 
" Limited evidence for long term resources required to sustain 
supervision required to maintain a comprehensive training programme 
or accreditation network in settings struggling to provide supervision 
to primary health care programmes 
" Need to expand the geographic coverage of existing studies to cover 
wide range of locations and capture potential variations in 
effectiveness across epidemiologic and health system settings and with 
different types of sellers found across Africa 
" Limited evidence on the impact of community level providers such 
CIIWS 
The drug policy changes for first line anti-malarial medicines from CQ to SP and, 
more recently, from SP to ACT has imposed challenges on the implementation of 
PMRs programmes. These changes require that the curriculum for training or messages 
for communication be reviewed, which is costly and confusing to the target audience. 
Since ACT is still a prescription only medicine in many countries, its introduction for 
use as an OTC generates legal bottle necks. In addition, the high cost of ACTs 
disproportionably increases the cost of treating malaria. Other problems include the 
potential for developing parasite resistance especially in settings where indiscriminate 
use is widespread, given the difficulties in diagnosis (Charlwood, 2004; D'Alessandro 
et al., 2005; Goodman et al., 2007b; Hetzel et al., 2007). Use of ACT subsidies in the 
HMM is being piloted with promising impact on costs in Tanzania (Samarasekera, 
2008a). However, concerns over sustainability of such programmes remain. 
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All the evaluations indicate limited evidence around sustainability of the interventions. 
Little consensus exists in the conceptual and operational definition of sustainability 
(DeRoeck, 1998; Shediac-Rizkallah and Bone, 1998). Several terms have been used, 
including "sustainability", "institutionalisation" "incorporation", "integration", and 
"routinization7' (Shediac-Rizkallah and Bone, 1998). Sustainability is defined as the 
ability of interventions to deliver their intended benefits over a long period of time, 
when the donor funding and technical assistance is terminated (DeRoeck, 1998; 
Shediac-Rizkallah and Bone, 1998). The focus of sustainability is continuity of 
programme benefits (Shediac-Rizkallah and Bone, 1998). Institutionalisation is the 
long term viability and integration of a new programme, or the process by which new 
practices become standard activities within an organisation, also called routinization or 
incorporation (Shediac-Rizkallah and Bone, 1998; Swerissen and Crisp, 2004). The 
focus of institutionalisation is persistence of the programme activities themselves 
rather than the benefits. In this context, sustainability encompasses both continuation 
of programme activities as well as potential benefits at end user or organisational level. 
Across all PMRs interventions evaluated, given the short period between 
implementation and evaluation, none of them examined potential sustainability. 
Sustainability is therefore a critical element to consider if long-term benefits of PMRs 
interventions are to be realised. 
1.5 Study Objectives 
The literature that has been discussed so far provides the background to this study by 
describing the development of home management of malaria and the role of PMRs in 
malaria control. In order to address some of the research gaps outlined above this 
section outlines the objective of this study. 
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1.5.1 General objective 
To compare overall performance of three malaria control programmes targeting PMRs 
by addressing impact on PMR knowledge and practices, population coverage and 
utilisation, and implementation processes. 
1.5.2 Speciric objcctives 
1. To determine the impact of the programme on PMR knowledge and practices 
(Chapter three). 
2. To estimate population geographic coverage and utilisation of programme outlets 
(Chapter three). 
3. To examine programme implementation processes and underlying explanatory 
factors (Chapter four). 
In addition to malaria specific programmes presented in section 1.4, there is a wider 
literature on evaluating public health interventions in general that was used to inform 
the evaluation approach used in this thesis. The next section provides an overview of 
approaches to the evaluation of public health interventions and the background to the 
methods used in this study. 
1.6 Evaluation of public health interventions 
This section provides an overview of approaches to evaluating public health 
interventions and how this was used to develop the conceptual framework for this 
study. It begins by describing operational definitions used, background literature on 
quantitative methods used in this study and'the approach to describing programme 
implementation processes. 
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Before examining the evaluation frameworks, a number of operational definitions are 
provided. Evaluation is a process that attempts to determine systematically and 
objectively the relevance, effectiveness and impact of activities in the light of the 
objectives (Last JM, 2001). An intervention comprises a set of actions that aim to bring 
about identifiable outcomes, while a public health intervention occurs when these 
actions are applied to community members with the aim of delivering a health benefit 
to the communities (Rychetnik et al., 2002; Rychetnik et al., 2004). 
There are three primary types of evaluation: process, formative and summative. 
Process evaluation involves the assessment of programme delivery and the context in 
which the programme is being conducted, the resources required and implementation 
process. It is also known as implementation assessment and monitors the activities 
conducted in relation to the proposed scope and timetable of work. Formative 
evaluation refers to the activities undertaken to fine tune programme implementation 
and entails use of data from process evaluation to make necessary adjustments. 
Surnmative evaluation measures the extent to which change occurs, consistent with the 
objectives of the programme. The results are used to make decisions about the value of 
the programme (Habicht et al., 1999; Rychetnik et al., 2004). 
1.6.1 Framework for evaluating public health interventions 
Most public health interventions are complex in that they have a number of 
components which may act both independently and inter-dependently to bring change 
(Campbell et al., 2000; MRC, 2000). A sequential framework for developing and 
evaluating complex interventions has been described. This framework is useful in this 
context since it focuses on both development and evaluation of an intervention (MRC, 
2000). It has distinct phases that parallel drug development stages: 
e Pre-clinical or theoretical stage 
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9 Defining components of intervention (phase 1) 
* Defining intervention design (phase 2) 
e Methodological issues (phase 3) 
9 Promoting effective implementation (phase 4). 
Although the framework is presented in stages, the process is iterative and acts as 
guide to the development or evaluation conducted at any stage of implementation 
(Campbell et al., 2000; MRC, 2000). The pre-clinical or theoretical phase entails 
establishing the theoretical basis for an intervention. This may not be necessary in 
some cases where an intervention is already widely practised or when its mechanisms 
of action are already understood (MRC, 2000). However, a review of the theoretical 
basis for an intervention may lead to changes in the hypothesis, improve specification 
of active components of an intervention (Campbell et al., 2000), and allow for 
potential to generalize outcomes (Bradley et al., 1999). 
The second phase addresses the understanding of how an intervention works (MRC, 
2000). This can be done by providing an impact model of the way that different 
elements inter-relate and lead to the observed effects (Campbell et al., 2000). This may 
provide an understanding of the anticipated or unanticipated outcomes, as illustrated in 
the multi-country IMCI evaluations (Bryce et al., 2005). The third stage is linked to the 
development of an intervention where evidence is gathered around acceptability and 
feasibility of the intervention. This is also called exploratory phase where different 
versions of the intervention may be tested to achieve optimal effectiveness (Campbell 
et al., 2000). 
The fourth stage is the main trial that requires comparison with an appropriate 
alternative using a standard protocol. A randomised controlled trial is considered the 
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gold standard for evaluating health interventions (Eccles et al., 2003). Attention to 
design issues such as sample size, inclusion and exclusion criteria, methods of 
randomisation, appropriate outcome measures and informed consent are essential 
(MRC, 2000). The final stage is long term implementation of the intervention to 
determine whether it can reliably be replicated in uncontrolled settings. Particular 
attention to the rate of uptake, the stability of the intervention, any broadening of 
subject groups and the possible existence of adverse effects is examined (Campbell et 
al., 2000). 
Embedded in the stages outlined above are a number of issues. The progression from 
one stage to another is not linear. Depending on the stage at which the intervention is 
being evaluated, both quantitative and qualitative methods may be necessary for 
defining and measuring outcomes. In addition, examining implementation process and 
context are critical to understanding the outcomes (Hawe et al., 2004). Design issues 
are important in appraising evidence of any evaluation and are described next. 
1.6.2 Evaluation design for public health interventions 
Habicht and colleagues propose an approach to assessing impact, performance and 
explanatory factors for public health interventions, presented in the matrix form in 
figure 1.4 (Habicht et al., 1999). The horizontal axis considers outcomes of interest 
while evaluating the performance of the intervention or its impact on health or 
behavioural indicators. Performance is measured through provision, utilisation and 
coverage. Impact refers to the long-term outcome or the ultimate objective of the 
programme, such as reduction in morbidity or mortality. It may also refer to 
immediate, short-term, or intermediate effects of an intervention which provide 
evidence of progress (Habicht et al., 1999). 
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The vertical axis focuses on the degree of certainty that the observed effects are due to 
the programme implemented, and is divided into adequacy, plausibility and probability 
assessments (Habicht et al., 1999). All types of inference may include impact and 
performance evaluation. If the level of inference needed is adequacy, then a control 
group may be unnecessary, and the results are compared against set criteria (Victora et 
al., 2004). Plausibility assessments, although not randomised, aim to make causal 
statements linking the intervention and measured outcome(s). To do this a control 
group is required. Control groups may be historical, that is, measurements are made 
among target population before and after implementation of the programme. An 
internal control refers to groups that should have received intervention but did not. A 
third category is use of an external control group, which refers to comparisons with 
other geographical areas without the programme. The comparison may be cross 
sectional, where comparisons are made at a single time point, or longitudinal, where 
comparisons are made between intervention and control from beginning to end of the 
cycle. Use of controls strengthens the plausibility of a causative link between 
interventions and outcomes measured by reducing the potential influence of 
confounders (Habicht et al., 1999). 
Probability assessments are based on randomised control trials and aim to reduce 
confounders, bias and chance (Kirkwood et al., 1997; MRC, 2000). Randomisation 
may be done at individual or community level. This becomes the unit of analysis 
depending on the nature of intervention or target group (Rosi et al., 1999). When the 
level of delivery of an intervention is a group of people, or communities in a 
geographic area, then the design is referred to as a cluster randomised design 
(Kirkwood et al., 1997; Eccles et al., 2003). 
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Figure 1.4 Evaluation design issues of public health interventions 
What do you want measure? 
.0 
Type of Performance Impact /Outcome 
evaluation Provision Utilisation Coverage 
/inference 
Adequacy Are Are Is target Were there 
(changes services services population improvements in 
occur) available? being used? being disease 
reached? patternsibehaviours? 
Plausibility Does intervention area appear to perform Are there changes in 
(effect better? health/behaviour that 
above and appear to be 
beyond beneficial to 
external intervention 
influence) compared to control 
group? 
Probability Is intervention better than control group? Are changes in 
(programme behaviour /health 
effect) more beneficial to 
intervention than 
I control group? 
While randomised designs are regarded as the gold standard, they may not be feasible 
for assessing effectiveness of large scale interventions (Black, 1996; Habicht et al., 
1999; Victora et al., 2004). A randomised trial may be inappropriate because the very 
act of random allocation may reduce the effectiveness of the intervention or when 
experiments are impossible due to ethical reasons (Black, 1996; Kirkwood et al., 1997; 
Rosi ct al., 1999; Victora et al., 2004). Randomisation may be unnecessary when the 
effect of an intervention is dramatic and the likelihood of unknown confounding 
factors is so small that they can be ignored. In any case, randomisation is rarely large 
enough to measure accurately infrequent adverse outcomes or prevent rare events, or 
when the outcomes of interest are far in the future and there are practical difficulties in 
maintaining prospective studies. Alternative options have been described as non- 
randomised or quasi-experimental designs. Three common designs are uncontrolled 
57 
before and after studies, controlled before and after studies and time series (Black, 
1996; Kirkwood et al., 1997; Rosi et al., 1999; Eccles et al., 2003). 
Apart from the design issues, the choice of an evaluation design may be influenced by 
the known efficacy of the intervention, the subject area of intervention, timing and the 
cost of evaluation (Habicht et al., 1999). In addition, regardless of the design chosen, 
the implementation processes and the influence of context on the intervention are 
necessary elements to consider while interpreting the outcomes. IMCI studies for 
example, have illustrated the importance of examining implementation process (the 
package of activities conducted) and the context (wider issues around management of 
health systems or geographical features) (Huicho et al., 2005; Victora et al., 2005). 
However, in many studies implementation processes are rarely described, and this may 
limit understanding of the outcome (Bradley et al., 1999). Examining the context of 
implementation may help understand how the interaction between the context and the 
intervention components produce observed outcomes (Bradley et al., 1999; Rychetnik 
et al., 2002). The integration of qualitative and quantitative methods provides plausible 
explanations of the outcomes or may define relevant components at the design stage 
(Bradley et al., 1999; Hawe et al., 2004; Victora et al., 2004). 
The approaches to evaluating public health interventions described in this chapter were 
drawn upon to develop the conceptual framework for this thesis, described in chapter 
2. To evaluate three PMR interventions implemented in Kenya, three main areas were 
examined: implementation process, the impact of intervention on PMR knowledge and 
practices, and coverage and utilisation of the programmes. Quantitative data collection 
methods used in this thesis addressing the impact of the interventions on PMRs' 
knowledge and practice were adapted from those used in previous evaluations (table 
1.2). The next section describes the background literature to these methods. 
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1.63 Retail audit and surrogate client survey 
In a review of methods used to evaluate private sector supply of public health products, 
Conteh and Hanson describe several quantitative methods, such as structured or semi 
structured questionnaires, direct observations, surrogate client surveys, and retail audit 
(Conteh and Hanson, 2003). The last two methods were identified for use in this 
evaluation since they are suitable for assessing the knowledge and practices of 
providers such as PMRs. 
Retail audits originated as methods used by market research firms to establish volumes 
of products, brands and stock levels sold by outlets (Conteh and Hanson, 2003). The 
retail audit has been adapted to establish drugs sold in retail outlets. In this case a 
census is first conducted of all outlets to allow a representative sample to be taken for a 
detailed retail audit. A number of studies have used this method to establish drugs sold 
by PMRs and knowledge gained from interventions (Tavrow et al., 2003; Goodman et 
al., 2004; Greer et al., 2004; Amin, 2005; Samarasekera, 2008a). 
The surrogate client survey is also known as an undercover, mystery shopper or 
simulated client survey. A researcher poses as a client seeking care from a provider 
who is unaware of their identity (Madden et al., 1997). The method offers a chance to 
record actual practice from the client's view in a standardized way (Madden et al., 
1997; Conteh and Hanson, 2003). The approach requires a clear definition of case 
scenarios, adequate recruitment of clients and preparation of field work (Madden et al., 
1997). The method has several limitations. First, standardized scenarios only extract 
information on a small part of a provider's behaviour and give no insight on 
characteristics and motivations of providers. It is also difficult to know whether the 
clients represent typical cases (Madden et al., 1997). A further reservation for this 
approach is the inability to ask providers for consent, which contradicts an important 
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principle of health research (Madden et al., 1997). It has been used to assess PMRS 
behaviour while selling medicines in several evaluations (Tavrow et al., 2003; Greer et 
al., 2004; Marsh et al., 2004; Ministry of Health, 2006; Hetzel et al., 2007; Hetzel et 
al., 2008). 
1.6.4 Assessing coverage and utilisation 
Whilst it is important to assess the extent to which practices are improved by an 
intervention, the overall impact at population level will be affected by programme 
coverage. Assessing coverage is therefore an important element of evaluating the 
performance of an intervention (figure 1.4). Coverage is the extent to which a target 
population in need of programme services is being reached (Habicht et al., 1999). The 
current study utilised geographical information systems (GIS) techniques to assess 
coverage, physical accessibility and the population likely to use PMR interventions. 
The section begins by an overview of the concept of access and its relationship to 
utilisation, with an aim to situate this component of the study in the wider context of 
physical accessibility to health care. It then describes studies that have examined 
physical distance as a barrier to health care and ends with an overview of studies where 
GIS techniques have been used for assessing coverage of malaria interventions in the 
Kenyan context. 
There have been debates around the concept of health care access since the early 1970s 
(Penchansky and Thomas, 1981; Goddard and Smith, 2001; Gulliford et al., 2002). A 
recent framework identifies three dimensions of access: Availability; Affordability and 
Acceptability referred to as the "A-Frame" (Thiede et al., 2007). Availability is also 
referred to as physical access and examines whether or not appropriate health services 
are available in the right place and at the time they are needed. Affordability is viewed 
as financial access and is the degree of fit between cost of utilising services and 
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individuals' ability to pay. Acceptability, sometimes seen as cultural access, is the 
nature of service provision and how this is perceived by individuals and communities 
(Thiede et al., 2007). Access is therefore a multi dimensional concept with the 
fundamental element underlying it being the notion of empowerment to allow 
communities make informed decisions about health service use (Thiede, 2005). 
In this evaluation, the access domain of interest concerned availability. Health service 
is represented by the act of selling anti-malarial medicines by trained PMRs. The 
trained PMRs are considered service providers; the functioning of the retail sector 
represents the system factors while household factors are linked to issues around 
utilisation of PMR services by community members. Since measuring physical access 
formed a component of this study, the next set of paragraphs describes the relationship 
between distance and utilisation of services. 
There is evidence suggesting that increasing distance to health service points acts as a 
hindrance to utilisation of available services (Noor, 2005). Distance has been shown to 
delay access to health service in formal health care settings. For example, in Uganda 
distance to a health facility was a determinant to delivery at home (Amooti-Kagunaa 
and Nuwaha, 2000). In another study, those living within 1-2 km of the health centre in 
Uganda sought treatment within 24 hours compared to those living more than 2 km 
away (Ndyomugyenyi et al., 2007). In Kenya, lack of money for transport contributed 
to delay of mothers from accessing health facilities (Mwenesi et al., 1995). In Ethiopia, 
those further than one hour's walk from the nearest health care facility initiated 
treatment later than those with less than one hour's walk (Deressa et al., 2003a). 
Physical distance has also been shown to decrease attendance rates. For example, in 
Papua New Guinea, distance decreased use of health services both overall and in 
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malaria and acute respiratory infections (Muller et al., 1998). Studies in Zambia, 
Kenya and Nigeria indicated that use of health services either diminished with 
increased distance to where potential users lived or was an impediment to service use 
(Atting and Egwu, 1991; Diop et al., 1998; Baume et al., 2000; Hjortsberg and 
Mwikisa, 2002; Mbagaya et al., 2005). In Ghana, distance had an inverse relationship 
with utilisation of health services (Bour, 2003; Dzator and Asafu-Adjaye, 2004). 
Decreased distance also influences use of preventive services. In Kenya, those living 
near a market centre were likely to use nets purchased from the retail sector (Noor et 
al., 2006b), while use of nets among pregnant women was significantly associated with 
one hour walking distance to clinics (Gikandi et al., 2008). Long distances to health 
facilities also influenced immunisation coverage (Omutanyi and Mwanthi, 2005). In 
Burkina Faso 28% of the total cost was used in transport to and from health facilities 
contributing to increased cost of accessing health care (Saucrborn et al., 1996). In 
Zambia and Ghana lack of transport limited access to malaria treatment from health 
facilities (Williams et al., 1999; Bazzano et al., 2008). The World Bank report also 
shows that affordable access to health services was low contributed largely by long 
distance to service points (World Bank, 2004). 
The relationship between physical accessibility and utilisation is complex. Utilisation 
is influenced by both demand (physical and financial accessibility and socio-cultural 
factors) and supply (price, knowledge of technology and management of efficiency 
factors ) (Ensor and Cooper, 2004). Potential utilisation is used to illustrate the 
relationship between the type and range of services provided by PMRs and the 
community health needs. Physical access is measured by examining distance between 
trained PMRs and clients while taking account transportation options examined using 
GIS techniques. 
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Recent developments of GIS techniques offer a potentially robust way of measuring 
physical access (Thiede et al., 2007). GIS techniques have been used to define health 
worker shortage§ in developed countries (Luo, 2004; Wang and Luo, 2005). In some 
contexts they have been used to assess the impact of health sector reforms on equity 
(Rosero-Bixby, 2004). GIS methods have also been used to understand physical 
accessibility and utility of primary health care facilities in developing countries (Noor 
et al., 2003; Gething et al., 2004; Noor et al., 2006a; Tanser et al., 2006). 
Recent utility of GIS methods in the Kenyan context include use of the geo-space time 
model to monitor health service use over time and predict national out patient 
treatment burden (Gething et al., 2007; Gething et al., 2008). In the context of malaria 
control interventions in Kenya, GIS modelling has been used to assess determinants of 
physical accessibility of ITNs and coverage across social economic groups (Noor et 
al., 2006b; Noor et al., 2007; Gikandi et al., 2008). GIS techniques are used in this 
thesis to estimate the physical distance covered by community members to access 
intervention outlets of three PMR programmes in Kenya. The approach is used to 
model potential utilisation that takes account of physical distance and not other 
parameters relevant to access. 
1.6.5 Assessing implementation process of PMR interventions 
This section examines the approach used in this study to assess the implementation 
process of the programmes evaluated. Theory and empirical work around policy 
processes, mostly from outside the health sector, considers the importance of 
implementation processes and their implications for policy achievements (Hill and 
Hupe, 2002). Going beyond conventional public health understandings, this literature 
sees the implementation process as full of contestation, negotiation and bargaining 
among implementing actors (individuals and organisations), leading to decisions that 
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shape the implementation (Walt and Gilson, 1994). This work indicates that examining 
the interactions between any intervention and implementing actors and context will 
generate a richer understanding of the way that outcomes are achieved or constrained. 
It adds concern for actors and their influence over implementation and a broader 
understanding of context (including, for example, political and institutional influences) 
to existing public health evaluation concerns. Examining implementation using this 
approach enables a deeper understanding of how the intervention works in real life and 
the factors underlying the outcomes observed. 
1.6.5.1 Theoretical concepts and policy analysis frameworks 
In broad tenns, policy analysis seeks to understand and describe processes of policy 
making and implementation, and use this understanding as a basis for 
recommendations on how to strengthen policy development and implementation (Walt, 
1996). This analysis is useful retrospectively or prospectively in various sectors such 
as health, education or trade to understand past or future failures and successes (Buse 
et al., 2005; Walt et al., 2008). Health policy refers to courses of action and inaction 
that affect institutions, organisations, services and funding arrangements of the health 
systems. It is expressed both explicitly, in statements, regulations and laws, and 
implicitly, through people's perceptions, understandings, and practices, which are in 
turn shaped by other factors such as their values, past experiences, and the wider 
context (Buse et al., 2005). 
There are a number of policy analysis conceptual frameworks, some of which help to 
understand and describe the policy process. The stages heuristic framework, divides 
the policy process into four stages; agenda setting (problems reach the attention of 
decision makers), formulation (policies are designed and enacted), implementation 
(governments carry out the policies) and evaluation (their impacts are assessed) (Buse 
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et al., 2005). The policy analysis triangle (figure 1.5), meanwhile, provides a picture of 
the sets of factors that have influence within any process of policy development and 
implementation. It emphasises that these processes are always political and need to 
take account of who (actors) and how (process) decisions are made, what (content) 
decisions are made and under what conditions (context) (Walt, 1994). 
Figure 1.5: Policy analysis triangle: source: (Walt and Gilson, 1994) 
Context 
Content Process 
Actors are central to the policy process and may block or support the process in many 
ways leading to various outcomes. Content is the substance of a particular policy; it is 
the nature and design of the policy. Context refers to systemic factors, political 
economic social or cultural, which may have an effect on policy either directly or 
through their influence over other elements of the triangle. Process refers to the way in 
which policy is initiated, developed, or formulated, negotiated, communicated, 
implemented and evaluated (Buse et al., 2005). As all four elements of the triangle 
interact to shape policy process, there is always a need for an integrated analysis of 
their influence. 
A wider body of policy analysis theory provides conceptual frameworks focussed on 
how all or some of these factors interact in influencing decision making. Policy 
network theory, for example, focuses specifically on systems, interactions and 
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interconnectedness between actors, including processes of shared decision making and 
exchange of resources to achieve goals (Walt et al., 2008). Relevant theory specific to 
implementation broadly encompasses 'top down' theory which is concerned with 
policy being decided at national level with implementation being conducted by 
administrative agencies. Bottom up theory is concerned with administrators and local 
networks shaping implementation (Walt et al., 2008). Innovation theory (Greenhalgh ct 
al., 2004) is a body of work that is coming to be seen as particularly relevant in 
understanding the early stages of implementing new interventions within health 
systems. Innovation theory concerns with how set of behaviours or routines are 
implemented by planned and coordinated actions either passively (diffusion) or 
actively (dissemination) to improve health outcomes. 
1.6.5.2 Policy analysis studies in low and middle income countries 
There is limited empirical evidence from studies that have utilized policy analysis in 
understanding the implementation process in low and middle income countries 
(LMICs). The bulk of the current evidence describes the technical content of policy 
rather than the role of actors, power and processes in implementing policy or the 
context in which decisions are made (Gilson and Raphaely, 2008). A review of health 
policy analysis work in LMICs between 1994-2007 has been conducted (Gilson and 
Raphaely, 2008). Empirical studies conducted in SSA were extracted from their 
review. Since this study addressed implementation of malaria related interventions, 
additional literature describing implementation process of malaria related policies in 
SSA countries were included. The studies are categorised according to the focus of the 
study using the elements of the policy analysis triangle (figure 1.5). 
Some studies primarily examine the implementation process of policies. In Ghana, for 
example, the process of implementing community-based health planning services 
66 
illustrates that policies that require large scale organisational change are complex to 
undertake. This is particularly in settings where internal resources for financing the 
process of change are lacking. For effective outcomes strategies are required to phase 
in changes through discrete components in small units. In addition pilot studies during 
scaling up are important in allowing adaptation to local realities (Nyonator et al., 
2005). 
The influence of context on implementation process has also been studied. In Kenya, a 
description of health sector reforms illustrated how some reforms were implemented 
speedily when research or clear evidence was presented or when political will existed 
(Mwabu, 1995). Another study, examined the means for, and methods of, 
interpretation of the policy context and its influence on implementation process. The 
key contextual factors that influenced implementation were demographic or 
epidemiological changes; processes of social and economic change; economic and 
financial policy; politics and the political regime; and ideology (Collins et al., 1999). 
Other studies have examined both the implementation processes and the role of actors. 
In Kenya, an exploration of the introduction of Malaroneg donation programme from 
inception to national level policy showed the political nature of implementation and 
the influence of national, regional or international actors on the development and 
implementation of the programme (Shretta et al., 2001). Other studies consider how 
the understanding of policy content influences actors and implementation processes. In 
Kenya, Shretta and colleagues reviewed experience on the change in policy from CQ 
to SP in 1998. This study shows the difficulties of using available evidence to change 
drug policy where actors perceptions of the credibility of data differed influencing the 
time taken to implement the new drug policy (Shretta et al., 2000). A recent study on 
the process of implementation of ACT as first line policy in Kenya showed how the 
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understanding of the new policy by international and local actors delayed 
implementation of the new policy. Reasons behind these delays were around lack of 
clarity on sustainable financing for the drug, funding mechanisms, poor dialogue with 
pharmaceutical companies with a national interest in anti-malarial drug supply, single 
sourcing and complex drug ordering, tendering and procurement procedures (Amin et 
al., 2007). Similar experiences in terms of delay and negotiations by different actors on 
the choice of best option for the countries have been described in Sudan and Zambia 
(Malik et al., 2006b; Sipilanyambe et al., 2008). 
A study in South Africa on the development of health care financing highlights the 
importance of actor management strategies by which reform drivers of any policy 
process could create alliances of support to overcome potential opposition to proposed 
policy changes (Thomas and Gilson, 2004). A study in a rural area of KwaZulu Natal 
in South Africa showed that abortion was supported by actors in specific 
circumstances, such as rape or incest, due to a perception that a child bom of rape 
would be seen as unwanted child. This illustrates the way that community norms can 
influence actors' implementation of a policy (Harrison et al., 2000). Other studies have 
shown how a policy is shaped by actors' views and values and the role of front line 
actors in implementation (Seidel et al., 2000; Kaler and Watkins, 2001; Walker and 
Gilson, 2004). 
The interaction between the role of actors, context and implementation process has 
also been studied. In a study that examined reasons behind the slow implementation of 
H1V/AIDS programmes in the first four years in South Africa, authors illustrate the 
role of political context in shaping the development of the AIDS policy (Schneider and 
Stein, 2001). The initial policy-making and mobilisation of resources were relatively 
straightforward but the implementation process was challenged by actors' lack of deep 
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understanding of the transitional political environment, changes in health system 
management, funding mechanisms appropriate leadership in facilitating the response to 
AIDS (Schneider and Stein, 2001). 
In Kenya, health sector reforms at the district level indicated that the process was 
based on several assumptions but the realities presented by the market orientation of 
the health system and poor governance of the political system led to failure to improve 
health (Oyaya and Rifkin, 2003). In Uganda, authors used theory to deepen their 
understanding of implementation processes during a change in information systems 
from a centralized to a district focussed system. The main challenges were a lack of 
clarity on the role of medical records officers and the structure within district 
constraining implementation (Gladwin et al., 2003). In Ghana, a qualitative analysis of 
the implementation process of an integrated policy on sexually transmitted infections 
and family planning was done to ascertain how sensitive the policy was to existing 
contexts and procedures. The study illustrated the way that implementation is 
influenced by local service contexts, economic and epidemiological factors, and socio- 
cultural attitudes and behaviours (Mayhew, 2000). In Tanzania, actors' role in the 
implementation of a new anti-malarial treatment policy (from SP to ACT) was 
examined to show the way that good intentions can be shaped by actors' role in 
implementation, leading to new practices that are different to those intended 
(Mwisongo, 2007). 
In summary, empirical evidence from the policy analysis literature highlights the 
complexity of implementation and that actors are central to these processes. This study 
utilises policy analysis understanding, and specifically innovation theory, to examine 
the implementation processes of three different PMR interventions. This component of 
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the study focuses on the role of actors, the policy-context interaction, the early 
implementation process and its relationships to the outcomes. 
1.7 Scope and role of thesis 
This thesis includes a series of inter-related studies measuring the performance and 
outcome of different PMR programmes aiming to improve IIMM in Kenya. As 
described, the study set out to address several gaps outlined in section 1.4. They 
included providing evidence of an impact of PMR programmes at scale and in different 
geographic locations, where the latter aimed to capture variations in effectiveness 
across different epidemiologic and health system settings and with different types of 
sellers. The study through assessing the implementation processes hoped to provide 
finiher evidence on the role of PMRs in malaria control and continue to inform policy 
for this sector by assessing the relative advantages of different programmatic 
approaches implemented in Kenya. Findings of this research may support national 
strategic planning for involving the retailers in malaria control and assist the Division 
of Malaria Control (DoMC) in monitoring and evaluating current and planned PMR 
programmes. 
This thesis is structured around five chapters. The current chapter has provided a 
review of literature relevant to this thesis and forms the introduction to the study. 
Chapter two describes the context for the thesis by describing the geographical 
location of Kenya, the organisational structure of the Kenyan health care system and 
the development of PMR interventions implemented. An overview of the retail sector 
programmes evaluated in this study is described in addition to the conceptual 
framework and the study methods. Chapter 3 presents results of the quantitative impact 
of the interventions on PMR knowledge and practices, and the estimation of 
population geographic coverage and utilisation of the programme. Chapter 4 utilises 
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health policy analysis methods to examine the factors influencing programme 
implementation and its performance. Chapter 5 pulls together a discussion on policy 
implications of this study by drawing both generic and specific lessons learnt from this 
evaluation, and provides the conclusion of the study. 
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Chapter 2: 
The Kenyan health system, background 
to thesis and study methods 
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2.1 Introduction 
The chapter lays out the country context for the thesis and provides a description of the 
conceptual framework and methodologies used in the study. It begins with a 
description of the geographical location of Kenya and describes the organisational. 
structure of the Kenyan health care system and broader health policy environment. It 
provides an overview of malaria control efforts in Kenya including the development of 
the Kenya National Malaria Strategy (KNMS), and presents the framework for the 
development of HMM and the retail sector interventions implemented in Kenya. An 
overview of the retail sector programmes evaluated in this study is then described. 
Information on the conceptual framework and the study methods used drawing on the 
literature described in chapter one (section 1.6) is also presented. 
2.2 Geographical location and basic indicators for Kenya 
Kenya is situated in the eastern part of the African continent. Uganda borders it to the 
west, Tanzania to the south, Ethiopia to the north, Sudan to the northwest, Somalia to 
the northeast and the Indian Ocean to the southeast (figure 2.1). The country is almost 
bisected by the equator and lies approximately between latitudes 5000'N and 4040'S, 
and between longitudes 33083'E and 41076'E. Kenya has five administrative levels for 
purposes of governance and resource allocation. The first level is the province, of 
which there are eight: Nairobi, Central, Coast, Eastern, North Eastern, Nyanza, Rift 
Valley and Western. The provinces are ftulher sub-divided into districts, the second 
administrative level. Districts are sub-divided into divisions, divisions into locations, 
and locations into sub-locations (third, fourth and fifth levels, respectively). 
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Figure 2.1: Map of Africa showing the location of Kenya 
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The 1999 National Population and Housing CenSLIS shows that Kenya's population 
was approximately 29 million people, concentrated along a corridor through the 
highlands, around Lake Victoria and along the Coast. Kenya's population is generallý 
young with 44% of Kenyans aged below 15 years. Those between 15 and 64 years 
were 52% and those aged 65 years and above were 4% (CBS, 2001). A recent estimate 
of life expectancy at birth is 52.8 years. The Kenya Demographic Health Survey 2003 2 
shows that under five mortality has not improved with I 10 deaths per 1000 live births 
in the period 1993-1997 and 115 deaths per 1000 1 ive births for the period 1998-2003 
(CBS, 2003a). 
2 There are limitations of the survey particularly on sample size with a small number ot'households. selected 
from Northern Kenya due to logistics making the sample less self weighting at national level 
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In terms of economic status, poverty measures have been derived from information on 
household consumption, expenditures on food and non-food items such as health 
transportation and rent through spatial analysis of the 1997 Welfare Monitoring 
surveys and the 1997 population census data. A monetary poverty line was derived 
based on the minimum expenditure required to purchase sufficient food to meet 
minimum nutritional requirements (2,250 calories/ adult/day) and non-food 
requirements. In Kenya, this was estimated at approximately Kenya Shillings (KES) 
1,239 and KES. 2,648 per month for rural and urban households respectively (CBS, 
2003b). Based on this, 54% of rural population live below the poverty line compared 
to 52% in urban areas. The national poverty indices stood at 54% (CBS, 2003b). Table 
2.1 summarises key Kenyan demographic and socio-economic indices. 
Table 2-1 Summary characteristics of the Kenyan demographic indices 
Indicator Value of indicator/units 
Demographics* 
Area 582,646 km2 
Population size (1999) 28,686,607 
Annual population growth rate 2.9% 
Projected population (2006) 35673917 
Population density 1 49 per km' 
Under five population j jý, OL3 3,4 91 
- Projected under five population (2006) 5648449 
Health indices t 
Infant mortality 77 per 1000 live births 
Under five mortality I 15 per 1000 live births 
Matemal mortality _ 0.69/1000 woman years exposure 
Life expectancy at birth 52.8 years 
Poverty indicest 
Percent living below poverty line 54% 
Urban poverty incidence 52% 
Rural poverty incidence 54% 
Literacy rate among men 88.1% 
Literacy rate among women 78.5% 
-Source: popuiation census ot 1999 (cBs, 2uo 1) 
t Source: Kenya Dcmographic and Ilealth Survey(CBS, 2003a) 
: Source: Poverty mapping exercisc(CBS, 2003b) 
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2.3 Kenyan health care system 
2.3.1 Kenyan Health Policy Framework: An overview 
The Ministry of Health (MoH) operates within a policy environment that is subject to 
internal and external influences. A number of key policy documents have shaped the 
Kenyan health policy landscape including the Kenya Health Policy Framework 
(KHPF) of 1994, the National Health Sector Strategic Plan (NHSSP) 1: 1999-2004, the 
NHSSP 11: 2005-2010, the National Social Health Insurance Fund of 2004 and the 
10/20 policy on cost sharing at government health centres and dispensaries (MoH, 
2005a) The history of health sector reform policies can be traced back to 1994 with 
the production of Kenya's Health Sector Policy Framework Paper (GoK, 1994). To 
operationalise this document, the MoH established the Kenya Health Policy 
Framework Implementation Action Plan and the Health Sector Secretariat in 1996. In 
1999, the MoH produced the NHSSP 1: 1999-2004, which covered a wide range of 
areas that needed to be strengthened to deliver better health care to Kenyans. However, 
these plans were not effectively implemented, prompting the development of the 
current second five year Strategic Plan 11 aimed to revitalise the direction of the health 
sector (NHSSP II) (MoH, 2005a). 
2.3.2 Structure of the Kenyan health care system 
The current Kenyan health sector comprises the public sector, with major players being 
the MoH, parastatal organisations, local government and the private sector, (MoH, 
2005b). Health services are provided by a network of over 7,312 facilities 
countrywide, with the public sector accounting for 48% of all facilities (Noor, A. 
personal communication). Figure 2.2 shows the organisational structure of the MoH. 
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In terms of health service provision, services are delivered though facilities at different 
levels (figure 2.3). The national level comprises national referral hospitals, providing 
rehabilitative and therapeutic services. 
Level I 
The provincial level acts as a referral resource for district hospitals, where the former 
provide specialised care. They oversee the implementation of policy at district level, 
maintain quality standards and coordinate health activities. The third level is the 
district hospital, which delivers services and generates their own expenditure plans and 
budget based on guidelines from the headquarters. Facilities at this level are managed 
by the District Health Management Team (DHMTs) and District Health Management 
Board (DHMBs). The fourth level is a health centre, which provides a wide range of 
curative and preventive services. The fifth level is the dispensary, which is meant to be 
the first line of contact with patients but, in some areas, this function falls to the health 
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Figure 2-2 Levels of health care delivery within the Kenya Essential Package for 
Health (KEEP) 
centres. Dispensaries provide a wide range of preventive and curative health services 
(NCAPD, 2004). 
The KEHP represents the integration of all health programmes into a single package 
towards the improvement of health with emphasis on the community level of care. The 
basic preventive and curative services for minor ailments are being addressed through 
the community package and synergise with services provided by NGOs, privately 
owned facilities, community and faith-based organisations (MoH, 2005b). The cuffent 
number of health personnel for Kenya is presented table 2.2. The enrolled nurses are 
the largest group of medical personnel contributing 48.3% of the entire health 
workforce. The health worker: population ratio is lowest for dentists, with one per 42, 
418 Kenyans. The doctor: population ratio stands at I doctor per 7,112 people. 
Table 2-2 Registered medical personnel and provider population ratio for Kenya 
Registered medical 
personnel 
Number of 
providers 
Provider: population 
ratio t 
Doctors 5,016 1: 7,112 
Dentists 841 1: 42,418 
Pharmacists 2,570 1: 13,880 
Pharmacy Technologists 1,620 1: 22,020 
B. Sc Nursing 280 1: 12,7406 
Registered Nurses 10,210 1: 3,494 
Enrolled Nurses 30,562 1: 1,167 
Clinical 0 icers 4,953 1: 7,202 
Public Health Officers 1,314 1: 27,149 
Public Health Technicians 5,861 1: 6,086 
*Number of health service providers was derived from registered medical personnel captured in the health 
information systems, Moll 2005. 
t Ratio calculated on the basis of the 2006 population projection 
2.4 Malaria control efforts in Kenya 
Global malaria control efforts were presented in chapter I section 1.2. In Kenya these 
efforts can be traced back to the colonial period when these were directed from the 
central govenunent. Later policies in the first quarter of the 1900s were a direct 
response to experience and anticipated epidemics (Moll, 1998). In 1926 there was an 
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increase in malaria epidemics, which affected the European highlands and accelerated 
concern for the colonial government to control malaria. Epidemics in the late 1930s 
and early 1940s intensified the need for a nation-wide policy for malaria control 
(MoH, 1998). 
Formal centralised control efforts were established by the creation of the Division of 
Insect-Bome Diseases in 1947. This was responsible for research and control of 
communicable diseases, including malaria. From the 1970s to the 1990s, vector control 
was organiscd through the Division of Vector Borne Diseases (DVBD) and 
administered at district level under the MoH. From the 1980s malaria control began to 
be linked to community-based health care programmes involving CHWs and 
Community Owned Resource Persons (CORPS). Such programmes were linked to the 
primary health care approach established after the 1978 Alma Ata conference (WHO, 
1978). In response there was significant investment in the Bamako Initiative through a 
number of NGOs which supported training of CHWs in Kenya (MoH, 1998). The 
development of guidelines for CHWs and CORPS in 1998 was an important step in the 
recognition of efforts made at community level to fight malaria (Snow et al., 2001). 
The development of a structured system of malaria control began to take shape in 1992 
through the establishment of National Plan of Action for Malaria Control (MoH, 
1998), which saw the establishment of the Malaria Control Unit in 1994 under the 
DVBD. This became the operational arm of the National Malaria Control Programme 
(NMCP) and was later upgraded to the DoMC in 2000 (Snow et al., 200 1). 
2.4.1 Role of DoMC in malaria control 
The DoMC is the operational. ann of the NMCP and is responsible for overseeing the 
implementation of the KNMS. The DoMC has the overall responsibility for planning 
and coordination of inputs and activities for malaria control at all levels. Donors and 
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the Kenyan government finance operational activities of the DoMC. Technical 
activities are supported by inputs of the technical working groups convened when need 
arises and drawing from implementation partners, consortia and advisers such as 
Department for International Development (DFID), WHO/AFRO and the Kenya 
Medical Research Institute (KEMRI). 
Through a consultative process, the DoMC embarked on a process of developing a 
national approach to malaria control that drew on all the existing evidence, experience 
and knowledge (Snow et al., 2001). The KNMS was launched in April 2001 with the 
aim of increasing coverage of specific malarial control interventions and to sustain 
these to 2010 (MoH, 2001). The four strategic approaches were drawn from the RBM 
initiative (chapter one section 1.2.2). These approaches are supported by two 
crosscutting strategies: IEC activities to arm the public with preventative and treatment 
knowledge; and monitoring, evaluation and research to update and inform malaria 
control strategies. For each of the approaches, the KNMS set targets against which 
progress could be assessed. Embedded within the KNMS is the recognition of the role 
of communities and the retail sector in malaria control under the case management 
strategic approach. As described in chapter one, one of the key targets for case 
management is that: "... 60% of fever cases which are treated at home by family 
members or caretakers will be managed appropriately". 
The case management strategy is also linked to the IMCI initiative. IMCI is a global 
strategy developed to reduce mortality among children under five. It aims at improving 
quality of care in first level health facilities through the introduction of standard 
treatment guidelines and training of health workers. Later it evolved into a broader 
strategy consisting of improving case management skills of health workers; improving 
the health system supports required for high quality care for children coming to 
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facilities; and improving household and community practices related to child health 
nutrition and development (Lambrechts et al., 1999). 
The role of retail sector in the management of malaria is tied to the third IMCI 
component which focussed on improving household and community practices related 
to child health nutrition and development (BASICS 11,2001). The programmatic 
elements in the implementation framework include improving partnerships between 
health facilities and communities; increasing appropriate accessible care and 
information from community based providers, including PMRs; and integrated 
promotion of key family practices for child health and nutrition (BASICS 11,2001). 
The role and responsibility of communities in malaria control is well recognised in 
malaria control prograrnmes and community IMCI. Community IMCI initiatives which 
focus on malaria have been variously implemented in Kenya over the last three 
decades. Examples include activities of NGOs such as CARE-Kenya using CHWs in 
Siaya; Aga Khan foundation in Mombasa supporting distribution of bed nets; and Plan 
International using CHWs and TBAs in Kwale (MoH, 1998). In order to harmonise 
such efforts, the KNMS embraced the HMM. One component implemented was PMR 
programmes aiming to optimise the management of fevers treated through the general 
retail shops and chemists. Since 1998 these have included participatory skill-based 
training of PMR in Kilifi; a modified social marketing programme training wholesale 
attendants and mobile vendors to distribute IEC materials to PMRs in the VTV 
programme in Bungoma; and the micro-finance and social franchise programme in 
Kirinaga and Mbeere districts developed by the CFW (Snow et al., 2001). 
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2.4.2 The role of retailer programmes in the HMM in Kenya 
This section describes three main programmes that supported the subsequent 
development of a national strategy for working with PMRs. 
2.4.2.1 The Kilifi shopkeeper training programme 
The Kilifi shopkeeper programme began in 1995 to examine the strategic role that 
shopkeeper training could occupy in malaria control using a main focus of community 
participation. The pilot project began in a rural division of Kilifi district with formative 
research to assess the feasibility and potential impact of training PMRs on anti- 
malarial use. This showed an impact in behaviour of participating PMRs and clients 
(Marsh et al., 1999) and led to a larger trial in 1999 in Kilifi district. The programme 
was developed collaboratively by the KEMRI-Centre for Geographic Medicine 
Research Coast (CGMRC), the Kilifi DHMT and the DoMC (Marsh et al., 2004). The 
main components of the programme were community selection of programme PMRs, 
participatory skill-based training workshops for PMRs, and public information 
activities, including distribution of IEC materials. Overall the study showed a marked 
improvement the use of recommended OTC anti-malarial medicines (chapter I table 
1.2). 
2.4.2.2 The Bungoina-AMREF programme 
The second PMR programme was part of the Bungoma District Malaria Initiative 
(BDMI) supported by USAID and the African Medical Research Foundation 
(AMREF). The BDMI aimed at exploring programmatic options for reducing malaria 
morbidity and mortality among children under the age of five years and pregnant 
women, and to strengthen local capacity to deliver effective and sustainable integrated 
malaria control at the health facility level and a component targeting PMRs (BDMI, 
1999). The PMR programme used the existing drug distribution channels to promote 
83 
better selling practices for anti-malarial medicines and improve the capability of 
mother and other caretakers to manage fever and anaernia at the household level. The 
programme was started in 1999 and involved training wholesale attendants, mobile 
vendors 3 and pharmacy attendants, and the distribution of job aids4 and posters with 
sales OTC anti-malarial medicines to PMRs. Training of distributors included 
information on malaria treatment and prevention, communication skills and use of job 
aids. Early evaluations suggested differences between intervention and control outlets 
six months post implementation. 
The Bungoma-AMREF programme illustrates a social marketing strategy targeting 
wholesaler level. Typically, social marketing is the application of commercial tools 
and concepts of commercial marketing to social health and problems. It intervenes on 
the demand and supply sides of the market to increase coverage. On the demand side 
this is achieved by promotional activities of branded products through price subsidies 
to allow a movement along a certain demand curve. The supply side involves the 
development of a branded product which is either new or competitive, where the 
existing product range is narrow and highly priced. In addition, a distribution chain is 
created or reinforced to ensure availability to meet demand created. Efforts are made to 
expand the distribution chain to lower socio-economic groups (Kikumbih et al., 2005). 
The Bungoma-AMREF programme aimed to increase the supply of anti-malarial 
medicines through strengthening the distribution chain coupled with promotional 
activities using job aids, training of wholesalers and mobile vendors. However, the 
programme did not apply price subsidies or over branding of existing anti-malarial 
products, and involved relatively low levels of mass marketing at the outset. 
3 they sell general wares and medicines to retail outlets using bicycles 
' Visual tools that support providers to offer adequate health care. 
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2.4.23 Cry for the World Foundation programme 
A third programme targeting PMRs was the CFVY' social franchise project funded 
through private subscriptions to CFVi' and locally implemented through the NGO 
Sustainable Healthcare Foundation. The project targeted diseases causing 70-90% 
morbidity in children and their families in Kirinyaga and Mbeere districts of Central 
province. The project drew on micro-enterprise principles to enable existing CHWs to 
own and operate franchised drugs shops. The franchise model included rules that 
CHWs must follow, such as those concerning diagnosis, treatment, and drug handling, 
as a condition of maintaining their business opportunity. CFW"' monitored 
compliance by ensuring that retailer adhered to the franchise rules. Since 2000, the 
network of outlets has more than quadrupled to 54 locations comprising 28 drug 
outlets and 26 private medical clinics. In 2004, the network treated 177,256 patients 
and in 2005, the number of patients was 435,527 
(http: //www. cfwshops. org/overview. html. ). 
2.4.2.4 Assembling experiences of PMR interventions in Kenya 
On the basis of experiences gathered throughout the implementation of these 
programmes, the DoMC held a consultation workshop in May 2001 to combine 
lessons learrit and define common approaches. The workshop involved actors with 
experience in conimunity-based health care prograrnmes such as NGOs, UNICEF, the 
social franchising model of the CFW", the social marketing strategy in Bungoma and 
the Kilifi shopkeeper training programme. The outcome was the formation of two 
working groups, one on legislative issues and the other on strategies for working with 
CORPS and PMRs. Both private and public sector actors were involved in the working 
groups under the auspices of the DoMC. The temporary working group on the 
strategies for working with PMRs and CORPs developed guidelines for the 
implementation of PMR programme at district level in 2002 (Moll, 2003). 
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The involvement of the retail sector in HMM was Ru-ther developed through a series of 
meetings held to facilitate dialogue with the DoMC and WHO in 2001. From these 
meetings the DoMC adopted a generic strategy that included increasing caregiver and 
provider knowledge on the use of OTC anti-malarial medicines through training PMRs 
and communities (MoH, 2003). Following this, an advocacy meeting was held in May 
2002 to induct district level managers on the proposed scaling up process. Scaling up 
was initially planned as a step-wise process starting with five District Demonstration 
Programmes (DDP) to develop capacity in these core districts, gain experience and 
provide evidence of effectiveness. With support from the GFTAM, a training of 
trainers' workshop was held in 2003 to build capacity in the first five districts. The 
KEMRI-CGMRC partnered with the MoH to provide technical implementation 
support and evaluation activities in three of the five districts (Kwale, Busia, and 
Makueni). However, due to pressure to scale up the strategy from international 
initiatives between 2003-2005, over 33 districts obtained funds through the GFTAM to 
implement PMR programmes prior to evaluations being completed for the DDP. 
2.43. Influence of drug policy change in the implementation of HMM in Kenya 
Since the late 1990s the MoH has changed its first line drug for the treatment of 
uncomplicated malaria twice (Shretta et al., 2000; Amin et al., 2007) due to the 
development of parasite resistance to anti-malarial medicines used. The first change 
was in 1998 when SP replaced CQ. In 2004 the policy was changed again from SP to 
ACT. 
The evidence gathered on CQ resistance ignited the process of policy change from CQ 
to SP between 1991 and 1998. Decisions to change were slowed down by confusion on 
what constituted failure, evidence required to change, lack of cost-benefit analysis data 
on the cost of change, and political hurdles. SP was initially a prescription only 
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medicine, and it was not until late 1999 that SP was made an OTC medicine to 
increase accessibility to communities (Shrctta ct al., 2000). Subsequent change in first 
line treatment recommendations from SP to ACT in Kenya in 2004 faced similar 
challenges. The process of change began by establishing evidence for clinical and 
parasitological failure rates in accordance with WHO guidelines (WHO, 1999). A 
number of working groups reviewed this evidence and considered options for change, 
including AQ, combinations of either SP or AQ with artesunate, or AL (Amin et al., 
2007). A number of challenges faced the working group including lack of nationally 
generated evidence and pressure from WHO to consider a specific product, AL. In 
2004, the DoMC recommended a new anti-malarial drug policy to the Kenyan 
Government thus a shift of first line anti-malarial treatment for uncomplicated malaria 
from SP to AL (MoH, 2004). This policy was to be implemented in a phased process 
through experience gained in the public sector, deregulation of ACT status for OTC 
use, and the development of evidence based operational research to maximise its use in 
the retail sector (DoMC, 2006). Despite these announcements, there remained several 
concerns about implementation, around perceived failures in long term predictable 
financing, procurement and supply. The process was also affected by political issues 
raised by the national and international pharmaceutical interests regarding single 
sourcing of AL and regulatory issues concerning widening access to this drug (Amin ct 
al., 2007). The latter was of particular interest in the implementation of the retail sector 
programmes, given the prescription only status of AL. 
Within such an anti-malarial drug policy landscape, programmes involving the retail 
sector met several implementation challenges. The national policy window for scaling 
up PMR programmes in Kenya coincided with the period when SP was losing its 
efficacy. The announcement of the change to ACT as a first line anti-malarial medicine 
in 2004 threw confusion into the scaling up. In view of the failure rates seen for SP in 
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many parts of Kenya, and the lack of alternative available OTC anti-malarial, the 
DoMC identified AQ as the appropriate OTC medicine for first line treatment of 
malaria in the retail sector. The main evaluation of PMR practices in this study was 
based on the use of AQ medicines. It is important to note that although AQ was both 
the second line malaria treatment and officially a prescription only medicine, the drug 
had been available in the retail sector in Kenya for many years in various branded 
forms (DoMC, 2005). 
2.5 Approach to programme evaluation in this thesis 
This thesis aimed to understand how three different PMR initiatives performed and to 
compare the relative advantages of each in terms of their effect on retailer knowledge 
and practices; geographic coverage of and utilisation by populations; and 
implementation processes (section 1.6) This thesis employed quantitative and 
qualitative methods to assess programme performance. It was designed and conducted 
between 2005 and 2006 based on a comparative analysis of the Bungoma-AMREF, the 
Kisii-Merlin and the Kwale-MoH PMR programmes. 
2.5.1 Overview of programmes evaluated 
This section introduces the implementation experiences of the evaluated interventions in 
Bungoma, Kisii and Kwale districts. This description provides background information on 
the key elements of intervention design and the implementation milestones. Across all the 
sites, as outlined in table 2.3, there were five main elements of the intervention, namely 
training, demand creation, accreditation, motivation, monitoring and evaluation, and 
formative research. Although mobile sellers in public health terms are potentially a key 
group of providers, the focus of these interventions was largely to reach non-mobile 
mcdicinc sellcrs in the pcriphery. 
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2.5.1.1 Bungoma-AMREF programme 
The BDMI programme was set up in 1999 following a number of baseline surveys and 
follow up studies conducted in 1998 to inform programme design (figure 2.4). Based 
on these findings, interventions were developed in malaria case management of 
children in health facilities and at community level; management of malaria in 
pregnancy; and use of insecticide treated materials. The VTV strategy was 
implemented as part of community IMCI and funded by the USAID-Quality 
Assurance Project (QAP) through contractual agreements between AMREF and other 
international partners such as CDC and QAP. The implementation process can be 
viewed as having occurred in three main phases: an initial development phase; the first 
implementation phase conducted with donor support from AMREF, funding partners, 
an external technical team and the DHMT; and a subsequent implementation phase 
following donor withdrawal. Following the withdrawal of the main funding agency in 
2002, the implementation process was managed by AMREF and DHMT (phase 3 in 
figure 2.4). The objective of the intervention was to improve the capability of 
caretakers to manage fever and anaernia at the household level through training mobile 
vendors, wholesale, and pharmacy attendants and distributing job aids to PMRs. 
As a social marketing approach, the Bungoma-AMREF intervention targeted the 
whole district, including retail shops, drug shops and private clinics. The key actors 
involved in the intervention at district level were representatives of the funding 
agencies and technical partners, the programme manager (AMREF), and the Moll field 
officers such as public health officers (PHOs), public health technicians (PIlTs)5, 
wholesalers, mobile vendors and PMRs. The training component targeted a range of 
wholesale drug suppliers across the district (mobile drug vendors, general wholesalers 
and suppliers in pharmacies) who were trained to provide information and job aids to 
5 MoH officers who oversee general public health activities 
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PMRs on the use of OTC anti-malarial medicines. This was preceded by training of 
wholesale outlet and pharmacy owners for one day to mobilise their support for the 
programme (Tavrow ct al., 2003). Training was conducted between April and June 
2000 (figure 2.4 phase 1), and included the signs and symptoms of malaria, dangers of 
malaria, prevention and treatment of malaria. 
Initial demand creation was based on the production of IEC materials such as flyers on 
malaria control and treatment. Evaluation conducted at the end of phase I indicated the 
need to strengthen demand creation, and a community based programme called the 
Brani kwa Jirani (JKj) 6 which was introduced in phase 2. The JKJ programme was 
based on a pyramid information dissemination approach. PHTs were trained to pass 
information and IEC materials to community members who would then pass the same 
messages to five neighbours. This process of training five others was to be repeated 
until the entire village was covered. The JKJ component also used song contests to 
encourage people to internalise five key messages on malaria control. In the early 
implementation phase of the programme (2000-2003) 1,400 copies of IEC materials 
were distributed to approximately 500 outlets across the district. 40 mobile vendors, 22 
wholesale pharmacy attendants and II wholesale shops attendants were trained 
(Tavrow et al., 2003). 
Another element of the intervention was accreditation. Accreditation focused on 
voluntary adherence to minimal standards to assure public safety and encourage 
quality service delivery (Smith et al., 2001). Accreditation was broadly meant to 
strengthen demand from community members and encourage PMRs to adhere to 
recommended guidelines of selling anti-malarial medicines. In the Bungoma-AMREF 
site, accreditation was achieved through signing of agreement forms by wholesale and 
Acronym in Kiswahili meaning neighbour to neighbour 
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chemist owners, letters of approval and copies of the official government notice on 
OTC medicines given to mobile vendors by the DHMT. 
The fourth element of the intervention covered strategies to motivate the DHMT teams 
and PMRs to implement the intervention. This was done through financial incentives 
given as routine allowances. A financial per them payment of USD 7.5 7 was given to 
mobile vendors and PHOs and members of DHMT during participation in the 
workshops. In addition, PHOs, mobile vendors or PMRs who performed well in the 
intervention activities were awarded with certificates of recognition during public 
meetings dubbed "Malaria Effective Treatment Nights". Incentives given to all actors 
generated a range of expectations discussed in chapter four (section 4.4). The final 
component was monitoring and evaluation. Attendants and mobile vendors were 
followed up by PHOs, where quizzes were administered and receipts on distributed 
IEC materials were collected. Operational and empirical research was used to inform 
programme planning in the Bungoma-AMREF site. This was conducted at different 
time points and the results were disseminated at district, national and international 
levels (figure 2.4). Details of the implementation processes are discussed in chapter 
four. 
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2.5.1.2 Kisii-Merlin PMR training programme 
Merlin (Medical Emergency Relief International) is a United Kingdom based 
humanitarian organisation providing health care to populations experiencing crisis 
(http: //www. merlin. org. uk/, 2007). The Merlin malaria control programme in Kisii 
Central and Gucha districts aimed at reducing morbidity and mortality associated with 
malaria. This was to be achieved through increasing capacity among formal and 
informal healthcare providers to diagnose and treat malaria according to the MoH 
guidelines. The programme was funded by the Government of Finland through a 
common project with International Centre for Insect Physiology and Ecology (ICIPE) 
and incorporated partners including the MoH, World Vision, PSI and communities. 
The PMR training programme was part of the larger malaria control component of the 
Merlin project. The underlying approach drew on the Kilifi shopkeeper training 
programme. The strategy used behaviour change principles of participatory skill-based 
training, as well as monitoring, supervision and demand creation. The programme 
described in this study began in 2003 in Kisii Central and Gucha districts (figure 2.5). 
At the time of this evaluation, the PMR programme was operationalised by Merlin. 
The key actors involved were the NGO programme manager, two NGO trainers, PHOs 
and PHTs in relevant divisions, PMRs and communities. The programme targeted two 
divisions in each district where Merlin was involved, that is, Mosocho and Kiamokama 
divisons of Kisii Central district and Sameta and Ogembo divisions of Gucha district. 
Activities in the Kisii-Merlin programmes involved direct training of PMRs in 
participatory skill based workshops lasting three days. Recruitment of PMRs was 
based on selection criteria such as remote settings, sale of anti-malarial medicines, 
relative stability and willingness to be trained. The training covered general 
information on malaria treatment and control; signs and symptoms of malaria, 
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including danger signs; communication skills; referral practices; and record keeping. 
Training activities were conducted between November 2005 and January 2006. The 
second element of the intervention was demand creation. Initial plans were to create 
demand through public meetings. Later, several changes were made to inform the 
communities of the innovation through schools, community leaders and churches. An 
additional approach was distribution of T-shirts with messages on fever management 
at comrilunity level. Demand creation was supported by accreditation conducted 
through awarding certificates to PMRs and providing wooden-backed posters to 
display outside trained outlets. These enabled community members to identify which 
outlets had been trained. 
The fourth element of the intervention was motivation. In the Kisii-Merlin site, PMRs 
and members of the DHMT who were involved in the implementation process were 
given allowances during training workshops. Per them allowances approximating USD 
3.7 was given to PMRs, and USD 5.2 for PHOs and DHMT members during 
participation in the workshops. The fifth component of the intervention was 
monitoring and evaluation. Follow up monitoring activities, including checking 
records and administering quizzes were conducted in the majority of outlets. Later, this 
was supplemented with dialogue to solve problems encountered and on site reminders 
to promote sustainability of the new knowledge. The final element of the intervention 
was operational research conducted by the monitoring and evaluation department of 
the local Merlin office to inform future planning for the intervention. Earlier formative 
research had been conducted by ICIPE to help target the intervention to areas most 
affected by malaria. Figure 2.5 summarises the implementation milestones of the Kisii- 
Merlin intervention. 
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2.5.1.3. Kwale-MoH PMR training programme 
Section 2.4.3 outlined the development of the DDP as the first step taken by the DoMC 
towards scaling up the HMM strategy in Kenya in a coordinated manner. The 
implementation was funded by the GFTAM and processed through the normal 
government system under the direction of the DoMC. The KEMRI-CGMRC provided 
technical support for trainers and conducted baseline surveys in 2003 and programme 
evaluations in 2005. The initial districts involved were Kwale, Nandi, Busia, Makueni, 
and Kisii and Gucha. On the basis of the implementation guidelines developed, the 
research team from KEMRI-CGMRC designed evaluation activities in collaboration 
with the DoMC and the DHMT of the three districts (Kwale, Makueni and Busia). Of 
the three districts evaluated in the DDP, quantitative and qualitative data from Kwale 
have been used for the comparative analysis that forms the main premise of this thesis. 
Kwale was chosen as a case study to represent the MoH-led programme for two 
reasons. Firstly, Kwale and Makueni were part of the monitoring and evaluation sites 
for the DoMC for assessing targets set within the KNMS (DoMC, 2002; Noor et al., 
2003). For this reason, data such as geographic positioning of retail outlets and health 
facilities, and community treatment seeking patterns were available for assessing 
coverage and modelling utilisation as part of this study. Of these two districts, Kwale 
was considered more suitable for this evaluation since it experiences a higher malaria 
burden than Makueni and was therefore likely to serve as a better comparator for 
programmes in Bungoma and Kisii. Data from the DDP evaluation in Kwale, Makueni 
and Busia are presented in annex I. 
The Kwale-MoH intervention represents a MoH-led large-scale approach that 
combined PMR workshops and public information activities to address PMR and 
client behaviour. The programme adapted the Kilifi. shopkeeper training approach to 
the constraints of the government health sector. The main objectives were to train 
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PMRs to stock MoH recommended anti-malarials; offer appropriate advice on the 
treatment of simple fevers in children with anti-malarials; and educate community 
members on fever management through public information activities. The programme 
initially targeted two divisions that had been randomised before intervention to 
programme implementation. A further two divisions were similarly allocated to 
control, allowing for the potential implementation in these areas depending on 
outcomes seen. Kinango and Matuga divisions were identified as the first 
implementation sites with Msambweni and Samburu acting as controls. The key actors 
involved were the district public health officer (DPHO), district health education 
officer (DHE08 ), four PHOs in charge of divisions, PMRs, CORPS and community 
members. At the time of this evaluation the intervention was being implemented by the 
DHMT. 
Like the Kisii-Merlin programme, the main component of the intervention involved 
participatory skill-based workshop training of selected PMRs and community 
education activities on malaria treatment and prevention. The selection process was 
similar to the Kisii-Merlin site. The PMR training workshop lasted two days covering: 
signs and symptoms of malaria including danger signs; malaria treatment; 
communication skill and referral of clients to healthy facilities. Prior to PMR training, 
capacity building workshops were held for the district and divisional level actors 
(figure 2.6), as for the Kisii-Merlin programme. 
In the Kwale-MoH site, plans were made to create demand for the programme and 
awareness of malaria treatment through public meetings and distribution of leaflets to 
the communities and PMRs. This involved pre-testing of PMR job aids and 
DPIlO and DHEO coordinate public health activities in districts supervise and regulate sale of food and 
drugs in general shops and chemists. 
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community leaflets which were later produced centrally through the DoMC. As part of 
the process of demand creation as well as accreditation, PMRs were supplied with 
posters to display outside their outlets to help community members identify trained 
outlets. 
PMRs and DHMT members involved in the intervention were given per them 
allowances during training to facilitate attendance and provide motivation. This was 
approximately USD 3.7 given to PMRs for transport and lunch and USD 5.2 for 
DHMT members who participated in the workshops. Other activities such as 
monitoring were also planned. Finally, baseline research was conducted by the 
technical team to guide implementation, such as the development of a database of 
retail outlets selling anti-malarial medicines. The main implementation gaps identified 
and the reasons behind the gaps are discussed in chapter four. Figure 2.6 presents the 
implementation milestones for the Kwale-MoH intervention. 
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Figure 2.7 presents a simplified timeline of the implementation process across all sites. 
The development phase of the Kisii-Merlin and Kwale-MoH programmes coincided 
with a policy window for retail sector interventions in malaria control at international. 
and national level?. However, during the same period (2002-2003), the main funding 
for the Bungoma-AMREF programme was coming to an end. Although the 
development phase for all the programmes took two years, the activities in the 
Bungoma-AMREF sites differed from other sites. The main activity for this site during 
the development phase was baseline formative research while the other two sites 
focussed on training trainers and developing work plans. After implementation, 
Bungoma-AMREF also had two sets of internal evaluations which informed further 
planning. The current evaluation was conducted three years after withdrawal of 
funding. In two sites (Kwale and Kisii), the preparatory phase coincided with the 
period when SP was being withdrawn as the first line OTC medicine, and its successor 
in the private retail sector was not clear. 
'Period where national strategy was being developed 
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2.6 Conceptual framework 
This section lays out the conceptual framework for the study presented in this thesis. It 
outlines the rationale for using this framework, and illustrates the linkages between the 
framework, objectives and indicators for the evaluation. A review of literature (chapter 
one section 1.6) indicated that measures of performance include provision, coverage, 
utilisation and impact (figure 1.4). In addition, implementation processes are necessary 
elements to consider while interpreting and understanding the outcomes. The 
conceptual framework for evaluating these interventions is drawn from that literature 
and covers the measures mentioned above (figure 2.8). 
Figure 2.8: Conceptual framework for assessing programme performance 
Geographical coverage Differences in PMR knowledge 
and utilisation. of and practice in programme and 
programm utlets non programme tlets eo ou 
Overall programme 
performance 
A 
Programme implementation: 
Levels of implementation; Factors 
influencing implementation 
process and outcome 
D 
The framework in figure 2.8 provides a guide to the evaluation as well as linking the 
indicators used in the objectives for this assessment. Overall performance of the 
intervention (Box A) was measured through: an assessment of programme impact on 
retailer knowledge and practices; provision (whether activities were implemented), 
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utilisation (whether trained seller services were used) and coverage (target population 
reached). The impact of the programme at retailer level was assessed by comparisons 
between programme and non-programme outlets (Box B), using quantitative indicators 
to determine the impact on PMR behaviour associated with programme activities. 
Study methods for this assessment were retail audit and surrogate client surveys 
described in section 2.8. In order to assess population coverage of trained PMRs (Box 
Q, quantitative indicators were measured using GIS techniques. Potential utilisation of 
the progrannne outlets (Box Q was modelled by combining mapping data and 
treatment seeking behaviour data from previous surveys (Gitonga et al., 2008). 
Implementation was assessed qualitatively using a health policy analysis framework 
(Box D). 
2.6.1 Indicators for assessing retailer's knowledge and practices 
The indicators outlined below were used to assess the impact of the programmes on 
PMR knowledge and practices, illustrated in Box B, figure 2.8. The primary indicator 
for assessing the impact of programme on PMR knowledge and practice was: 
9 The proportion of sales where anti-malarial medicines are sold accompanied 
with advice in accordance with MoH recommendation 
Secondary indicators were: 
e The proportion of progrwnme outlets that stock MoH recommended anti- 
malarial medicines 
* The proportion of outlets where the main seller understands Moll 
recommendations on anti-malarial medicines and can identify appropriate 
dosages for children. 
The primary and secondary indicators aimed to answer objective I and were derived 
from the retail audit and the surrogate client survey. 
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2.6.2 Indicators for estimating population coverage and utilisation of programme 
As described in chapter one, coverage refers to the extent to which population in need 
of programme services is reached while utilisation is the extent to which the services 
are being used (Habicht et al., 1999; Shengelia et al., 2005). In line with objective two, 
indicators for assessing coverage and utilisation (Box Q were grouped into two sets: 
Firstly, indicators of coverage defined through spatial access to examine the public 
health impact: 
" Proportion of programme outlets per unit administrative area (division) 
" Ratio of outlets with trained PMRs to health facilities per unit programme area 
(division) 
" Retailer-population ratios 
Secondly, indicators of potential utilisation were derived by modelling mapping data 
from previous fever surveys (conducted as part of evaluating RBM targets) to identify: 
e Derived threshold distance (the distance within which most caregivers would 
be likely to access treatment through a given retail outlet) 
*% under five population living within the calculated threshold distance of a 
trained retailer for each specific location 
2.63 Assessing implementation and factors influencing process 
Although achieving stated impacts are the ultimate goals of programmes, tracking the 
process of implementation is key. As a precursor for medium and long term results 
(Bryce et al., 1994), they provide evidence for observed impacts, provide lessons on 
how to adapt programmes in the future and strengthen the internal validity of 
outcomes. The study employed policy analysis technique in understanding the 
implementation process and gaps, and exploring factors influencing practice which had 
a bearing on the outcomes of interest. In this study, the term implementation gap refers 
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to differences between planned and implemented activities. Key sources of data are 
described in section 2.9.3 and have been used to achieve objective three: examining 
programme implementation factors influencing the process. 
2.7 Geographical location and characteristics of study districts 
2.7.1 Bungorna district 
Bungoma is among districts in Western Province lying between longitude 34.38(' and 
35.1 0 east and latitude 0.300 and 0.540 south (figure 2.9). The mean annual rainfall is 
1250-1800 mm and annual temperatures between 21-30T. Malaria transmission 
occurs all year round with higher rates during the rainy seasons. The endemic pattern is 
similar to the lakeside endemic malaria (Snow et al., 2003). 
Figure 2.9 Geographic location of the study districts in Kenya 
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2.7.2 Kisii Central district 
Kisii Central district is within Nyanza province and lies between longitude 34.210 and 
35.30 cast and latitude 0.250 and 0.510 north. The average annual rainfall is 1500 mrn 
with temperatures between 14 -27T (DoMC, 200 1 a). The district is characterised by a 
highland/epidemic type of malaria transmission. This is a feature of malaria in 
highland districts where there is a potential for limited transmission lending itself to an 
overall low disease risk on an average year, with variations in rainfall and ambient 
temperatures between years leading to epidemics (Snow et al., 2003). 
2.7.3 Kwale district 
Kwale district is in the Coast Province between latitude 3.5500 and 4.6670 south and 
longitude 38.4500 and 39.6670 cast. Average annual temperatures range from 24.6 to 
27.5'C with an average annual rainfall of 1,288 mm (DoMC, 2001b). 'Me district has 
coastal endemic malaria transmission with parasite prevalence often exceeding 50% 
with a maximal disease risk period exhibiting stronger seasonality (Snow ct al., 2003). 
A summary of the socio demographics and other health indices for the comparative 
analysis sites are given in table 2.4. 
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Table 24 Demographic, and malariometric indices of the study districts 
Indicator Kwale-MoR Visii-Merlin I Bungoma- 
AMREF 
Demographics* 
Area 8295 km' M2 649 k 
2 2069Km 
Population size (1999) 496133 491786 876491 
Inter-censal population 
growth rate 
2.6% 2.1% 4.3% 
Proj cted population (2006) 595 168 565689 1 1184323 
Population density 60 pers ns iO; T 758 persons/km2 422 persons/km" 
Population under five 85474 75733 167574 
Proiected < five population 102536 87114 226428 
Altitude 
!7 t 0-842 m 1000-1800 m 1200-21 00 m 
Health status indices t 
Infant mortality per 1000 live 
births 
91 90 78 
Under five mortality per 
1000 live births 
149 109 126 
Number of Healthfacilifies 
Hospitals (NGO/MoH) 3 5 4 
Health centres 7 13 7 
Dispensaries 54 39 24 
Private clinics 35 71 24 
_ Maternity & nursing homes _ 7 4 2 
Private hospitals 2 6 0 
Institutional facilities 0 1 0 
Specialised facilities I 1 0 
_ Poverty indices I 
% living below poverty line 1 63% 1 62% 157% 
Malariometric indices 
Malaria risk Endemic coast Highland Lake endemic 
P. fialciparum preýalence § 67.5% 27.56% 55.9% 
Fever prevalence in <5 **-, 43.3% 40.8% 64% 7: 777] 
*Source: 1999 Population and Housing Census, f Source: Kenya Demographic health survey 2003, ý Source: 
Poverty mapping exercise in 2003 and Kenya Demographic health survey 2003, § Source: Malaria A 11as project 
based on a number ofstudies between 1985 to date, ** Source: care-seeking surveys conducted in sentinel Districts 
2002-2005, and other studies conducted in Bungoma. 
2.8 Study design and selection of study sites 
The overall study design for the comparative analysis was based on cross sectional 
surveys conducted in each of the three districts. Impact on PMR knowledge and 
practice (Box B figure 2.8) was assessed through quantitative surveys of programme 
and non-programme outlets in each district. In the Kwale-MoH site, the surveys were 
part of a larger cluster randomised trial comparing intervention and control divisions. 
The other two sites utilised a pragmatic design based on post implementation surveys 
in programme and non-programme areas. Data on population coverage and utilisation 
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(Box Q was based on mapping surveys and drew from existing treatment seeking data 
to model utilisation. Implementation processes were assessed qualitatively using health 
policy analysis (Box D). 
As described earlier, the Kwale-MoH site was part of DDP planned in advance of 
implementation. The study sites were selected randomly before implementation and 
the unit of randornisation were divisions. To minimise bias the DHMT in Kwale 
district identified four divisions they considered similar in socio-economic 
characteristics, malaria burden, malaria control programmes and access to health care 
facilities prior to randomisation. In Kwale, 4 out of 6 divisions; (Matuga and Kinango) 
had been randomly allocated to intervention area (starting 2003), while (Msambweni 
and Samburu) acted as control divisions. 
For Bungoma-AMREF and Kisii-Merlin programmes, the evaluations for all aspects of 
programme performance were designed and conducted post intervention based on 
purposive selection of study sites. This pragmatic design was necessary because the 
current study occurred after implementation and pre-intervention data were not 
available. In order to assess the impact of programme on PMR knowledge and 
practices, the study adopted a non random allocation of one division to intervention 
area and one to control, with matching based on DHMT's local knowledge for 
similarity in geographical features, malariometric indices and other malaria control 
activities. Indicators for Boxes C and D were assessed in intervention areas only. 
The Bungoma-AMREF programme presented unique challenges in identifying 
intervention and control areas because the intervention design targeted outlets in the 
whole district. In order to select the intervention area, a meeting with all active mobile 
vendors identified divisions they frequented most in the last six months. They included 
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Kanduyi, Webuye, Bumula Ndivisi, Chwele and Malakisi divisions. Chwele, Ndivisi 
and Malakisi divisions were excluded due to other retailer training activities that had 
been conducted by AMREF and MoH with GFTAM support. Webuye and Kanduyi 
divisions have a greater urban concentration making it difficult to match a control area 
with similar features. Bumula division was therefore identified as the intervention area. 
To select the control area, a discussion with both the DHMT and AMREF staff led to 
the section of Tongaren division as the control. 
The choice of the intervention area of the Kisii-Merlin was made in consultation with 
Merlin and MoH staff where the trainings had been conducted in the last six months in 
Kisii Central district. Of the two divisions where training had been conducted, 
(Mosocho and Kiamokama), Kiamokama division was selected as the intervention to 
match the only available division (Suneka as the control). Figure 2.10 shows the 
geographical location of the study sites in each district. 
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2.9 Study methods 
2.9.1 Quantitative studies 
A number of methods exist for studying providers (chapter I section 1.6.3). Two main 
methods were used. The retail audit was used to assess the knowledge and specific 
characteristics of both PMRs and their retail outlets. The surrogate client survey 
assessed normal PMR practices. 
2.9.1.1 Sampling for Retail Audit and Surrogate Client Survey 
The study was designed around a null hypothesis which stated that there was no 
difference between programme and non-programme outlets in the proportion of PMR 
who sold MoH recommended anti-malarial medicines in adequate doses for a 
childhood fever. Sample size calculations for the evaluation of PMR practices in all 
three programmes were derived from earlier surveys conducted in 2003 in Kwale, 
Makueni and Busia districts and linked to the primary indicator outlined in section 2.6. 
The study was powered to demonstrate a 20% difference between control and 
intervention outlets at district level from an estimated 5% of control outlets showing 
appropriate practice in surveys of untrained PMR (Abuya et al., 2007). From this 
calculation, observations of 60 anti-malarial sales were required in each group and a 
total of 80 outlets were targeted to allow for data losses. In all the intervention areas, 
the sample frame was a list of all the trained or accessed outletslo. To select a 
comparison group in all the districts, PHOs and local administrators, constructed hand 
drawn maps and listed all retail outlets likely to sell medicines. They were then visited 
to establish whether anti-malarial drugs were stocked and those without anti-malarial 
medicines were excluded from the sampling frame since the intervention outlets were 
selected on the basis of availability of anti-malarial medicines. From this list, a random 
" outicts supplicd with JEC matcrials 112 
selection process was conducted without replacements using STATA version 8 (Stata 
Corp, College Station, Texas, USA. 
2.9.1.2 Planning and preparation of surveys 
Preparation for the survey involved sensitisation and planning meetings with local 
leaders from the study areas. In addition a meeting the District Medical Officer of 
Health (DMOH) was held to introduce planned research activities. In all districts, 
planning also involved recruitment of field workers through an advertisement put up in 
every study division two weeks before the survey. Depending on the geographical 
areas to be covered, 12 to 24 female candidates were selected and an additional six 
candidates for the mapping exercise in each district. Female candidates were preferred 
for the surrogate client survey since care for younger children is predominantly a 
domain of mothers in these settings. All the candidates were trained for three days on 
the study activities, the importance of how to maintain the covert nature of the survey, 
communication skills, and obtaining informed consent. 
2.9.1.3 Surrogate Client Survey method 
As described in chapter one, the surrogate client survey aimed to collect information 
on the behaviour of PMRs while selling OTC anti-malarial medicines. Six female field 
workers per division were trained and visited sampled outlets. They visited outlets 
away from their own homes to avoid recognition by community members. They used a 
standardised scenario, which entailed asking for an anti-malarial medicine for a child. 
If asked, they provided standardised responses to questions about the age of the child 
(three years), the symptoms of the illness (simple fever") and any previous treatment 
11 Defined by the perception of the caregiver and not associated with signs of severity, including diarrhoea 
and vomiting more than three times a day 113 
given (none). Details of the transaction, questions asked and information given were 
entered in a simple questionnaire after leaving the outlet. 
2.9.1.4 Retail audit method 
The survey entailed an audit of outlets to collect information on general characteristics 
of the outlets and PMRs, drugs stocked; retailers' knowledge and reported practices in 
selling and advising on malaria medicines stocked; and their referral practices. In 
contrast to the surrogate client survey, the child in the scenario developed for the retail 
audit was aged 5 years. This difference arose in response to observations during the 
surrogate client survey that PMRs were reluctant to sell anti-malarial medicines to 
children under five. Field workers visited outlets using public transport or by foot in 
their respective divisions. The supervisor met them after every two days to review their 
work. Before each interview, the field workers gave a careful explanation of the 
purpose of the survey and sought verbal consent from the main seller. Any refusals to 
participate were recorded and the reasons for refusal noted. A pre-tested structured 
questionnaire was used to collect the information. This survey was conducted after 
completion of the surrogate client survey. 
2.9.1.5 Generating coordinates for assessing coverage 
In order to map all outlets in the programme areas and generate coordinates for 
modelling and assessing coverage of the programme, field workers were trained on the 
use of the global positioning systems (GPS) hand held receivers (Germin etrex and 
Trimble 12 band GPS units). Mapping was conducted after the surrogate client and 
retail audit surveys. Field workers then conducted a short interview on ownership of 
the outlet and involvement in the retailer programme. Thereafter the field workers took 
three geographical coordinates of the outlet. Each of the readings was taken when the 
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accuracy level was below 20 metres. An average was then taken to generate 
coordinates to mark each outlet. 
2.9.2 Quantitative data management 
2.9.2.1 Storage and analysis of the surrogate client survey and retail audit data 
All the quantitative data from the surrogate client survey and retail audit were checked 
for errors and coded each day. Assessment of adequateness of advice of anti-malarial 
medicines was based on the national malaria control drug charts (annex II). Data were 
double entered using FoxPro Version 6 software (Microsoft Corp, Redmond, USA). 
Verification, cleaning and analysis was conducted using STATA version 8 (Stata 
Corp, College Station, Texas, USA). Analysis within each district was done using chi- 
square tests of association to compare proportions for key outcome indicators. Where 
differences between the control and intervention areas were observed, a logistic 
regression model was conducted to measure the magnitude of effect. 
2.9.2.2 Generating maps 
All the data collected during the mapping exercise was entered in excel sheet (2003) 
and later transferred to GIS software to generate maps. The average coordinates 
calculated in excel were exported to Arcview GIS 3.2 (ESRI Inc., USA). The point 
data was then overlaid with the polygon features of the division surveyed. This helped 
in validating the geo-positioning of the outlets. The outlets were classified in Arcview 
GIS software into trained and non-trained. Maps generated are presented in chapter 
three. 
2.9.2.3 Developing models for assessing utilisation 
This section provides an overview of the model used to derive threshold distances for 
estimating utilisation (mean distance travelled by community members in which 
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utilisation for those outlets begin to decay). The proportion of clients using retail 
outlets for a fever in a particular locality was derived from a previous household 
survey. Using the enumeration area (EAs 12) maps in the programme areas, distance in 
terms of walking time to visit each treatment source for fever was derived using a 
surface model allowing for the terrain. The basic inputs for the model were journey 
time to the nearest retail outlet for fever treatment which was represented by a numeric 
code (I for retail outlets and 2 for other options). The reference table was exported to 
S-Plus for widows 6.1 version (Insightful Corporation, Inc., Basingstoke, Hampshire, 
UK). The script calculated utilisation rate (UR) at each journey-time interval. UR was 
smoothened by taking a moving average window of 50 minutes for each point interval. 
The purpose was to assess the relationship between UR of retail sector users versus all 
other sources outside home. The following mathematical function is the fit onto the 
resulting plot (Noor ct al., 2006a): 
UR a 
exl3[- 
(T 
b 
C) for T>c 
a for T <-- c 
UR = Utilisation rate (between I and 0, arbitrary units); T= Journey time from facility 
of interest (minutes); a= parameter value determining initial constant rate of UR; b= 
parameter value determining rate of decline of UR; c =parameter value determining 
distance at which UR starts to decline which was considered the threshold distance. 
This was derived in terms of walking time later transformed into distance in kilometres 
(km) based on a5 krn per hour for normal walking time. 
Once a threshold distance was derived, an under five population surface model was 
developed using the projected under five population for 2006. In this analysis tbiessen 
polygons (TP) were used to generate the catchment areas for each of the market 
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centres. TP assigned each point of the market centre or village with retail outlets and 
based on straight line distances, (and using the threshold distance), polygon maps of 
retail outlet catchment areas were generated. A polygon in this context is an area of 
influence of each market centre or village points with retail outlets. A population 
surface for children under five covering a grid of 100m by 100m cell generated was 
used to extract the number of children in each polygon. The under five population of 
all EAs falling within the centre's catchment area was summed as the potential users of 
the retail outlets. Copies of all the tools are provided as annex III. 
2.93 Qualitative study and policy analysis 
This study employed a retrospective policy analysis approach to describe 
implementation processes and investigate the factors influencing the outcomes 
observed. As described in chapter one, policy analysis offers frameworks to understand 
implementation process (chapter I section 1.6.5). The policy analysis triangle was used 
to guide areas of investigation. The innovation theory allowed an understanding of 
how specific elements of the policy triangle interacted with each other to influence 
implementation processes and outcomes of interest (chapter four). The analysis of 
context drew on documents describing social demographics, local malariomctric data, 
other malaria control programme activities and perceived contextual features as 
discussed by local actors. Content was examined through interviews with actors, 
review of training manuals, and relevant policy documents plans and budgets. To 
examine the process, a chronology of events was drafted from records and triangulated 
from interviews. In addition, a stakeholder analyses were conducted to deepen 
understanding of implementation process (Varvasovszky and Brugha, 2000). 
A number of data collection methods were employed. These included FGDs, document 
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reviews, in-depth interviews and field diaries. FGDs are an important tool in 
qualitative health research (Kitzinger, 1995; Jones, 2000; MacDougall and Fudge, 
2001; Duggleby, 2005). They were used to explore perceptions and experiences of 
clients and PMRs in the implementation of the programmes. In-depth interviews were 
used to elicit information on key actors' understanding, perspectives and experiences 
with the programme and underlying reasons for the implementation gaps. Use of a 
diary of events and interactions with programme actors kept by the principal 
investigator helped construct a picture of social reality with regard to events (Jones, 
2000). Use of a diary supplemented information from interviews, described 
observations and enhanced reflexivity. Finally, relevant policy documents at district 
level were reviewed to provide data on implementation process. 
All the qualitative data collection tools were developed through preliminary 
discussions with key actors in study sites. Issues around the role of actors, chronology 
of implementation, funding processes and overall implementation experiences were 
then listed and guided the development of policy analysis protocol and tools. The main 
objective of this exercise was to determine factors that explained implementation 
experiences and gaps across study sites. Specifically the qualitative study sought; to 
determine features of expected implementation practice; to examine the actual 
experience of programme implementation and differences with expected practice; to 
explain the differences between the expected and actual practices of programme 
implementation with particular reference to actors and the design of intervention. 
Tools were pre-tested in Kwale district and modified at each site depending on the 
context and programme under assessment. Figure 2.11 is a summary of the overall 
qualitative research strategy. 
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Figure 2.11: Research strategy for the qualitative and policy analysis study 
Meeting relevant DHMT members and programme personnel 
Step 1 to explain research process. Identify available documents for 
I 
review and seek consent for review. 
Step 2 
Document Review 
T-- 
Identify key actors for inclusion in interviews, identify 
issues for clarification, draft process of implementation as 
output, firialise tools and allow continuous exploration of 
Step 3 
issues, prepare for interviews 
collection 
Step 4 
Lri-depth interview FGD with 
with co-trainers (-4C'Iients 
'In-depth interview other 
Step 5 intermediate level programme 
managers 
FGD with In-depth interview 
Retailers with main trainers 
In-depth interview with senior 
district level programme 
manager 
Check for inconsistencies/clarification, follow 
up, transcription, coding, and preliminary 
analysis to feedback for information for 
clarification 
The arrow designates an iterative approach in which data was collected among actors 
2.93.1 Sampling technique for the qualitative study 
Sampling in qualitative studies differs fundamentally from quantitative approaches. 
Sampling focussed on key actors, maximised diversity and provided flexibility needed 
for an iterative process. Purposive sampling (Marshall, 1996), was used to select actors 
who played key roles in the programme. Identification of primary actors such as 
PMRs, clients, trainers and managers was done through document reviews and 
snowballing techniques 13 .A structured tool was used to log all the actors involved, 
their roles in the programme and their current position within the districts. Actors for 
13 asking respondents interviewed who else was involved in the programme and interviewing them 119 
the in-depth interviews were managers at district level, main trainers, implementing 
officers at divisional level and co-trainers responsible for operational ising the 
programme. All programme actors available on site were interviewed. Study 
participants for FGDs were selected purposively in the implementation divisions. They 
included trained PMRs and potential clients from the intervention areas. Sampling for 
FGDs endeavoured to create a homogenous group with similar experiences to facilitate 
free dialogue (MacDougall and Fudge, 2001). Factors such as gender and age were 
considered for clients FGDs. Although these varied between groups, gender was less 
important for the retailers' FGDs than for client groups since the study did not include 
sensitive questions. 
2.93.2 Desk review of programme activity 
A review of documents was done at various time points. A review of global and 
national HMM documents was conducted in the preparatory phase of the study to 
understand the policy framework. Records reviewed include reports of implementation 
activities, work plans, minutes of planning meetings, letters or memos on programme 
implementation, financial returns, and IEC materials produced for each programme. 
Other documents include government reports on poverty levels and demographic 
health data for study districts. Desk review also enabled tool modification, supported 
triangulation of experiences and helped to construct a description of the 
implementation process. 
2.9.3.3 Focus group discussions 
FGDs were conducted with potential clients and PMRs. Participants were recruited by 
local administrative leaders using two criteria. For the client FGD the criteria for 
selection were mothers with children under five and from different the programme 
areas. Trained PMRs were also recruited from programme areas. The number of 
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participants varied in each group across the districts, averaging between 8-12 persons 
per session. All interviews were conducted in convenient venues for the participants. 
Biographical data of all participants were collected to assess homogeneity of the 
groups and examine the relationships between findings and these variables. An attempt 
to capture group interaction was made through recording non-verbal expressions. Two 
research assistants and the principal investigator supported in note taking and logistics. 
Two types of recording were used; written notes and tape recording. Written notes 
were used to provide back up copies in case of mechanical failure or human error and 
to capture of nonverbal cues. All discussions were done in languages understandable to 
the participants and recordings were conducted within the boundaries of confidentiality 
agreed at the time of discussions. The discussions focussed on normal client-PMR 
interactions, views on programme activities, goals, perceived barriers and facilitating 
factors. 
2.9.3.4 Interviews and informal discussions 
The first in-depth interviews were conducted with co-trainers to allow an exploration 
of implementation experiences at the point of delivery. Issues raised were followed up 
during interviews with managers for clarification. Thereafter, district level and 
programme managers were interviewed after conducting FGDs with PMRs (figure 
2.11). All the interviews were held at convenient places for the participants. Invitations 
were made orally through prior contacts with all potential interviewees. Note taking 
was enhanced through use of two note takers who took notes on alternate days or 
times. Field notes were counter checked against tape recorded information 
immediately after each discussion. The focus of the discussion was the role of actors in 
the programme, views on programme goals, implementation experiences and their 
perceptions of factors influencing that process. 
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2.93.5 Use of diaries 
A field dairy was kept by the principal investigator throughout data collection in all the 
districts. This documented data from informal discussions with various actors in the 
study site. Emerging issues and ideas were recorded which enhanced reflexivity. 
Reflexivity refers to the process of examining the social world and how that influences 
interpretation. The researcher takes account of their own beliefs, values, knowledge, 
and biases of data as well as the impact of the researcher on the subject under 
investigation (Cutcliffe, 2003). This supported transparency in the interpretations and 
judgement made. Rigour and reflexivity during data collection was enhanced through 
describing in detail activities for each day and any relevant issues were followed up 
through informal discussions with the key actors. Information in the diaries was also 
used as field memos (information that aided in understating the data) during the 
analysis stage. Table 2.5 surnmarise all interviews held in each site. 
Table 2.5: Types and number of qualitative interviews and discussions 
Data collection 
technique 
Category of 
participants 
Kisii- 
Merlin 
Kwale- 
MoH 
Bungoma - 
AMREF 
In-depth Main trainers 1 2 1 
Interviews Co-trainers 1 4 3 
District level health 
managers 
0 2 2 
Programme I 
Managers 
2, na I 
Total in depth interviews 4 8 7 
Focus group Rural based PMR 2 2 2 
Discussions Urban based PMR 2 2 2 
Rural based clients 2 2 2 
Urban based clients 2 2 2 
Vendors na na 2 
Total FGD s1 81 81 10 
2.9.4 Managing qualitative data 
Qualitative interviews were taped, translated into English, transcribed and typed into 
Microsoft word software. Debriefing sessions were held by the principal investigator 
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and the research team after each interview to provide an overview of issues raised. 
Informal analysis was conducted and summaries of the collected data made after each 
session for clarification or follow up. Tapes and diaries were kept in locked cabinets 
and were only accessible to the research team. Copies of transcribed data were stored 
at the research centre and backed up in the server. 
Qualitative data were stored and managed using Nvivo7 (QSR international). 
Preliminary analysis entailed open coding and progressive categorisation of issues 
based on inductive (where analytical categories were derived gradually from the data) 
and deductive approaches (where ideas from the interview schedule shaped the coding 
scheme) (Pope et al., 2000). These categories (themes) were further modified as more 
issues were examined from the data. Regular consultations were held with other 
members of the research team to enhance reflexivity. Categories derived from the data 
were further analysed through the development of analysis charts, which were guided 
by the policy analysis triangle (Walt and Gilson, 1994). At this stage, triangulation of 
data was enhanced through comparisons of analysis charts within and across sites to 
look for similarities and differences to support identification of key issues around 
implementation processes. Final analysis was organised around a description of the 
implementation process and factors underlying gaps. Validity and rigour was enhanced 
during the interpretative analysis through a series of feedback sessions with members 
of the research team. A range of analyses were prcpared to examine experience within 
and across sites around key issues. This led to a deeper understanding of the complex 
interactions of key explanatory factors which are likely to account for the variation in 
implementation practices and the primary outcome observed across the programmes. 
Two complementary theoretical frameworks were applied which aided in explaining 
implementation experiences and its influence over the quantitative outcomes observed. 
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2.9.5 Ethical considerations 
Informed consent is universally recognized as a central component of ethical conduct 
in research involving people. Informed consent is given when a competent person who 
has received and understood sufficient information voluntarily decides whether or not 
to take part in research (Allmark et al., 2003; Marshall, 2005). Informed consent can 
be obtained in verbal or written form depending on the nature of the study and the 
setting. In this study verbal consent was sought for retail audit and GPS surveys. 
Seeking consent for the surrogate client survey presented a dilemma since this action 
would have been highly likely to undermine the outcomes and the purpose of the study 
(Madden et al., 1997). To strike a balance between the social value of this research in 
assessing provider behaviour and adhering to ethical research principles, an alternative 
approach of consulting with local leaders on the activities to be conducted was used. 
The popularity of the retail sector, concerns of widespread inappropriate practices 
amongst the PMRs, and the lack of alternative methods to assess provider practices 
support the need for including this covert method in the study. The study was also 
reviewed and approved by national scientific steering and ethical review committees. 
For the participant, the main cost associated with participation in the surveys was the 
time spent in interviews. As far as possible, data collection was planned around local 
community timetables and took considerations of events and routine activities. The 
research aim and processes were explained to all participants as appropriate, and their 
informed consent was obtained both for participation and for recording of interviews 
where applicable. 
Protecting the identity of participants at the point of data collection and reporting is an 
important ethical procedure. However, a dilemma recognised in this study is lack of 
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complete anonymity of data especially during reporting given the small number of 
actors being interviewed. Attempts were made to minimise these problems and strike a 
balance between the value of providing information on implementation experiences 
and anonymising participants. During all FGDs, use of number tags in place of names 
was used to ease note taking and to anonymise data at the point of collection and 
reporting when using quotes. Interviewees were also given an option of not using tape 
recorders during interviews or if they did not want their quotes used during reporting. 
Another measure used to maintain anonymity in reporting was the use of broad actor 
groups in relation to quotes, such as 'DHMT members', to indicate the perspective of 
the information without linking to a particular actor. This was important as certain 
information provided was considered sensitive but necessary to illustrate challenges of 
implementation. Copies of the information sheet are attached as annex III. 
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Chapter 3: 
Quantitative Assessment of the Impact of 
PMR Programmes on Retailer Knowledge, 
Practices, Coverage and Potential 
Utilisation 
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3.1 Introduction 
This chapter contributes to the first and second objectives of the thesis. The first 
objective was to determine the effect of programmes on PMR knowledge and practices 
while the second one was to estimate population geographic coverage and utilisation of 
PMR services. It also discusses methodological limitations; assesses the plausibility of 
a causal relationship between the intervention and the outcomes measured in each site; 
and examines the generalisability of these findings to other settings. 
As discussed in chapter two section 2.6, measures of coverage relate to Habicht's 
framework of evaluation of "progranune performance" (Habicht et al., 1999). They are 
examined by the proportion of all outlets in the intervention areas reached by the 
programme and the extent to which programme targets were achieved (the proportion 
of outlets stocking anti-malarials reached by the programme). Measures of coverage 
relates to spatial distribution of outlets in relation to population and transport networks. 
Other non-spatial measures include provider: population ratios, such as trained outlet: 
population ratio; trained outlet: under five population ratio; health facilities: population 
ratio and the number of programme outlets per unit area. The second set of measures 
relate to potential utilisation, including threshold distance and under five population 
within the threshold distance to generate potential users of the programme outlets. 
These data were derived from GPS mapping of all outlets in the intervention areas. 
Objective one focuses on the impact of programme at retail outlet level (chapter two 
figure 2.8 box B). The impact of the programmes was measured using intermediate 
outcomes linked to or reflecting PMR behaviour. They were derived from retail audits 
and surrogate client surveys. These surveys provided two main types of infon-nation. 
Descriptive information about the outlets and PMRs aimed to assess the extent to 
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which comparisons of control and interventions were valid, or other factors 
(confounders or bias) might explain any measured differences; and to indicate the 
generalisability of these findings to other settings. The second category of information 
addressed the impact of programmes by comparing the knowledge and practices of 
PMRs in programme and non programme outlets, and assessing the extent to which 
differences between them could be attributed to the interventions. 
3.2 Measures of coverage and potential utilisation 
3.2.1 Spatial distribution of retail outlets in the three sites 
Following patterns of programme implementation, GPS coordinates for this assessment 
were collected from one division in Kisii Central and Bungoma districts, while in 
Kwale district coordinates were collected from two divisions. Figure 3.1 (a-c) shows 
the spatial distribution of retail outlets and health facilities of the three sites in relation 
to the population densities and transport networks. For each site, the first map shows 
projected population densities for 2006 in each EA. The second map illustrates 
distribution of retail outlets and health facilities, while the third map combines retail 
outlets, health facilities and transport networks in the study divisions. 
From figure 3.1 a and table 3.1, the Kisii-Merlin site had the highest population density 
(757 people/km2), which was more evenly distributed than the other sites. In the 
Bungoma-AMREF site, the population density (508 people/km2) is in between that of 
the other two districts, with the population distribution characterised by pockets of high 
and low densities in different EAs. For the Kwale-MoH site, the population density in 
Matuga (253 people/km2) is much higher than that in Kinango (47 people/kM2) . The 
overall population density for Kwale is lower than that of the other two districts. 
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To assess the overall programme coverage, the second map in figure 3.1 a provides a 
visual illustration of a relatively even distribution of trained outlets in the Kisii-Merlin 
site compared to the other sites. Overall, Kiamokama division of the Kisii-Merlin site 
had the highest coverage of all existing outlets, with 83/306 (27.1%) outlets trained 
(table 3.1). In the Kwale-MoH site, figure 3.1b shows that most of the trained outlets 
were clustered around the coastal strip and major market centres. The programme 
covered 96/679 (14.1%) of all existing outlets across two divisions. There were 
variations in coverage at divisional level with Kinango division covering 18.5% 
compared to 10.5% in Matuga division. However, the overall coverage in the Kwale- 
MoH site was generally similar to the Bungoma-AMREF site. The Bungoma-AMREF 
site (figure 3.1c) had most accessed outlets located along the main road networks 
coinciding with the population distribution patterns of the division. The overall 
programme coverage was 73/437 (16.7%). 
To assess the extent to which the programme targets were achieved, table 3.1 illustrates 
the number of trained outlets with anti-malarial medicines. For the Kisii-Merlin and 
Kwale-MoH sites this was an important recruitment criterion. For the Bungoma- 
AMREF site, the aim was broad outreach by channelling IEC materials through normal 
anti-malarial distributors. Availability of anti-malarial medicines in the programme 
outlets is therefore a measure of how well programmes reached targeted outlets. Table 
3.1 shows that most outlets in each of the sites did not generally stock anti-malarials; 
for example, only 39.4% of all operational outlets in the Kisii-Merlin site stocked anti- 
malarials. There were a relatively high proportion of outlets (56.1%) which stocked 
anti-malarial medicines in the Kwale-MoH site, likely to have been influenced by the 
inclusion of Matuga division which had the highest proportion of outlets with anti- 
malarial medicines (69.4%) compared to other districts, and to the more rural Kwale 
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division of Kinango (44.3%). In the Bungoma-AMREF site, only 37.6% of all outlets 
had anti-malarial medicines. The Kisii-Merlin site reached a higher proportion of 
outlets stocking anti-malarial medicines (69.7%) than other sites. The Kwale-Moll site 
reached 25.3% of outlets stocking anti-malarial medicines. Divisional level analysis 
indicates that Matuga covered 16.7% while of Kinango reached 42.2% of outlets with 
anti-malarial medicines. The Bungoma-AMREF site covered 44.5% of outlets stocking 
anti-malarial medicines. Overall, the Kwale-Moll site had the lowest coverage of 
targeted outlets. 
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Table 3-1 Retail sector service indices across the programme sites 
Characteristics Kisii-Merlin: 
Kiamokama 
division 
Outlets in 331 391 
division 
Open outlets 306/331 387/391 
/all outlets (92.4%) (98.9%) 
Trained 83/306 42/387 
outlets/all open (27.1%) (10.9%) 
outlets* 
Outlets with 119/302 251/387 
anti- (39.4%) (64.9%) 
malarial/open 
outlets f 
Trained 83/119 42/251 
outlets /all (69.7%) (16.7%) 
outlets with 
anti-malarials 
Health facilities ndpopulation ution 
Health facilities 9 4 
Area 161 Km 341 Km2 
Population 121844 86 284 
projections by 
2006§ 
Population 757 T ersons 253 
density Krn person 
Projected under 18226 12781 
f ive 
Under five 29876 8260 
population 
potentially 
reached 
Kwale-MoH 
T-Kin-ango Both 
I il*, lrl-*nn 
I 
divisions 
318 
291/318 
(91.8%) 
54/291 
(18.5%) 
709 
679/709 
(95.8% 
96/679 
(14.1%) 
128/291 
(44.3%) 
379/676 
(56.1%) 
Bungorna- 
AMREF: 
Bumula 
division 
462 
440/462 
(95.2%) 
73/437 
(16.7%) 
164/436 
(37.6%) 
54/128 96/379 73/164 
(42.2%) 
1 
(25.3%) (44.5%) 
486 
1842 Km2 2183 Km2 343 iým 
86405 172689 174321 
47 persons/ 79 persons/ 508 persons/ 
Km 2 Km 2 Km 2 
15897 28678 34123 
39575 47785 29475 
Population service indices 
PMR: 1-368 1: 220 1: 272 1: 243 1: 377 
population 
_ PMR: under 1: 56 1: 33 1: 50 1: 40 1: 74 
five population 
Trained PMR: 1: 219 1: 304 1: 294 1: 299 1: 467 
under five 
population 
_ Health facility: 1: 13538 1: 21571 1: 10800 1: 21608 1: 29053 
population 
Trained PMR: 1: 1007 1: 2054 1: 1600 1: 1798 1: 2387 
population 
Health facility: I 1: 9 1: 9 1: 8 I 1: 12 I 1: 12 
trained PMR 
II 
*training status of three outlets in Bungoma could not be established; f1here were a number of outlets 
where information on anti-malarial medicines in stock could not be established, tAvadability of anti- 
malarial in trained outlets could not be established in 2 outlets in Kisil, and I in Kwale and Bungoma 
districts respective, * §population projectionsfor 2006 are based on the 1999 census 
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3.2.2 Provider-population ratios of retail outlets 
Provider-population ratios reflect the coverage of the programmes in relation to 
population. Population density was presented in figure 3.1 a-c. These maps were used 
to derive the population densities at EA level from which provider-population ratios 
were extmcted. Provider-population ratios are useful for gross comparisons of supply 
between geographic units and guide policy where minimum standards are set for 
identification of underserved areas (Guagliardo et al., 2004). In this context, the under 
five population was the main target population. 
Based on 2006 population projections, the Bungoma-AMREF site was the site with the 
highest under five population (34123) in the three sites, served by 462 outlets (table 
3.1). In the Kwale-MoH site, divisional level analysis indicates that both divisions had 
low target populations (12781 in Matuga and 15897 in Kinango), but, when combined, 
it becomes the site with the second highest target population (28678) served by 709 
outlets. The Kisii-Merlin site had the lowest target population (18226) served by 306 
retail outlets. 
The differences in under five population in the three districts led to variations in 
provider-population ratios. With 83 outlets trained in the Kisii-Merlin site, the site had 
the lowest number of under fives per trained seller (1: 219). The population density of 
Matuga was 253 persons/Km2 compared to 47 persons/ý in Kinango. However, the 
provider population ratios were relatively similar, with Matuga having a ratio of 1: 304 
compared to 1: 294 in Kinango. The Bungoma-AMREF site had the highest number of 
under fives per trained seller (1: 467). 
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3.2.3 Threshold distance for using retail sector services. 
Results in this section were derived from modelling utilisation rates of retail outlets for 
fever treatment against all other treatment sources. Utilisation enabled a critical 
assessment of physical access beyond the gross provider: population ratios. This 
included examining the surface factors such as road networks and existence of 
geographical features that may influence physical access. 
Figure 3.2 illustrates the output of the analysis of threshold distance (considered as the 
minimum distance a care giver is likely to travel to access PMRs services). The y-axis 
shows the proportion of patients (under five) who used retail outlets at each interval 
while the x-axis shows predicted travel times in minutes to the outlets. Due to lack of 
fever data from the Bungoma-AMREF site and insufficient data from EAs that fell 
within any of the intervention areas of the Kwale-MoH site, fever survey data from 
four EAs of the Kisii-Merlin site was used to derive threshold distance. The parameter 
C in figure 3.2 represents the distance within which most caregivers would use the 
retail outlets. This parameter was 90 minutes, translating to a travel distance of 7.5 kin 
(assuming a walking rate of 5kni/hour). The 7.5 km threshold distance was then used 
to estimate the underlying under five population likely to use trained retail outlets. 
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Figure 3.2: Graph showing utilization rates of retail sector services for treatment of 
fevers in the Kisii-Merlin site 
Greater Kisii (Smoothed values) 
discontinuous exponential model Moving window (min): 100 
a: 0.31 
b: 80 
c: 90 CO 
Ci SER: 2.378466 
0 c L 2 
Ci 
.................................. ...... 
0 
0 20 40 60 80 100 120 
Journey time (minutes) from predicted facility 
3.2.4 Potential under rive users and average distance to access retail outlets 
Using the TP technique (chapter two section 2.9.2.3), the under five population was 
derived in each of the polygons for each market centre. Thereafter mean Euclidean 
distances (straight line distance to the nearest retail outlet) travelled in Km were 
computed for each point in the division presented in figure 3.3 a-c. 
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The site with the lowest average travel distance to a centre with a programme outlet 
was the Kisii-Merlin site (1.30 kin) followed by the Bungoma-AMREF site (1.40 km) 
and the Kwale-MoH site (1.86 km) (table 3.1). However, the average travel distance to 
a centre with a trained PMR in each of the divisions of the Kwale-MoH site varied. 
Matuga, division had an average travel distance of 1.05 km compared to 2.66 krn in 
Kinango division. 
In tenns of population coverage, the under five population for each polygon varied 
with the population densities. Based on two divisions, the Kwale-MoH site had the 
highest coverage of the potential target population (47785 children under five years). 
On finther examination of each division, Kinango division had the highest coverage of 
the potential target population of about 39525 compared to 8260 under fives in Matuga 
division (table 3.1). The programme with the second highest coverage of target 
population was the Kisii-Merlin site with 29876 potential under fives and 29475 in the 
Bungoma-AMREF programme. The subsequent sections present data on the impact of 
programme on PMR practices and knowledge. 
3.3 Description of outlets and PMRs across sites 
3.3.1 Distribution of IEC materials in the three sites 
Based on early district programme reports, data on the distribution of IEC materials are 
summarised in table 3.2. They help to illustrate the coverage of reference materials as 
an indicator of programme performance. The data presented reflect the different 
intervention designs and implementation processes across sites. IEC materials were to 
contribute to demand creation and provided essential reference materials for PMRs. As 
a social marketing programme, the Bungoma-AMREF site relied heavily on the 
distribution of IEC materials targeting the whole district. 
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Availability of the distributed IEC materials in the trained study outlets was recorded 
during the retail audit. This helped to triangulate information presented in table 3.2. 
PMRs were asked whether they had booklets, drug or referral charts, leaflets or posters 
in their outlets at the time of the survey. These materials were to be distributed during 
training workshops in the case of the Kisii-Merlin and Kwale-MoH sites and during 
the normal business encounters with mobile vendors or wholesalers in the Bungoma- 
AMREF site. Figure 3.4 is a graphical illustration of the availability of IEC materials 
in the trained outlets for each site. The denominator is targeted outlets operational at 
the time of the survey. 
Figure 3.4 Distribution of IEC materials in the intervention areas 
100 
90 
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40 
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10 
0 
Leaflets Posters Booklets DrUgcharts Refei-ral 
charts 
Type of IEC materials clsitributed 
* Kisii-Merlin 
* Kwale-MoH 
* Bungoma-AMREF 
There was considerable variation in the availability of IEC materials in the trained 
outlets across sites. In the Kwale-MoH site, there were a relatively high proportion of 
study outlets with IEC materials, followed by the Kisii-Merl I 
in and the Bungoma- 
AMREF site. Availability of reference materials for PMRs such as drug and referral 
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charts was higher in the Kisii-Merlin compared to the other sites (100% and 93% 
respectively). There was also a high distribution of durable posters (93%) in Kisii- 
Merlin, essential to direct clients to trained outlets and enhance demand creation. 
Examples of IEC materials used in the KA, ale-MoH are presented in figure 3.5 and 3.6. 
Figure 3.5: Image of drug dosage charts used in the Kwale-MoH site 
CHART[ YA MATUMIZI YA DAWA YA AMODIAQUINE 
SIKL YA I SIKýý YA SIKU YA 3 JUMLA 
chini ya miezi 6 17 
miezi 6 hadi 11 17 Y4 
miaka 1 hadi 32 
miaka 4 hadi 52 3ý 
miaka 6 hadi 12 3 Y4 
Miaka 13 hadi 15 K:: --7 GG,::: 7 6 
Y4 
Zaidi ya miaka 15 7 3ý 
m. fano wa maj . ina ya dawa tizuri za kundi Id AýQ 
Amobin, camoquin, Diaquin, malaratab, uniquin 
Figure 3.6: Images of job aids and posters used in the Kwale-MoH site 
J"b %; d Rctailer ! moklet 
3.3.2 Number and status of retail outlets visited 
The sampling frame for the retail audit and surrogate client surveys aimed to include 
outlets similar to those in the programme. A key selection criterion for programme 
outlets was the stocking of anti-malarial medicines. The sampling frame for these 
surveys therefore aimed to include only outlets stocking anti-malarial medicines 
(Chapter two section 2.9.1). This was different to the GPS study (chapter two section 
2.9.1.5) which sampled from all retail outlets in the intervention sites. The number and 
status of retail outlets visited during the retail audit and surrogate client surveys are 
presented in table 3.3. Status refers to whether outlets were open or closed when 
visited and stocked anti-malarial medicines. Differences in outlet status at the time of 
visits during the retail audit and surrogate client survey led to differences in the 
denominators presented in table 3.3. 
Amongst the logistical challenges associated with assessing provider behaviour using 
surrogate clients was the inability to prepare for interviews ahead of visits. Outlets 
were often visited more than once to secure an observation, particularly intervention 
outlets in the Kisii-Merlin site (Odds Ratio: (OR); 13.9: 95% Confidence Interval (Cl): 
4.1,47.8). A similar phenomenon was observed in the retail audit where temporary or 
permanent closure was common among trained PMRs in the Kisii-Merlin and Kwale- 
MoH sites, leading to significant differences between intervention and control outlets 
in these sites (OR; 5.5: 95% Cl: 1.2,26.1 and OR; 3.2: 95% Cl 1.3,8.2, respectively). 
Availability of anti-malarial medicines in stock varied in each site. In the Kisii-Merlin 
site up to two thirds of control and intervention outlets had anti-malarial medicines in 
stock with no significant differences between the two areas. In the Kwale-Moll and 
Bungoma-AMREF sites, around half of intervention outlets had anti-malarial 
medicines in stock (OR; 0.6: 95% CI 0.3,0.9 and 0.2: 95% Cl 0.1,0.5) respectively. 
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3.3.3 Characteristics of retail outlets 
The basic characteristics of retail outlets and PMRs were derived from the retail audit 
and are presented in table 3.4. Characteristics of the retail outlets and PMRs are 
presented to determine comparability of the control and intervention areas, assess the 
extent of generalisability of the study findings and describe the functioning of the retail 
sector and its implication for PMR interventions. In the Kisii-Merlin and Kwale-Moll 
sites, the programmes targeted general retail outlets using the criteria described in 
chapter two, section 2.5. The denominator is the number of outlets that were open and 
stocking OTC medicines at the time of visit. 
Most outlets were general retail shops, with no significant differences between the 
intervention and control outlets except in the Bungoma-AMREF site, where 
specialised drug shops were more common amongst the control group (OR; 0.1: 95% 
CI: 0.01,0.6). As an indicator of overall outlet size, a majority of outlets in both areas 
were manned by one PMR. In terms of gender, education and age, PMRs in the control 
and intervention areas in all sites were comparable. Across intervention and control 
sites, most PMRs were relatively young (< 35 years) and had between 8 and 12 years 
of schooling, although those in Kwale had lower median years of education than the 
other sites. 
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3.3.4: Patterns of medicines stocked in the retail outlets 
During the retail audit PMRs were asked questions on medicines in stock at the time of 
the survey (table 3.5). In interpreting this data, it should be remembered that the outlets 
sampled were likely to stock anti-malarials, as explained in section 3.3.2. With the 
exception of the Bungoma-AMREF site, where PMRs in the intervention area less 
often stocked anti-malarial medicines compared to those in the control areas; (OR; 0.1: 
95% Cl: 0.1,0.4), there were no statistical differences between the intervention and 
control areas on this indicator in the other two sites. 
Of importance is the availability of the MoH recommended anti-malarial medicines 
(AQ). Figure 3.7 shows the proportion of outlets with AQ medicines in stock. In all 
sites, there were no significant differences between the control and intervention areas 
in the proportion of outlets with AQ medicines in stock. In the Kisii-Merlin site 96.7% 
of intervention outlets stocked AQ medicines compared to 86.5% in the control area 
(OR; 4.6: 95% Ch 0.9,23.1). In the Kwale-MoH site, the proportion was 92% 
(intervention) compared to 87.8% in the control areas (OR; 1.6: 95% Cl: 0.5,5.5). In 
the Bungoma-AMREF site, this was 78.1% (intervention) compared to 71.6% in the 
control areas (OR; 1.4: 95% Cl: 0.5,3.7). 
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Figure 3.7 Proportion of outlets with anti-malarial medicines that stocked AQ 
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In addition, different brands of anti-malarial medicines were identified in each site. 
This helped to characterize the retail sector in these districts for comparisons with 
other settings. Different brands of AQ and SP medicines available at the time of the 
study are presented in table 3.6 and 3.7. The frequency is expressed as a percentage of 
all outlets stocking anti-malarial medicines and is aggregated since there were no 
significant differences between the intervention and control areas. Overall. for AQ and 
SP medicines (table 3.6 and 3.7), there were variations in the patterns of brand 
dominance between districts, for example, Betaquine(K and Malaratab* were most 
commonly available in Kisii-Merlin and Kwale-MoH sites, while Malarid(K and 
Uniquine dominated in the Bungoma-AMREF site. In terms of the numbers, 6 brands 
of AQ medicines were identified in the Kisii-Merlin site, 4 brands in the Kwale-MoIA 
site and 12 in the Bungoma-AMREF site. 
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Table 3-6 Frequency of AQ brands of medicines 
Brand name Kisii-Merlin Kwale-Moll Bungoma-AMREF 
MalaratablD 90/113 (79.6% 107/124 (86.9%) 3/106 ( 2.8%) 
Amobing 4/113 ( 3.5%) 0/124( 0%) 4/106 ( 3.7%) 
EmoquineV 0/113( 0%) 2/124 ( 1.6%) 10/106 (9.4%) 
AmodiaquinelD 4/113 ( 3.5%) 0/124( 0%) 4/106( 3. %) 
Betaquineg 14/113 (12.4%) 11/124 (8.9%) 2/106 ( 1.8%) 
Alphaquineg 0/113( 0%) 0/124( 0) 2/106 ( 1.8%) 
MalaridlD 2/113 ( 1.8%) 0/124( 0%) 55/106 (51.8%) 
Falciquineg 0/113( 0%) 0/124( 0%) 1/106 ( 0.9%) 
Kamocg 1/113 ( 0.9%) 0/124( 0%) 0/106( 0%) 
LaeoquinelD 0/113( 0%) 1/124 ( 0.8%) 2/106 ( 1.8%) 
MalarabitV 10/113( 0%) 0/124( 0%) 51106 ( 4.7%) 
Uniquineg 10/113( 0%) 0/124( 0%) 20/106 (18.9%) 
Diaquineg 10/113( 0%) 0/124( 0%) 2/106 ( 1.8%) 
Amongst all the SP medicines stocked, 6 brands were encountered in the Kisii-Merlin 
site, with the common brands being Orodar4D and Methomine So- In the Kwale-MoH 
site 10 brands were identified with Orodaro and Falcidinlo being the commonest brand. 
In the Bungoma-AMREF site 12 brands were encountered with common ones being 
Maloda? and Malostae (table 3.7). 
Table 3-7 Frequency of SP brands of medicines. 
Brand name Kisii-Merlin Kwale-Moll Bungoma-AMREF 
OrodarlD 14/113 (12.3%) 16/124 (12.9%) 11/106( 10.3%) 
FalcidinO 2/113 ( 1.8%) 39/124 ( 31.5%) 3/106 ( 2.8%) 
Fanlarg 1/113 ( 0.9%) 2/124 ( 1.6%) 9/106 ( 8.5%) 
MalereichID 0/113 (0%) 1/124 ( 0.8%) 0/113 (0%) 
Fanisdarg 4/113 ( 3.5%) 3/124 ( 2.4%) 4/106 ( 3.7%) 
- Metakelfing 1/113 ( 0.9%) 0/124 (0%) 1/106 ( 0.9%) 
Betakelfin(W 0/ 113 (0%) 0/124 (0%) 1/106 ( 0.9%) 
Methomine SO 9/113 ( 7.9%) 8/124 ( 6.5%) 6/106 ( 5.6%) 
Malodarg 0/113 (0%) 0/124 (0%) 13/106 ( 12.3%) 
MalostatR 0/113 (0%) 1/124 ( 0.8%) 10/106 ( 37.7%) 
MalaramedID 0/113 (0%) 0/124 (0%) 2/106 ( 1.8%) 
Beta SPID 0/113 (0%) 3/124 ( 2.4%) 1/106 ( 0.9%) 
MalaradoselD 0/113 (0%) 0/124 (0%) 1/10 ( 0.9%) 
Zentakelfint 0/113 (0%) 1/124 ( 0.8%) 0/106 (0%) 
Malaradog 0/113 (0%) 4/124 ( 3.2%) 0/106 (0%) 
Images of the common types of AQ and SP brands encountered in the study sites are 
presented in figure 3.8. 
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Figure 3.8: Images of common brands of AQ and SP medicines encountered 
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3.3.5: Storage conditions and expiry dates of anti-malarial medicines 
A secondary indicator in this study concerns storage conditions of anti-malarial 
medicines since all programmes included training on the importance of adequate 
storage of medicines to maintain their quality. In the Bungoma-AMREF site, PMRs 
were inducted on general hygiene practices while handling drugs. In the Kisii-Merlin 
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and Kwale-MoH sites, the training curriculum contained recommendations to store 
such medicines off the floor, away from direct sunlight and in a dry place. During the 
retail audit, field workers made an assessment of the extent to which storage conditions 
satisfied these three criteria by scoring each from 0 to 3, where 3 was a score used 
when all the criteria were met. To determine whether medicines were within the expiry 
period, packages of each drug were checked for the manufacturer's printed expiry 
dates and compared against the date in which data collection was completed for that 
outlet. 
There were no significant differences in storage practices between the intervention and 
control outlets across all districts and therefore this data was combined. The proportion 
of outlets which stocked AQ medicines within the expiry period was over 98% in the 
Kisii-Merlin and the Kwale-MoH sites and 100% in the Bungoma-AMREF site. 83.7% 
of outlets stored AQ medicines adequately in the Kisii-Merlin site, 90% in the Kwale- 
MoH and 91.3% in the Bungoma-AMREF sites. 
3.3.6 Sources of SP and AQ medicines 
Sources and prices of common anti-malarial medicines in stock were useful measures 
in understanding the functioning of the retail sector, comparability of selected sites and 
comparisons with other settings. Sources and prices of medicines also have 
implications for the supply and accessibility of the intervention. Figure 3.9 and 3.10 
provide a summary of sources of AQ and SP medicines in the three districts. 
Figure 3.9 shows variations in the sources of AQ medicines in each site. Chemist 
shops and general wholesalers were the main sources of AQ medicines in the Kisii- 
Merlin site. In Kwale, PMRs sourced AQ medicines from general wholesalers or 
vendors. Vendors were mainly drug distribution company representatives and others 
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who sold medicines and general wares on motorbikes or vehicles. Although the 
programme in the Bungoma-AMREF site was anchored on wholesalers and mobile 
vendors who were already distributing anti-malarial medicines, PMR sourced AQ 
medicines mainly from chemist shops and wholesalers. 
Figure 3.9 Sources of AQ medicines 
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The common sources of SP class of medicines in the retail outlets of the Kisii-Merlin 
site were chemist shops and general wholesalers for the Kwale-MoH site. In the 
Bungoma-AMREF site, PMRs sourced SP medicines from general wholesalers and 
about a third from chemist shops (figure 3.10). 
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Figure 3.10 Sources of SP medicines 
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3.3.7 Price of SP and AQ medicines 
Figure 3.11 is a box plot illustrating the median prices and IQR for both SP and AQ 
medicines sold in the districts. Price data was derived from all outlets that stocked each 
class of anti-malarial medicines and where information on wholesale and retail prices 
was available. Again there were no variations in the prices between the control and 
intervention areas in both sites and therefore all data were merged. For each drug class, 
the PMRs were asked to describe quantities in which they bought and sold the drugs. 
In almost all cases PMRs sold drugs in tablet form, packed either in blister packs or in 
some cases in loose tablets from tins. Retail and wholesale prices were derived by 
multiplying the quantity bought per tablet with the number of tablets required for a full 
adult course as recommended in the MoH treatment guidelines. 
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Figure 3.11 Wholesale and the retail prices of SP and AQ classes of medicines 
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Note: on the y-axis is the cost in KES while the x-axis represents the class of medicines. The dark middle bars in 
each box represent the median and the blue and red boxes represent the IQR for prices of both AQ and SP boxes 
respectively. The whiskers represent extreme non-outlier observations while the circles show outliers 
In the Kisii-Merlin site, the median wholesale price for a full adult course of AQ 
medicine was KES 30 (IQR; 26.4,33.6), and retailed at KES 60 (IQR; 45-60). In the 
Kwale-MoH site, the median wholesale and retail prices for AQ medicines were KES 
36 (IQR; 30-71.5) and KES 60 (IQR; 45-60) respectively. In the Bungoma-AMREF 
site, these prices were KES 30 (IQR; 26.4-33.6) and KES 45 (IQR; 45-60), 
respectively. There were no variations on the wholesale and retail prices for full adult 
courses of SP medicines in the districts. The median wholesale price for SP class of 
medicines was approximately KES 12 (IQR; H -22), with retail price of KES 20 (IQR; 
20-25). Overall. higher retail prices of each class of medicines represent a retail mark 
up of about KES 8 for SP medicines and KES 15-30 for AQ medicines based on adult 
courses. 
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3.4 Impact of programme on PMR knowledge and practices 
3.4.1 PMR's ability to identify simple febrile events 
Table 3.8 presents data on the frequency with which PMRs sought to identify the 
nature of an illness by asking questions before selling medicines. These data were 
derived from the surrogate client survey and the denominator was the number of 
outlets that were operational at the time of the survey. Appropriate management of 
febrile events among under fives begins with the ability to identify fevers that can be 
safely treated with OTC medicines. The training curriculum in the Kisii-Merlin and 
Kwale-MoH sites included situations in which children should be referred to a trained 
health worker (instead of being treated at home). These were defined as age less than 6 
months, long duration of symptoms (more than 14 days), the presence of breathing 
difficulties, undue sleepiness or convulsions and vomiting and diarrhoea more than 
three times a day. In the Bungoma-AMREF site, danger signs were described as 
convulsions, breathing difficulties, unconsciousness, pale hands, tongue and inner part 
of the eyelids, generalized body weakness and dehydration. In this study, this 
assessment was based on the proportion of PMRs who asked for the presence of at 
least one danger sign. 
Apart from age, PMRs in control and interventions areas, rarely asked questions at the 
time of selling medicines in all sites. However, in the Kisii-Merlin site, trained PMRs 
more often asked about the following areas than their colleagues in control outlets: at 
least one danger sign (OR; 9.9: 95% CI 2.6,35.4); about the age of user (OR; 4.8: 95% 
CI 2.3,10.4); about the presence of fever (OR; 13.8: 95% Cl 6.5,29.7) and about the 
number of days the user had been unwell (OR; 43.1: 95% Cl 5.6,329.1) 
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3.4.2 Sale of medicines in the retail outlets 
To assess appropriateness of fever management at the retail level, surrogate clients 
asked for an anti-malarial medicine for a child. If questioned, they provided 
standardised information on the age and symptoms of the illness (a three-year old 
febrile child with a simple fever). Table 3.9 presents data on the observations where 
OTC medicines were sold and reasons for not selling medicines. In the Kwale-MoH 
and Bungoma-AMREF sites, less than half of PMRs in intervention and control outlets 
sold medicines for a child of this ýge, with no significant differences between 
intervention and control outlets. In Kisii-Merlin, PMRs in intervention outlets were 
significantly more likely to sell drugs than those in the control group. Reasons for not 
selling medicines included PMR's perceptions that current medicines in stock were 
unsuitable for a child of that age. This reason was given significantly more often in 
control than intervention outlets in both Bungoma-AMREF and Kwale-MoH sites. 
Lack of anti-malarial medicines was another reason underlying non-sales, and this was 
more common in intervention than control outlets in the Kisii-Merlin site. In all sites, 
mothers were often advised to seek advice at a health facility. 
One of the primary indicators for this study is to determine the impact of the 
programme on PMR knowledge and practices. The denominator for this indicator is 
the number of surrogate client survey observations where a sale took place. The 
relatively few observations with a sale (table 3.9), presents several limitations. First, 
sample size calculations were based on the number of anti-malarial sales. This means 
that the low number of sales potentially limited the power of the study in measuring 
the true effect of the intervention. Secondly, observations without a sale were not 
included in the denominator introducing a potential bias probably leading to an 
overestimate of the measured impacts. Finally, the reasons behind low number of 
sales identified during the survey included refusal to sell medicines to three year old 
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children, the absence of drugs in shops, and shop-keepers preferring to refer clients to 
health facilities. These reasons were given by PMRs spontaneously since surrogate 
clients were unable to probe due to the covert nature of the study and thus may not 
represent the real picture. The latter limitation was minimised through the qualitative 
component of this study which explored reason behind these practices and are 
discussed in chapter four. 
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3.4.3 Type of anti-malarial medicines sold and adequacy of advice given on 
dosages 
Table 3.10 presents data on PMRs' selling practices derived from the surrogate client 
survey. Against a background where surrogate clients were trained to ask for an anti- 
malarial medicines, results indicate that more than half of the PMRs visited sold an 
anti-malarial medicine in the control and intervention areas for all sites. Anti-malarial 
medicines were more often sold in the intervention compared to the control outlets in 
the Kisii-Merlin (OR; 4.4: 95% CI 1.1,17.9) and the Kwale-Mol I sites (OR; 4.4: 95% 
CI 1.4,13.8). No significant differences were observed in the Bungoma-AMREF site. 
The primary indicator for the assessment of PMR practices was the proportion of 
programme outlets where recommended anti-malarial medicines were sold 
accompanied by appropriate advice on their use. As described in chapter two, this was 
based on sales of AQ medicines. Over half of trained PMRs of the Kisii-Merlin and the 
Kwale-MoH site sold AQ medicine, and this was significantly more frequently 
experienced in the intervention outlets compared to the controls ((OR; 6.1: 95% CI 1.9, 
19.0) and (OR: 6.2: 95% CI 2.2,17.7), respectively). No significant differences were 
observed in the Bungoma-AMREF site for this measure. In the Kisii-Merlin site, 
60.5% of trained PMRs sold AQ medicines accompanied with adequate advice on use 
compared to 2.8% of untrained PMRs (OR; 53.5: 95% CI 6.7,428.3). In the Kwale- 
MoH site, these percentages were 18.8% in the intervention and 2.3% in the control 
outlets (OR; 9.4: 95% CI 1.1,83.1). In the Bungoma-AMREF site there were no 
significant differences measured between the two areas. 
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3.4.4 PMR knowledge on OTC drug types 
Thi's section addresses the main secondary indicator, which is the proportion of 
programme outlets where the main PMR is aware of MoH recommendations on anti- 
malarial medicines and can identify appropriate dosages for children. The assessment 
drew on the findings of the retail audit and was based on use of a vignette (Annex II) 
concerning recommendations for treatment for a five year old febrile child 'With no 
other symptoms. 
In table 3.11 the proportions are expressed as a percentage of all outlets with anti- 
malarial medicines in stock. In the Kisii-Merlin 54.1% and 72.9% of the Kwale-Moll 
trained PMRs recommended an anti-malarial for a febrile event compared to 20.0% 
and 18.9% of the control PMRs(OR; 4.7: 95% CI 2.0,11.1) and (OR; 12.0: 95% CI 
4.5,31.9), respectively). No significant differences were observed in the Bungoma- 
AMREF site. Amongst those who recommended an anti-malarial, 96.8% of trained and 
70.0% of control PMRs in the Kisii-Merlin site recommended the use of AQ medicines 
(OR; 13.3: 95% CI 1.1,147.5). There were no significant differences observed in the 
other sites. 
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3.4.5: PMR's knowledge on dosing anti-malarial medicines 
To assess the secondary indicator on PMRs' knowledge of dosing for anti-malarial 
medicines, PMRs were questioned on the use of any AQ or SP medicines available in 
the outlets at the time of the survey for a five year old child (table 3.12). 79.3% of 
trained and 16.7% of control PMRs in the Kisii-Merlin site had correct knowledge on 
adequate dosing of AQ medicines (OR; 18.6: 95% CI 6.6,52.2). Trained PMRs also 
less often recommended AQ in either low or high doses than the control ones. In the 
Kwale-MoH site, although the measure of effect could not be derived, there were 
significant differences between the intervention and control areas in the proportion of 
PMRs who had correct knowledge on dosing of AQ medicines (48.8% versus 0% in 
the control outlets). No significant differences were observed in this indicator in the 
Bungoma-AMREF site. A common pattern of incorrect use across all districts was 
adminstration of AQ for one day. This was often seen in the control sites of the Kisii- 
Merlin and Kwale-MoH and both control and intervention outlets of the Bungoma- 
AMREF site. 
Across all the districts, there were no statistically significant differences between the 
control and intervention areas in the proportion of PMRs who had correct knowledge 
on the dosage of SP medicines. However, there appeared to be a pattern of 
recommending use of SP for three days in the intervention outlets of the Kisii-Merlin 
and the Kwale-MoH site. These differences were significant in the Kwale-Moll 
progamme (OR; 8.9: 95% CI 2.1,37.5). 
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3.5 Discussion 
This section discusses two objectives of this thesis; to determine the impact of the 
programmes on PMR knowledge and practices and to estimate the geographic 
coverage and utilisation of the PMR programmes. It begins with a summary of the 
main findings for both objectives. The second part presents study limitations of the 
methods used. Subsequent sections present a discussion that helps interpret 
quantitative outcomes on the impact of programme on PMR knowledge and practices. 
It examines the strength of the evidence for a causal relationship between the 
intervention and any differences assessed between programme and non programme 
outlets within each district by assessing factors that may have acted as confounders or 
produced bias. It also examines the contextual factors that may influence comparisons 
between sites, and the generalisibility of these findings. 
3.5.1 Summary of quantitative outcomes across the three sites 
Table 3.13 summarises the main indicators for the two objectives. Quantitative data 
indicate that the Kisii-Merlin programme had a significant and the greatest impact on 
PMR knowledge and practices. There was limited impact in these indicators for 
Kwale-MoH, but the study was unable to show any impact for Bungoma-AMREF, 
although there are some important limitations to this analysis. Kisii-Merlin also 
achieved the highest programme coverage, in terms of the proportion of all retail 
outlets covered by the programme (27.1%). It was the site which accessed most 
targeted outlets with 69.7% of outlets with anti-malarial medicines reached. Kwale- 
MoH and Bungoma-AMREF had similar and relatively low coverage with 14.1 % and 
16.7% outlets reached, respectively. The Bungoma-AMREF site was more successful 
in covering retail outlets selling anti-malarial medicines than Kwale-Moll (44.5% 
compared to 25.3%). 
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In addition, the provider population ratios indicate that the Kisii-Merlin site had the 
lowest ratio (1: 219) compared to the Kwale-MoH (1: 299) and Bungoma-AMREF 
sites (1: 467). However an interesting finding resulted from the utilisation modelling, 
showing that the highest levels of utilisation were likely to have resulted in one 
division of the Kwale-MoH site, Kinango, with 39,575 potential under five users. This 
was also the division with the lowest number of trained outlets and population density. 
Potential under five users in the Bungoma-AMREF, Kisii-Merlin and Matuga division 
of the Kwale-MoH site programme numbered 29,475,28,876 and 8260, respectively. 
The PMR services were likely to be accessed within a walking distance of 1.30 km in 
the Kisii-Merlin site, 1.86 km in Kwale and 1.40 km in Bungorna. 
The first objective of this thesis addressed the impact of the intervention on practice 
(primary indicator) and knowledge (secondary indicator). In relation to the primary 
indicator, table 3.13 shows that 60.5% of trained PMRs in the Kisii-Merlin site sold 
AQ medicines with appropriate advice on their use compared to 2.8% of untrained 
ones (OR; 53.5: 95% Cl 6.7,428.3). This difference was also significant in the Kwale- 
MoH site, where 18.8% versus 2.3% among the intervention and control PMRs sold 
AQs medicines with correct advice, respectively (OR; 9.4: 95% CI 1.1,83.7). No 
impact was observed in the Bungoma-AMREF site. 
Consistency in positive outcomes in the Kisii-Merlin site was further observed in the 
ability of PMR to identify fevers treatable at the retail level. 25.4% of trained PMRs in 
the Kisii-Merlin site asked for at least one danger sign compared to 3.3% among 
control PMRs; (OR; 9.9: 95% Cl 2.6.35.4). In addition, 84.5% of the trained PMRs in 
the Kisii-Merlin programme asked for the age of user compared to 52.7% among the 
control PMRs; (OR; 4.8: 95% CI 2.3,10.4). No significant differences were observed 
for the two indicators in the other sites. 
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In terms of the main secondary indicator, the intervention appears to have improved 
PMR knowledge in the Kisii-Merlin and Kwale-MoH site, but no significant 
differences were detected in the Bungoma-AMREF site. 79.3% of the trained PMRs in 
the Kisii-Merlin site were aware of appropriate dosages of AQ medicines for children 
compared to 16.7% among the control PMRs (OR; 18.6: 95% Cl 6.6,52.2). For the 
same indicator, this was 48.8% in the Kwale-MoH site compared to 0% in the control, 
but no significant difference was noted in the Bungoma-AMREF site. 
3.5.2 Study limitations 
3.5.2.1 Limitations of methods used to measure coverage 
There are some limitations to the methods used to measure coverage and potential 
utilization in this study. They include limitations of using provider-population ratios 
and intrinsic limitations of the methods. The study used provider-population ratios as 
one estimate of coverage of the intervention. Provider-population ratios ignore overlap 
in potential border crossing between polygons by patients, which can be substantial in 
smaller areas, and instead assume homogeneity in utility (Council on Graduate 
Medical Education, 1998). Secondly they do not incorporate measures of distance 
dimension (Guagliardo et al., 2004), or provide any information on quality of services 
provided. 
Spatial access to services offered by PMRs was defined using a Euclidean model 
which has intrinsic limitations. Catchment areas were delineated using the TP 
techniques based on several assumptions. Firstly, it was assumed that patients would 
choose the nearest retail outlet regardless of the type and services offered. However, in 
practice only a certain proportion will use retail sector services and the issue of 
preferences is not factored in the analysis. Secondly, it assumes that utilization rate is 
constant throughout a catchment area, and thirdly, the analysis of distance in the TP 
172 
assumes that people travel in straight line distances. Another challenge associated 
with distance-based measures is the determination of actual routes used as well as the 
mode of transport. Distance-based measures do not provide information on 
overlapping coverage, size. of population served and variability of quality of care (Noor 
et al., 2003; Rosero-Bixby, 2004; Noor, 2005; Noor et al., 2006a). 
3.5.2.2 Limitations in assessing impact on PMR knowledge and practices 
This section examines limitations in interpreting the evaluation of PMR knowledge 
and practices in this study. Two main areas of limitations are those concerning the 
study design, and limitations that are specific to the methodologies used. On the design 
limitations and in keeping with Habicht's proposed "plausibility" criteria, an argument 
is developed from the data on the likelihood of a causative relationship between the 
programmes implemented and any measured effects. For methodological limitations, 
the discussion will present ways in which these were addressed in this study. 
The evaluation approach for retailer level impacts, as discussed in chapters I and 2, 
was based on a pragmatic design that included multiple methods. Randomised 
controlled trials are regarded as a gold standard for evaluating the impact of an 
intervention (Victora et al., 2004), but in practice they may have limitations for the 
assessment of large scale public health interventions, given the complexity of the latter 
and the frequent lack of opportunities to undertake such evaluations prospectively 
(Black, 1996; Habicht et al., 1999; Victora et al., 2004). An alternative approach 
proposed in the literature is to compare one or more programme and non programme 
sites, either contemporaneously or historically, and construct an argument for whether 
the intervention is likely to have led to any differences measured, while addressing 
possible sources of bias and confounding (Ilabicht et al., 1999). 
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Therefore, in all the sites, there is a limitation imposed by the design of basing 
comparisons on one or two control and intervention clusters and generating data from a 
single cross sectional survey without baseline data. Lack of randomisation and 
replication at the point of intervention means that the assessment cannot exclude 
chance effects or confounding. However, the fact that the main indicator (the 
proportion of PMRs who sell recommended OTC anti-malarial with appropriate 
advice) was closely linked to the intervention itself (training of PMRs and 
communities on use of OTC anti-malarial medicines) may limit the likelihood of such 
effects. 
In the Kisii-Merlin and the Bungoma-AMREF sites, the evaluation employed a 
retrospective design based on one programme site and one non random 
contemporaneous control through a single cross sectional survey. Randomisation of 
several areas as intervention or control areas could not be achieved in these two sites as 
this was a retrospective evaluation of on-going programmes. On the other hand, the 
Kwale-MoH programme had been designed as part of the DDP using a prospective 
cluster randomised design with two intervention and two control areas (annex 1). The 
prospective design strengthens the evaluation in Kwale, but the analysis is still affected 
by the low numbers of clusters available. Use of a single survey is a further 
complication in interpreting the data. Without a historical control, it is not possible to 
establish whether differences (or similarities) between contemporaneous controls and 
interventions existed before the intervention, or result from the intervention. As above, 
plausibility has a major role in assessing the likelihood that important differences 
between control and intervention areas pre-dated or followed the intervention. 
At the outset, in order to limit the effect of potential confounders, the selection of the 
control areas took into account relevant characteristics of the intervention areas, such 
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as access to formal health care, malaria burden and geographical location and socio- 
economic factors. This was done, as explained in chapter two, through discussion with 
local health and administrative stakeholders. 
Some information on the success of this selection process can be obtained by 
comparing the characteristics of PMRs and outlets in intervention and control areas in 
each district. There were no significant differences in gender, education or age 
between intervention and control PMRs within each site. These factors, particularly 
educational status, were considered important potential sources of bias or confounding 
for an educational intervention. In addition, a majority of the outlets in the control and 
intervention areas were classified as general retail shops manned by a single PMR. 
Specialist drug shops were more common in the control than intervention areas in the 
Bungoma-AMREF site, pointing to a weakness in the selection of this control area, 
and potentially influencing the comparison. This effect is discussed later in section 
3.5.2.3. Outlets operated by a single PMR points to small outlets with similar 
economic viability, an indicator that has been previously used to reflect size (Marsh et 
al., 1999; Amin et al., 2003). 
Other characteristics which can be used to illustrate comparability of the outlets in 
intervention and control areas were the drug stocking patterns, price of medicines and 
storage conditions. Similarities in all these features suggest that differences in the main 
outcomes measured were unlikely to have been influenced by characteristics of the 
retail sector in these settings. Price of medicines at the retail level is also influenced by 
the normal sources and distribution chains. There were no significant differences in the 
sources of AQ and SP medicines in intervention and control outlets in all districts. 
Different sources of these medicines could have influenced retail prices especially if 
different PMRs sourced medicines from distant suppliers. This would then affect 
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affordability of medicines by community members. However, in this study, surrogate 
clients were given money to buy medicine so that the price of medicines was unlikely 
to have affected the primary indicator, linked to PMR selling practices for anti-malarial 
medicines. Source and price of medicines would directly influence PMR's stocking 
pattern which was a secondary indicator for this assessment. However, this 
characteristic was similar across and within sites. 
Another set of limitations concern the methods used, which could potentially introduce 
bias. The primary indicator was derived through surrogate client surveys, which 
although frequently used and recommended for evaluating provider performance is 
open to bias. The surrogate client survey is limited in terms of standardization of 
information, which potentially undermines the reliability of the results (Madden ct al., 
1997; Marquez, 2001). A further drawback of the method is inflexibility, including the 
inability to probe to uncover reasons behind any observed behaviours. For example, 
data show that surrogate clients who asked for anti-malarial medicines were sometimes 
sold antipyretic compounds. This could arise from a lack of standardisation of 
information, for example, the surrogate client might in practice have asked for an 
antipyretic medicine in error. It could also indicate the PMR's lack of understanding of 
the difference between anti-malarial and antipyretic medicines or their need to ensure a 
sale where there were no anti-malarial medicines in stock. 
In all sites, data loss was experienced during the surrogate client survey because of 
relatively high rates of PMRs refusing to sell OTC medicines; (60.6% and 39.6% in 
the Kisii-Merlin; 41.6% versus 42.4% in Kwale-MoH and 39.1% versus 44.2% in the 
Bungoma-AMREF sites of the intervention and control area respectively). This is a 
central challenge for such programmes given that the intervention focussed on 
strengthening appropriate treatment of OTC medicines to this vulnerable group. The 
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reasons for these refusals were difficult for surrogate clients to explore without 
revealing their identity. However, details of the reasons behind such practices were 
explored qualitatively. Qualitative data pointed to the centrality of confusion from the 
information presented on the drug packages, which did not recommend use of these 
medicines for children younger than two years old The retail audit on the other hand 
is subject to response bias. Field workers interviewed PMRs on their knowledge of 
anti-malarial medicines directly. This may have resulted in PMRs reporting practices 
that they assumed to be "desirable" rather than those they actually undertake, and over 
reporting of correct practices. In addition, in both the surrogate client survey and retail 
audit, field workers were not blinded to the control or intervention group which may 
have influenced information recorded. 
Efforts were made to minimise these sources of bias. First, surrogate clients were 
trained using a skill based approach to support standardisation of information given to 
PMRs. Secondly, data was collected on simple standardised collection forms and their 
work was regularly reviewed. However, direct supervision was not possible given the 
covert nature of the method. Thirdly, to limit the chances that surrogate clients were 
recognised and "uncovered" in their surrogate role, field workers were recruited 
locally but visited outlets outside their normal locations. However, inevitably, this 
meant they were working outside familiar areas and would have to sometimes openly 
ask local residents about the exact location of the outlets they intended to visit. To 
avoid this problem, field workers were oriented on the areas they were expected to 
visit, but getting lost still remained a logistical problem and a potential source of bias. 
All the above processes drew on experience with this method in other districts (Marsh 
et al., 2004; Abuya et al., 2007). 
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A further limitation relates to the number of observations available for use in the 
analysis, resulting from low numbers of programme outlets, low levels of stocking 
anti-malarial and high rates of reftisal by PMRs to sell anti-malarial medicines. The 
assessment of the primary indicator was designed to have at least 60 anti-malarial sales 
in the control or intervention area in order to show a 20% difference between the two 
areas. It was envisaged that 80 outlets in either the control or intervention area would 
yield the required numbers. In the Kisii-Merlin site for example, there were 91 trained 
outlets which appeared adequate at recruitment, but the number of observations with 
an anti-malarial sale fell below the expected numbers. In practice only 43/71 (60.5%) 
and 36/91 (39.5%) encounters resulted in sales in the intervention and control areas 
respectively. In the Kwale-MoH site, out of 94 trained outlets only 32/77 (41.5%) and 
42/99 (42.4%) encounters resulted in a sale in the intervention and control areas 
respectively. The Bungoma-AMREF site had unique challenges in that the IEC 
materials were distributed within the whole district. It is not possible to know the 
extent to which the division chosen for this evaluation was representative of those 
across the district. Only 66 trained outlets were observed in the surrogate client survey 
making it the site with lowest number of intervention outlets observed. The end result 
was the problem of low observations with sales ((25/64 (39.1%) and 42/95 (44.2%) in 
the intervention and control areas, respectively). 
3.5.2.3 Specific limitations for the Bungoma-AMREF site 
The Bungoma-AMREF site presented difficulties in determining an effective control 
area due to the design of the intervention (chapter two section 2.5.1. ). The different 
rate of stocking anti-malarial medicines in intervention and control groups in Bungoma 
(with higher rates seen in control outlets) further suggests that control outlets may not 
have provided an effective comparison. This is potentially important because 
specialised drug shops may have been more exposed to information on 
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pharmaceuticals than general retail shops, leading to better performance in these 
outlets prior to the intervention. The effect would be negative confounding in the 
intervention area, with any programme impact being masked by the already higher 
levels of anti-malarials stocks (and possible associated knowledge) in control outlets. 
An underlying assumption for this interpretation is that the higher rates of stocking 
anti-malarials in control outlets is very unlikely to have been a result of the 
intervention. 
In practice, the difficulties in establishing comparable control outlets were linked to the 
social marketing design of the programme, which meant that programme and non 
programme outlets would be interspersed, difficult to tell apart and have a high 
potential for contamination. Several efforts were made to limit this problem. First, use 
of local knowledge of the DHMT, AMREF personnel and mobile vendors as well as 
review of programme documents helped in developing a list of programme outlets. 
Secondly, during the surrogate client survey, field workers were trained to look for 
specific IEC materials distributed as a potential marker of exposure to the programme. 
Thirdly, during the retail audit, direct questioning and reporting of the PMR's 
involvement in the programme facilitated the process of establishing programme 
outlets and those that were not were excluded from the analysis. 
The other set of limitations for the Bungoma-AMREF site concerns the timing of this 
survey in relation to the programme cycle. This is likely to have negatively impacted 
on the outcomes of interest, and differed from the other two sites. As mentioned 
earlier, the period between implementation and evaluation was similar to the other 
sites. However, the current evaluation was conducted in a phase of implementation that 
followed withdrawal of the main programme funders. This phenomenon is likely to 
have impacted on the levels of programme implementation during the evaluation 
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period, and limits the interpretation of the findings in the Bungoma-AMREF 
programme as well as the comparison of this programme with Kisii-Merlin and Kwale- 
MoH (section 3.5.2.4). 
To respond to the limitations around the timing of the evaluation in Bungoma, it is 
worth looking at an earlier evaluation of the programme, conducted by QAP, six 
months after the first phase of implementation using SP medicines. This early 
evaluation showed an impact on PMR practices. For example, of all surrogate clients 
who were sold SP medicines, 38% of intervention PMRs sold SP medicines 
accompanied with information on correct dose compared to 15% in the comparison 
group (Tavrov et al., 2002). The study further indicated that although SP medicines 
were the recommended medicine, AQ medicines was the most commonly stocked anti- 
malarial (81% versus 39% of SP medicines). Of those that purchased anti-malarial 
medicines, 35.7% were sold AQ versus 14.7% who were sold SP. The authors also 
report that of those who purchased AQ medicines, 26% received correct information 
on how to use it compared to 76% of those who received SP medicines (Tavrow et al., 
2003). 
The initial evaluation reported above used a retrospective evaluation design comparing 
control and intervention using a surrogate client survey method (Tavrow et al., 2003), 
and could be affected by the same limitations that have been discussed in this chapter. 
In addition, there are several differences that make it difficult to compare data from 
this earlier evaluation with the current one. First, the previous study used two scenarios 
that were different to the current evaluation. In addition, the evaluation was based on 
SP compared to AQ medicines in the current evaluation. Since SP medicines are used 
in a single dose, it is difficult to extrapolate from knowledge and practice in relation to 
this drug to the same attributes in relation to a multi-dose medicine, like AQ. In the 
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earlier study, no information was collected on selling practices for AQ. Despite these 
limitations, QAP argue for some evidence of an impact of intervention in the initial 
stage of implementation. 
Overall, this section has illustrated that there were more limitations to the evaluation in 
the Bungoma-AMREF site than the other two sites. These may contribute to the lack 
of evidence for the impact of intervention on PMR practices and knowledge in the 
current evaluation. 
3.5.2.4 Contextual factors influencing interpretations 
The discussion so far has examined the evidence for an effect of the intervention in 
each of the districts. However, a main aim of the study at the outset was to compare 
programme impact among districts in order to contribute to an understanding of the 
relative advantages of different approaches to working with PMRs for malaria control. 
As part of this latter analysis, this section examines the extent to which different 
district contexts could influence any comparison of the key outcomes measures 
between sites. Aspects of this context that will be considered are similar to some of 
those discussed in section 3.5.2.2 as potential influences for within district 
comparisons. They include characteristics of the retail sector, including PMRs 
themselves, poverty and timing of the evaluation. The characteristics of the PMRs, 
type of outlets, stocking patterns, price of medicines and quality of medicines assessed 
through storage conditions were similar across sites, although some variations in the 
type of outlet occurred in Bungoma. These similarities strengthen the validity of 
comparisons between districts. 
Poverty is likely to influence the ability of PMRs to stock anti-malarial medicines and 
clients' ability to buy medicines, and differences in poverty indices could therefore 
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contribute to differences in programme impacts between the districts. The influence 
of poverty on stocking patterns is to an extent excluded in this study since all outlets 
were selected on the basis of availability of anti-malarial medicines. In addition, all 
three sites have generally high and similar proportions of community members living 
below the poverty line (chapter 2). Discussions with PMR and potential clients during 
the qualitative study highlighted the challenges of stocking anti-malarial medicines 
among PMR and the ability of clients to afford them, since anti-malarial medicines 
were perceived to be expensive. The influence of poverty on the implementation 
process is addressed in chapter four. 
A further potential factor is the differences in the timing of the surveys between 
districts. Although the interval between the last training activities and the evaluation 
was the same in all three districts, the surveys were conducted in two separate years, 
with Kwale-MoH programme evaluation being conducted in 2005, and those in Kisii- 
Merlin and Bungoma in 200615. This allows a possibility that temporal changes may 
have played a part in the differences in the outcomes measured. Examples of such 
temporal changes could be rainfall and therefore malaria prevalence, or the 
introduction of other malaria control activities. However, care was taken to exclude the 
possibility of contamination by other malaria control programmes in all districts 
through discussion with the DHMT. An important potential influence linked to the 
timing of these surveys that cannot be discounted is the introduction of the new 
national anti-malarial drug policy, which would have been new and unfamiliar in 2005, 
but may have become more established by 2006. If this had an impact, it may have 
15 in the Kisii-Merlin site training of PMRs were conducted between November 2005 and January 2006. 
The current evaluation was conducted in July 2006. In the Kwale-Moll site, training of PMRs were 
conducted between November 2004 and January 2005. The evaluation was conducted in July 2005. In 
the Bungoma-AMREF site, distribution of IEC materials based on AQ medicines was conducted 
between December 2005 and February 2006. The current evaluation was conducted in October 2006. 
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contributed to the relative success of the programme in Kisii in contrast to that seen in 
Kwale, but no such effect is apparent in Bungoma. 
Timing of an evaluation in relation to programme implementation is important in the 
interpretation of outcomes. Evaluation of interventions conducted once and in 
relatively short periods of time after implementation may not show whether the 
impacts observed are on the rise or decaying. Overall, contextual features around the 
functioning of the retail sector and socio-economic status were unlikely to have had an 
influence on the comparisons of the primary and secondary outcomes between 
districts. The next section compares these findings with other studies conducted in 
other settings to establish genemlisibility of the findings. 
3.5.2.5 Generalizability of findings 
The aim of this section is to show how findings from this study compare with other 
settings to illustrate general isability. As has been reviewed in chapter 1, the retail 
sector is generally characterised by a variety of actors who sell medicines 
(WHO/RBM, 2005). This study like other evaluations in the sector has focussed on a 
group of PMRs that appear to represent an optimal opportunity for behaviour change 
interventions. Characteristics used for involving PMRs included stability in time and 
place, relative financial security, and diversity of retail activities in contrast, for 
example, to itinerant hawkers in market places who may be difficult to target for such 
interventions. First this section endeavours to address the question of how similar the 
findings on the impact of these PMR interventions are to others. Secondly, it addresses 
how similar these outlets are to those described elsewhere. 
In terms of PMR practices, other studies have shown an im . provement in PMR 
practices after different interventions were implemented. For example in Uganda, the 
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proportion of drugs stores giving appropriate drugs for uncomplicated malaria 
increased from 2% to 73% after negotiated sessions while those that recommended 
correct anti-malarial dose (CQ and SP) increased from 0% to 49% (Tawfik et al., 
2006). In Nigeria through training and pre-packing of anti-malarials, the proportion 
that recommended correct anti-malarial doses improved from 9% to 53% (Greer et al., 
2004). In Kenya, 86% of PMRs gave appropriate advice on anti-malarial (CQ) after 
training compared to 0% on the untrained areas (Marsh et al., 2004). 
Regarding the characteristics of the PMRs, data from other sites illustrate variations in 
type of outlets, education levels and age of PMRs. In terms of education, there are 
variations across different sites with some PMRs having little or no education or 
formal training (Goodman et al., 2007a). For example, earlier studies conducted in 
Bungoma district, indicated that over 25% of PMRs had at least 8 years of schooling 
(Tavrow et al., 2003). Across four other districts of Kenya, the median number of 
years in school was 10 years (Amin, 2005) whereas in Uganda most of the PMRs were 
illiterate (Adorne et al., 1996). In terms of the age of the main seller, again this varies 
from very young sales boys and girls in Nigeria where 89% of PMRs studies were 
below 21 years (Adikwu, 1996) to relatively middle aged PMR observed in the four 
districts in Kenya with a median age of 35 years (Amin, 2005). 
Although the current evaluation focussed on a selected group of PMRs, the types of 
outlets surveyed in this evaluation were comparable to those found in other settings. In 
Tanzania and Kenya for example the majority of outlets were general retail shops 
selling a range of medicines alongside other household goods such as soap, cooking 
oil, and grocery (Marsh et al., 1999; Goodman et al., 2004; Amin, 2005). Additional 
types of PMRs in some areas of East and West Africa include drug shops specialising 
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in pharmaceuticals (Oshiname and Brieger, 1992; Adikwu, 1996; Adome et al., 1996; 
Brieger et al., 2004; Dzator and Asafu-Adjaye, 2004; Goodman et al., 2004). 
Similarities between PMRs in this study with other settings especially in the East 
African region can be noted in their drug stocking patterns. Among studies aimed to 
characterise the availability and range of medicines in the retail sector, nearly all 
outlets studied stocked medicines under proprietary names. In rural Kenya over 30 
brands of SP medicines and 13 brands of AQ medicines were identified. The type of 
brands were also similar with Falciding and Malartab@ being the commonest SP and 
AQ medicines (Amin and Snow, 2005). In Tanzania, of all the general outlets that 
stocked anti-malarial medicines, nearly all of them had CQ with a wide range of other 
anti-malarial medicines in stock (Goodman et al., 2004). 
Regarding sources of anti-malarial medicines, the current evaluation agrees with the 
literature on retail sector in other parts of Kenya and Tanzania. In the rural settings of 
four districts in Kenya, sources of anti-malarial medicines to the district PmRs were 
classified by type of retailers (either large, small or drugs shops). The study indicated 
that large retailers obtained their drugs from general wholesalers outside the districts 
(39.8%), or inside the districts (34.8%). Most small retailers (45.3%) sourced anti- 
malarial medicines from general wholesalers within the districts (Amin and Snow, 
2005). In Tanzania, 92% of sources of anti-malarial medicines mentioned by PMRs 
were general wholesalers who stocked a variety of other products (Goodman et al., 
2004). In summary, the outlets that have been studied are found commonly across 
Kenya, but many different types of PMRs have also been described across the malaria 
endemic settings of SSA. If the comparison is then restricted to outlets that are similar 
to the ones that have been included in this study, the findings on the impact of PMR 
185 
interventions in this study are supported by evaluations conducted elsewhere. This 
strengthens the external validity of the outcomes. 
3.6 Summary 
In this chapter, quantitative data were presented for two objectives. GIS techniques 
were used to estimate spatial coverage and physical distance of the three PMR 
interventions. Two sets of outcomes were presented; measures of spatial access and 
utilisation. Data on the impact of programme on PMR knowledge and practices were 
derived from post intervention surveys in programme and non programme outlets. It 
covered availability of programme materials, descriptive characteristics of PMRs and 
outlets, impact of programme on PMRs practices on sale of anti-malarial medicines 
and PMR's knowledge on type and adequacy of anti-malarial medicine recommended. 
The study design was a mix of cluster randomised trial and a pragmatic non random 
design tied to the implementation stages in each site. Data was collected through the 
surrogate client and retail audit surveys. 
In terms of coverage and spatial access, the study shows that the Kisii-Merlin site had 
the highest programme coverage (both in terms of all outlets in the programme area 
reached as well as targeted outlets) compared to the other sites. However, the 
programme reached just under 30000 potential under five users, a similar number to 
the Bungoma-AMREF site but lower than the KwaIc-MoH site. The Kwale-Moll site, 
meanwhile, had the lowest coverage (in terms of all outlets in the programme area 
reached as well as targeted outlets). All the sites appear to have attained the minimum 
average travel distance of 2 km range from the household stipulated in the guide for 
scaling up PMR interventions. 
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The assessment of the impact of the intervention on PMR knowledge and practices 
was challenged by a number of limitations. These included the study design of basing 
comparisons on one or two control and intervention clusters and generating data from a 
single cross sectional survey without baseline data. Other design limitations were 
challenges around establishing control areas especially in the Bungoma-AMREF site, 
low numbers of outlets assessed and timing of the surveys. Methodological limitation 
was mainly potential information bias from the retail audit and surrogate client 
surveys. 
Despite limitations addressed in this chapter, assessment of the primary and secondary 
indicators across all sites provides strong evidence of an improvement in PMR 
knowledge and practices as a result of the programme implemented in Kisii-Merlin. 
There is also good evidence of significant improvements amongst PMRs who were 
trained in the Kwale-MoH programme. No impact of the programme was 
demonstrated in the Bungoma-AMREF site at this stage of the project cycle. Broad 
comparisons of the impacts measured in the Kisii-Merlin and Kwale-Moll 
programmes are likely to be valid, but comparisons between these two programmes 
and the Bungoma-AMREF site are challenged by limitations in the latter's evaluation, 
and differences in the phase of implementation for the evaluations in these districts. 
The data further suggest that the levels of programme implementation in the three 
districts were different. Details of how implementation experiences are likely to be 
related to the outcomes presented in this chapter are examined in chapter four. 
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CHAPTER 4: 
Qualitative assessment and policy analysis 
of implementation process 
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4.1 Introduction 
This chapter addresses objective three of the thesis: to examine the factors influencing 
programme implementation and its performance, with specific concern for the roles 
and influences of key actors, and for understanding how these experiences help explain 
programme performance in each site. In addition, this chapter explores reasons for the 
performance variations between programmes. The key questions that drive this chapter 
are: what features of programme implementation explain their individual performance 
and the differences in performance between programmes? 
The methods for data collection and analysis for this sub-study have already been 
outlined in chapter 2 section 2.9.3. After inductive analysis of empirical data a range of 
interim analyses were prepared to examine experience within and across sites around 
key issues, including stakeholder positions on the programmes. Review of these 
analyses then enabled identification of key issues in the experience for each site. This 
led to a deeper understanding of the inter-play of factors underpinning implementation 
gaps. In the next step of analysis, two conceptual frameworks (Greenhalgh et al., 2004; 
Simmons and Shiffman, 2006), were used to support further analysis of experience in 
the three sites. The study was not set up to allow propositions about factors explaining 
implementation problems and achievements to be derived from these frameworks and 
tested. Nonetheless, the use of the frameworks in analysis helped guide systematic 
consideration, both within and across sites, of factors that wider theory and empirical 
evidence suggest can facilitate or hamper effective implementation of innovative 
programmes. This process enabled reflection on explanations for the observed 
variations across programmes in the primary outcome. 
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The two conceptual frameworks are based on complementary bodies of theory, 
innovation diffiision and related policy analysis work around implementation, but draw 
on different sources of evidence. The Simmons and Shiffman framework is derived 
from consideration of experiences of public health innovation, and specifically those 
linked to reproductive health services in low and middle income settings, while that of 
Greenhalgh et al. is based on a systematic review of evidence from high income 
country experiences around the introduction of technology, products or health care 
innovations, and was developed for consideration in the health sector. 
These frameworks were used because innovation theory is directly relevant to this 
chapter's primary questions. All programmes evaluated represented innovative 
approaches to address an important public health problem: improving access to quality 
malaria treatment in remote settings. In addition, the programmes involved efforts to 
scale up PMR training from small-scale pilot activities implemented initially in small 
areas to district-wide implementation in other areas. Although activities in the 
Bungoma-AMREF site were not based on pilot activities, initial research within this 
site did change the scope of activities implemented over time and this is considered 
one form of scaling up. Overall, this analysis contributes to the scarce literature on 
innovation and scaling up of public health interventions in low and middle income 
countries (Gilson and Raphaely, 2008). The next section is a brief account of the two 
frameworks. 
4.2 Overview of the frameworks used 
The two frameworks identify five main areas of influence over the successful uptake of 
an innovation. These are the attributes of. the innovation; the resource team; the user 
organisation, the scaling up strategy, and the context. Figure 4.1 is a framework for 
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scaling up innovations in health service delivery. It identifies circumstances that may 
facilitate or hamper effectiveness and sustainability of an innovation (Simmons and 
Shiffman, 2006). The current analysis draws heavily on this framework because it 
provides ways of thinking about how to implement an innovation to achieve success. 
The additional framework presented in figure 4.2 is a conceptual model that 
illuminates some additional areas to consider when implementing an innovation 
(Greenhalgh et al., 2004). The terminologies adopted in this chapter have been derived 
from the body of knowledge underlying the two frameworks. Innovation implies a new 
set of ways of working directed to improve quality of care and implemented through 
coordinated actions. Inherent in this definition is that the innovation should have been 
tested in pilot settings and proven successftil. In addition, diffusion is the passive 
spread of an innovation whereas dissemination is an active and planned effort to 
persuade target groups to adopt an innovation. 
The first set of influences over successful innovation identified in the frameworks is 
the attributes of the innovation. Innovations can be conceptualised as having two 
distinct but interrelated aspects. The first are the actual elements of the innovation 
itself, referred to as the 'hard core'. The second aspect is the organisational structure 
and system including management required for implementation, referred to as the 'soft 
periphery'. For successful adoption the innovation should be perceived by users as 
compatible with their values, including professional norms; it should be based on 
sound evidence; and it should be easy to install and implement. In addition, success is 
likely to be experienced if the potential users see it as relevant in addressing felt 
problems and have room to modify the innovation to suit their needs. 
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The second set of influences is the resource team and its attributes. The resource team 
or change agents are individuals or organisations that have been involved in the 
development and testing of innovations and seek to promote its widcr use. Innovations 
are likely to be adopted if the resource team has effective leaders who command 
authority, respect and have considerable understanding of the socio-economic 
enviromnent in which the innovation is being implemented. There is evidence to 
suggest that their managerial skills, training capacity and ability to generate technical 
and financial resources are likely to enable adoption. 
Thirdly, the attributes of the user organisation are key to successful transfer of an 
innovation. The term "user organisation7' refers to public sector managers working at 
district level and responsible for provision of health services. The innovation is likely 
to be successfully transferred if members of the user organisation perceive the need for 
the innovation and have appropriate capacity to implement it. There is evidence to 
suggest that successful transfer is likely when the user organisation possesses effective 
leadership, is in close physical proximity and has similar characteristics to the resource 
team. Effective leadership and implementation capacity within the user organisation 
may be affected by hierarchical government systems where managers are faced with 
multiple priorities and limited resources. Success may be realised if the user system is 
characterised by individuals who are willing to support the innovation. Members of the 
user organisation with established linkages both inside and outside the organisation are 
more likely to influence adoption and ensure innovations become part of the user 
system (Greenhalgh et al., 2004). Both frameworks recognise that managing internal 
change (such as roles and adequate funding) associated with implementation of 
innovations is an important clement of success. Determinants such as technical 
capacity, managerial attitude towards change and resources are positively associated 
with the ability of the user organisation to adopt an innovation. 
194 
The fourth set of factors influencing successful uptake of an innovation is the scaling 
up strategy. Uptake is more likely if the strategy employed has clear messages on the 
merits of the innovation, systematically uses evidence on the process and outcomes 
and employs participatory approaches in implementation. The scaling up framework 
(Simmons and Shiffman, 2006), suggests that innovations that require large changes in 
impact would need extensive technical, supervisory and training support, which in turn 
require well resourced organisations. Greenhalgh and colleagues (Greenhalgh et al., 
2004) provide further evidence to suggest that if an innovation is augmented by 
training it will be more easily assimilated. Personal communication in the form of 
training, technical assistance through site visits, policy dialogues and advocacy are 
important dissemination approaches that are likely to increase the chances for adoption 
since they are interactive. Impersonal communication strategies such as policy briefs, 
web sites, manuals are essential but insufficient to scale up innovations (Simmons and 
Shiffman, 2006). 
The organizational strategies of managing the innovation adopted may also influence 
the likelihood of adoption. For example, an innovation is supported when new partners 
are brought into the promotion of an innovation, referred to as a multiplicative 
strategy, but this has cost implications and requires alignment of the goals of different 
partners to avoid tensions associated with lack of consensus. The approach is 
frustrating especially where capacity building entails training personnel who are 
subsequently transferred or leave their positions. If the innovation is directed by a 
central authority like the MoH, it is likely that the innovation will be constrained by a 
rigid process that may not take into account the local contexts. An innovation is also 
less likely to be adopted if the resource team is dominated by experts and donors than 
when there is more participation by the user organisation. The latter is more likely to 
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provide positive outcomes although capacity constraints in the user organisation may 
limit sustainability (Simmons and Shiffman, 2006). 
The pace at which an innovation is implemented may affect outcome. Gradual 
expansion through adapting it to local realties is important for successful adoption. 
There are three paths that can be pursued in the guided expansion of an innovation. 
One is replication, also referred to as horizontal expansion, where innovations are 
replicated in different locations or are expanded to cover larger populations or 
geographic areas. The second type is functional scaling up or diversification where 
new aspects are added into the existing innovation; and the third type is vertical scaling 
up, where innovations are implemented through policy or legal action (Simmons and 
Shiffman, 2006). 
The fifth and last set of factors influencing innovation success concerns the wider 
context and how unexpected circumstances that arise are managed. For example, 
political directives may include a 'policy push' in the initial stages of implementation 
and may boost the chances of an innovation succeeding by making financial resources 
available for implementation (Greenhalgh et al., 2004). Taking advantage of policy 
windows (opportunities where policy initiatives are supported) may also enhance 
uptake although long term sustainability may be dependent on resources and sustaining 
the enthusiasm after the policy window is over (Simmons and Shiffman, 2006). 
Another important contextual feature is the bureaucratic process of the public sector. 
Public sector bureaucracies implement policies enacted by political bodies. Many of 
them are slow characterised by staff with low salaries, infused with political interests 
and guided by many laws (Simmons and Shiffman, 2006). In terms of authority, 
bureaucracies vary, with some institutions having considerable authority while others 
have minimal legitimacy which accomplish little. By understanding such environments 
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it is important to identify constraints and enabling factors at the onset. This may entail 
identifying environmental opportunities through analysis of external conditions in the 
planning phase. If the resource team understands and identifies the kind of bureaucratic 
environments they are dealing with they will be able to navigate it for successful 
implementation. Other factors such as socio-economic and cultural forces may also 
shape the demand and supply of services in question and so either constrain or provide 
opportunities to scale up the innovation. 
The two frameworks illustrate that the five sets of factors do not operate in isolation 
from each other. Linkages among them may themselves bring about intended or 
unintended outcomes. For example, effective inter-organisational communication 
between the user organisation and resource team is likely to enhance implementation 
of the innovation. In particular, complex innovations require active management of 
inter-organisational networks and timely feedback on the implementation process for 
success. Overall, both frameworks highlight factors to consider in examining 
innovations for successful transfer to the user organisation, either when the focus is to 
spread nationally or in localised health systems. Both frameworks also recognise that 
this process is not insulated but is shaped by local and international forces. 
4.3 Implementation experiences of evaluated interventions 
The second part of this chapter summarises the implementation experiences of the 
evaluated interventions in Kisii, Kwale and Bungoma districts vAth a focus on 
implementation gaps, defincd as differences between what was intended and what was 
implemented in practice, the role of actors and relative power relations. Key elements 
of the intervention were summarised in table 2.3 in chapter two, section 2.5.1. The 
table drew out implementation gaps that were considered an important influence over 
the primary outcome of interest. This section is structured around the intervention 
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design, the management model of the intervention and the role of actors and relative 
power relations. The implementation experiences are later analysed to illustrate how 
they influenced process and outcomes in section 4.4. 
43.1 Intervention design 
This section addresses the "hard" core elements and the "soft periphery" of the 
innovation and highlights implementation gaps. All the innovations were characterised 
by a number of common attributes. Across all sites, the innovations aimed at 
improving home treatment of fevers with first line anti-malarial medicines. Tley were 
based on research conducted in malaria endemic areas which showed that training 
PMRs to provide adequate advice on anti-malarial use improves their performance 
(Goodman et al., 2007a). The approach of training PMRs differed considerably from 
the conventional ways of delivering malaria treatment services. 
Integrated within the hard core elements of the innovation are two sets of users. The 
first set comprises the district health managers, who are considered here as the user 
organisation. The second sets of users are the beneficiaries: PMRs and community 
members. Both groups are innovation adopters but the role of PMRs in practising the 
innovation was significant to its success, as it specifically sought to change their 
practices. In this study the practices of community level actors are considered an 
integral part of the innovation. Community members and local leaders were key actors 
involved in creating demand for the services of the innovation. Another set of 
community level actors were the CORPS involved in the Kwale-Moll site. Their role 
in recruitment, monitoring, supervision and demand creation aimed to ensure 
sustainability of the innovation and strengthen local regulation of PMRs' activities. 
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Across all sites, there were variations in the hard core elements of the innovation that 
were planned for implementation and were actually implemented. In the Kwale-MoH 
site, planned refresher training was not implemented. In terms of demand creation, 
implementation gaps were identified in the Kwale-MoH and Bungoma-AMREF sites. 
Public information activities planned in the Kwale-MoH site were not implemented 
while in the Bungoma-AMREF site there was incomplete implementation of the JKJ 
strategy which was introduced in phase three to strengthen demand. Another element 
of the innovation was accreditation with the main implementation gap observed in the 
Kwale-MoH site where trained PMRs were not issued with certificates in recognition 
of their trained status. 
Common strategies to motivate those within the user organisation and PMRs to 
implement the innovation were present across all sites. For actors from the user 
organisation and PMRs, allowances for lunches and transport during training were 
important motivators, with members of the user organisation in the Bungoma-AMREF 
site receiving higher allowances compared to the other two sites. Additional 
motivating element for PMRs was profit making, largely through stocking goods with 
a low profit margin and rapid turn over. A key motivator was the potential to increase 
profits by selling anti-malarial medicines in adequate doses, since these medicines 
were generally sold in under-doses prior to the intervention (chapter one). However, 
costs of purchasing expensive stock of anti-malarial medicines compared to anti- 
pyretics, lowered this profit and yet trained PMRs were also obliged to incur costs 
associated with time spent in training and advising their clients, and would not 
necessarily be able to recoup these due to the inability of customers to afford 
expensive medicines. They had the additional social costs of the extra responsibility 
that goes with being an advisor. 
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In summary, the Kisii-Merlin site implemented practice matched intentions in all 
important respects at the time of study. In contrast, in the Kwale-MoH site there were 
four important gaps between implementation intentions and practice: baseline data 
were not used in the design of the innovation; public information campaigns were not 
conducted; trained PMRs did not receive certificates to prove qualification, and trained 
PMRs were not monitored or followed up. Similarly, in the Bungoma-AMREF site, 
incomplete implementation of the JKJ strategy as well as delays in the production and 
delivery of IEC materials were key gaps relative to intentions. The ways these 
experiences shaped programme effectiveness is discussed in section 4.4. 
43.2 Management model of the innovations. 
The management approach of each of the implementing team determined the type of 
scaling up strategy used in implementing the innovation. In the Kisii-Merlin and 
Kwale-MoH sites, the implementation process targeted geographical divisions with 
gradual expansion through replication of activities to other areas with the aim of 
covering the entire district. The type of scaling up used in the two sites can be tenned 
horizontal scaling up. The Bungoma-AMREF site, a social marketing programme 
applied more of a functional, diversification or grafting scaling up strategy. The 
process entailed adding a new element (the JKJ-strategy) to the existing innovation 
(VTV training) on the basis of research outcomes. Once the experience on the 
elements of the innovation was gained within the district, then the approach was 
popularised to other districts interested in the approach. 
All the innovations were implemented within a wider context of malaria control 
activities. For example the innovation in the Kisii-Merlin experience was part of the 
wider malaria control activities in the district. The Kwale-MoH innovation was part of 
a national programme for training PMRs within the DoMC. Kwale was one of the 
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districts chosen for demonstration programmes to inform further scaling up activities. 
The Bungoma-AMREF innovation was implemented within a larger BDMI project 
which was built on developing partnerships with several agencies and institutions. 
The final characteristic of the management model relates to the decision making 
processes. In the Kisii-Merlin innovation, implementation was driven by action 
research reflecting ability to adapt the innovation to the local environment. Decision 
making was decentralized to local Merlin offices allowing local initiative, mutual 
learning and problem solving. Decisions about adaptations were made on site after 
consultations with relevant actors. In contrast, the Kwale-Moll innovation was run by 
the user organisation with a less flexible decision making process given that it was 
implemented within a government system. Although extensive research had been 
conducted on how to adapt the innovation to local realities (Marsh et al., 2004), the 
planning process for the innovation did not generally take these lessons into 
consideration during implementation. The Bungoma-AMREF site had a relatively 
flexible decision making process but changes made utilised research experiences to 
guide the design and implementation process and established indicators for measuring 
project success. 
4.3.3 RoIcs of actors 
The innovations were implemented by a combination of actors outside and within the 
district health system. Actors outside the district health team provided technical 
support to the district health managers and are referred as the resource team. This team 
worked with the district health managers described earlier as the user organisation. 
This section provides a description of the identity and role of the resource tcams and 
user organisations and their interests in the programmes, drawing on tables 4.1-4.3 for 
the Kisii-Merlin, Kwale-MoH and Bungoma-AMREF sites respectively. 
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In the Kisii-Merlin and Kwale-MoH sites (table 4.1 and 4.2), there were fewer actors 
involved from the user organisation compared to the Bungoma-AMREF site (table 
4.4). Across all sites a core team of individuals acted as a bridge between the resource 
team and the user organisation. In the Kisii-Merlin site (table 4.1), the resource team 
selected a core team which comprised a project coordinator, a senior programme 
officer and two field officers working with two PHOs from the user organisation. In 
the Kwale-MoH site (table 4.2) the user organisation selected one divisional PIIO to be 
the core person mandated to work with other divisional heads to implement the 
innovation. The corc pcrson was also rcsponsible for collating infon-nation about the 
innovation for both the resource team and user organisation and liased vdth other 
divisional level actors to implement the innovation. 
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The core team in the Bungoma-AMREF site was selected by the user organization on 
the basis of the actors' roles in the district health system and comprised six members 
of the user organisation (table 4.3). At the district level the external partners through 
AMREF requested the user organisation to select a core team to spearhead the 
innovation. The intent was to cover all the departments perceived relevant to the 
innovation. Overall, the role of the core team across all sites was intended to be those 
that of a policy champion, that is, to harness support within the organisation, facilitate 
implementation and strengthen linkages between the relevant organisations 
(Greenhalgh et al., 2004). 
Across all sites, the primary role of the resource team was to provide technical support 
to the implementation of the innovation. Composition of this team varied in each site. 
Tables 4.14.3 also indicate that the resource teams had technical skills relevant to 
designing elements of the innovation. In the Kisii-Merlin site, the resource team within 
Merlin comprised members of the core team supported by officers from other 
departments such as IEC, monitoring and evaluation. This group worked closely with 
PHOs in charge of the implementing division (table 4.1). In the Kwale-Mol I site, the 
resource team comprised officers from the DoMC and actors from the KEMRI- 
CGMRC (table 4.2). The Bungoma-AMREF site had a large number of actors as a 
resource team ranging from representatives of the funding agencies-USAID, CDC, 
AMREF and IEC specialists (table 4.3). In the Kisii-Merlin and Bungoma-AMRE-F 
site, the resource team controlled funding for the innovation. In the Kwale-Moll site 
the resource team were involved in the initial piloting of the innovation outsidc the 
district. This was a facilitative team working within government funding structures. 
Most of the resource team members in the Bungoma AMREF and the Kwale-Moll site 
were not resident in the sites. 
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In terms of the management structure, in the Kisii-Merlin experience, the resource 
team was managed in an organisational environment structured around five 
departments with clear job descriptions. In the Kwale-Moll site, the overall 
responsibility for the implementation lay in the district public health office. The 
resource team utilised the existing government structures. The Bungoma-AMREF site 
was characterised by an external technical team and donor representatives. They were 
short term consultants (CDC/QAP) who worked through the government system while 
partnering with AMREF. At the district level, the user organisation was responsible for 
planning, implementation, training, supervision and deployment of staff for operational 
activities. 
The user organisations, across all sites comprised district health managers and the 
divisional implementing teams. In the Kwale-MoH site (table 4-2), three district 
managers were involved, two in the Kisii-Merlin (table 4.1) and four in the Bungoma- 
AMREF site (table 4.3). They supervised PHOs in charge of the divisions where the 
innovation was implemented. Their roles in coordination and logistical support for the 
innovation influenced process and outcome (section 4.3). In the Kisii-Merlin site, the 
user organisation was characterised by stable leadership unlike the other sites. For 
example, there were no transfers of personnel who had been inducted on the 
innovation during the implementation phase unlike the other two sites. In the 
Bungoma-AMREF and the Kwale-MoH site, the burden of implementing the activities 
was placed on the core team with support from the resource team. In the Kisii-Merlin 
site, the resource team took the responsibility of most of the implementation activities. 
Finally as part of the "soft periphery" all the innovations were linked to actors beyond 
the district level and other local actors. Networks and collaborations provide resources 
that facilitate implementation and contribute to its sustainability (Greenhalgh ct al., 
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2004). In the Kisii-Merlin experience, actors beyond the district level were involved 
through linkages developed by the resource team. In the Kwale-Moll site the DoMC 
formed part of the resource team (table 4.2). In the Bungoma-AMREF experience 
(table 4.4), the resource team included representatives of donor agencies and technical 
partners and were instrumental in influencing decisions on the implementation process. 
Networks with local actors varied. Networking in the Kisii-Merlin experience were 
characterised by more formally constituted networks at the district level than the other 
two sites. The Bungoma-AMREF innovation included networking with existing 
partners such as governmental, private institutions, the community, NGO's and the 
donors. In the Kwale-MoH site, partnership was developed with communities through 
the involvement of CORPS but other local organisations were not drawn into 
supporting the innovation. These networks, and their importance, are discussed in 
section 4.4. 
4.3.4 Actors' interests and influence over programme implementation 
Tables 4.1-4.3 include infonnation on actors' interests, level of power and influence 
over implementation for the Kisii-Merlin, Kwale-Molf and Bungoma-AMREF sitcs 
respectively. 
Empirical work illustrates that power matters to implementation and policy outcomcs. 
In a recent article on how to investigate power, authors outline a number of theoretical 
insights on the practice of power in implementation (Erasmus and Gilson, 2008). They 
include the top-down theory which emphasises power as the coordination and control 
by those with authority at upper hierarchies where implemcnters are tasked with 
executing the plans to achieve policy objectives. The bottom-up theory has divcrsc 
range of explanations with some emphasising power as consensus building to gain 
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influence whereas others view power as conflict and bargaining. The key issue is 
around the discretionary power exercised by implementing actors since central 
decision makers cannot foresee all the circumstances that must be addressed in 
implementation. Others describe power by looking at how people give meanings to the 
language of policy. These interpretations influence individuals' responses to policy 
interventions. Policy language can be constructed not only by politicians or senior 
goverrunent officials but is also constructed by implementers who interpret policy for 
themselves and their clients (Erasmus and Gilson, 2008). These theoretical positions 
show that power is multi layered but does not necessarily provide sufficient 
information on ways in which power is exercised. Authors of this article go further to 
provide empirical examples of how power was exercised in hospitals and clinics 
(Erasmus and Gilson, 2008). The methods used to investigate power in this study were 
largely drawn from the article by Ermin and Gilson (2008). 
In this study the term power is used to mean an actor's ability to influence the 
implementation process either by directly or indirectly resisting or supporting the 
innovation. Two power issues were examined here. First, the source of power, where, 
for example, actors may derive their power from the discretionary authority of their 
offices, their professional roles, their roles in the implementation, their personal 
characteristics or links established to networks. The second aspect examined was how 
power was exercised by various actors in the implementation process, idcntif'ied from 
any evidence of the actors' actual influence over the process and on the outcomes of 
interest. This can be shown, for example, when actors adapt policy or interpret it to 
address their own understanding of local needs (Erasmus and Gilson, 2008). 
Information on power was collected in three main ways. First, in-depth interviews on 
the role of actors in the innovation and the factors that may have hindercd or facilitated 
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their role in the implementation process provided empirical data on power. Secondly, 
by keeping a field diary of events, informal discussions and observations over the 
period of data collection a deeper understanding of existing relationships amongst 
actors was developed. Both methods enabled understanding of actors' interests in the 
innovation and how these interests influenced the implementation process. Finally, a 
review of documents allowed an understanding of the role of actors and their potential 
source of power. This was triangulated with interview and observational data. 
A stakeholder analysis was also conducted (Varvasovszky and Brugha, 2000) to 
examine how the power balances among actors influenced the implementation process. 
This analysis allowed a deeper understanding of the influence of power dynamics 
between actors and helped examine the characteristics of the user environment. Using 
data from the sources described above, information on the power of different actors 
and its implications for implementation and outcomes is presented in a force field 
analysis. This is a useful technique for looking at all the forces for and against a 
decision. It is a way of organising and presenting the outputs of a stakeholder analysis 
(Varvasovszky and Brugha, 2000). The information used in the force field analysis is 
drawn from tables 4.14.3. Figure 4.3 is a force field map for the Kisii-Merlin site. 
Two force field maps are presented for the Kwale (Figures 4.4 and 4.5) and Bungoma- 
AMREF (Figures 4.6 and 4.7) sites since different actors were involved at different 
times of implementation. 
In the Kisii-Merlin site, figure 4.3 shows that there was no opposition from any actor, 
but some variation in levels of support. Members of the resource team, including the 
project coordinator and senior programme officer, had relatively high power and were 
supportive of the innovation. They also had a positive influence (enabling 
implementation in accordance to plans) of the innovation. For example, they made 
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resources available on time to implement the hard core elements of the innovation 
and supported the core team members in terms of skills and materials necessary for 
implementation. On the other hand, members of the user organisation had middle 
support for the innovation, which provided a relatively conducive environment for 
successful implementation of the innovation. This ensured completion of most hard 
core elements of the innovation on time, contributing to the relative success observed. 
The PHOs were also actively involved in previous malaria control activities. They 
wielded medium power and were generally the link between the user organisation and 
the community in terms of health matters. Their role in the innovation positively 
influenced implementation and acceptance at community level. Acceptance generated 
demand which contributed to the relative changes in knowledge and practice observed. 
in the other sites there was opposition from different actors at different phases of 
implementation. In both sites, the resource team wielded relatively high power and 
were supportive of the approach. In the Kwale-MoH site (figure 4.4 and 4.5), the 
resource team were actors involved in popularising the innovation and supported the 
innovation. In the Bungoma-AMREF site (figures 4.6 and 4.7) the resource team 
involved a number of different organisations with different interests. They all 
supported the innovation and exhibited relatively high power because of their technical 
expertise and financial resources wlýich gave them decision making powers. I lowcver, 
in the process of achieving their goals, tensions between actors emerged and hampered 
successful adoption of the innovation (section 4.4). 
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In the Kwale-MoH and Bungoma-AMREF sites, (figure 4.5.4-6), most core team 
members were supportive of the innovation because their interests lay in ensuring 
implementation success. However, the pharmaceutical technologist in the Bungoma. 
AMREF site (figure 4.6) had slightly less support for the innovation because he had 
minimal involvement in the implementation process, advising the core team on the 
legal status of medicines. In the Kwale-MoH site, in contrast, the core person was 
selected to oversee the implementation because he was a strong facilitator. This 
position drew more interests thus supportive of the innovation. The position of the 
divisional level PHOs did not change over time and generally drew low support. 
Support for the innovation from the user organization varied across the two sitcs. 
Figure 4.4 show variations in the position of different actors in the user organisation in 
the Kwale-MoH site. The user organisation was characterised by changes in district 
leadership and tensions between members, which affected implementation of various 
activities and contributed to lower outcomes compared to the Kisii-Merlin experience. 
At the district level, DMOH_I (district health manager in charge of the district during 
the set up phase) opposed the innovation in the set up phase because of the unclear 
processes of ftmding and uncertainty about the value of this innovation in the district 
health system. His opposition led to delays in setting up the innovation. During the 
tenure of DMOH_2, there were no implementation activities. His successor 
(DMOH_3) was partially supportive after being briefed of the activities during the 
continuation phase, enabling implementation. She attended a few of the PMR training 
workshops which motivated the divisional level actors. The DPHO had a powerful 
position but his support for the innovation was in the middle through out the set up and 
continuation phase influenced largely by his poor relationship with other district heads 
(figure 4.5). For example, his relationship with the DMOII_3 delayed planning and 
supervision of the implementation process. The DHEO did not have officers at the 
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local levels that would have supported implementation of the innovation. Ile was 
therefore not involved in most of the implementation activities. As a result of his off"Ice 
he wielded low power and was non-mobilised but his exclusion reprcscnts a lost 
opportunity for supporting implementation. 
In the Bungoma-AMREF site (figure 4.7), there were some opposition observed from 
actors at the divisional level of the user organisation. They were less involved in the 
initial stages, affecting implementation of public information activities. The DPIIO 
had medium power and was supportive in the set up phase but with time this drifted to 
opposition because of a lack of involvement. The innovation was run by his 
department but instead a junior officer was involved during the implementation 
process (figure 4.7), representing a lost opportunity for the innovation. Similarly the 
PHO and PHTs had high power and opposed the innovation because they were not 
involved in the earlier phase of the VTV training. They perceived themselves as 
having been left out although the programme was driven by their department. -nicir 
involvement was only during the JKJ phase influencing support for implementation of 
the JKJ activities. Although the DMOH's position did not change over time, his 
relatively high power diminished to medium power because of his minimal 
involvement at later stages in actual implementation of activities. However, his middle 
support facilitated implementation by virtue of his off"ice through release of funds and 
coordinating reporting systems. The next section addresses factors that influenced the 
implementation process and outcomes across sites. It draws from the implementation 
experiences described above and other evidence from the analysis, and is framcd by 
the conceptual frameworks already described. 
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4.4 Explanatory factors influencing implementation process and 
outcome 
This section presents an analysis of explanatory factors underlying the differences in 
outcomes observed across the three programmes. Table 4.4 summariscs the main 
indicators measured across sites. Data presented in chapter three shows that the Kisii- 
Merlin programme performed better than the other sites on all dimensions examined. 
The programme had a significant, and greater, impact on PMR knowledge and practice 
than elsewhere and achieved higher coverage levels. Planned activities were 
implemented as expected and the overall performance seems to have been underpinned 
by good management of the implementation linked to the strengths of the resource 
team, good relationships with the user organisation and supportive management 
procedures. The Kwale-MoH programme 17 , meanwhile, 
did impact significantly on 
PMR knowledge and practice, though not across as many indicators as in Kisii, but 
coverage was low. Not all planned activities were implemented and the programme 
was characterised by managerial challenges compounded by a complex implementing 
context. Finally, in the Bungoma-AMREF site, the study was unable to show an 
impact on PMR knowledge and practice. As described in chapter 3, this may be 
attributable to methodological challenges as well as differences in the phases in which 
it was evaluated. Implementation processes in the Bungoma-AMREF programme 
makes a particular contribution, therefore, to issues of sustainability. I lowevcr, at the 
time of evaluation, the coverage levels were similar to Kwale but lower than Kisii. 
Although it was well resourced, not all planned activities were implemented. Thc 
programme had limited efforts to work with and through local managers to sustain 
implementation within the local setting. 
17 Kwale has been taken as a case study for Moll PMR programme in this thesis, its important to note that 
similar MoH programmes in other districts have been shown to have greater and more consistent impacts on 
PMR knowledge and practices see annex I 
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Table 4.4 Summary of key indicators measured across sites 
Indicators Kisii- I 
Merlin 
Kwale- Bungoma- 
MoH AMREF* 
Indicators of differences in practice 
% asking at least one danger sign _Vt xI x 
% asking about age of user N/ x x 
% sold anti-malarial medicine for fever _V %/ x 
% sold AQ medicine for fever _V x 
% selling AQ in adequate doses§ V x 
Indicators of differences in Knowledge 
% recommended anti-malarial medicine for fever N/ x 
% recommended AQ medicines V x x 
% recommended AQ adequately _1/ V x 
*The study unable to illustrate impact at this stage ofprogramme evaluation; fV significant differences between 
intervention and control areas where trained PAIRs performed better than controls; I Xno significant differences 
between the intervention and control areas, § The main primary indicator for assessingpractices ofPMRS, 
11 the main secondaiy indicatorfor assessing knowledge of trained PMRs 
This section explores the reasons for this variation in outcomes by examining the five 
main areas identified from innovation literature that are likely to influence the 
successful uptake of an innovation. These include the innovation, resource team, user 
organisation, scaling up strategies, and the wider context. Through out the discussion 
actors are central and their role and influence on implementation is drawn from the 
stakeholder analysis. For each of these areas, the factors identified from empirical data 
of this study as influencing process and outcomes are discussed. This discussion first 
presents explanations that provide evidence for the relative success of the Kisii-Merlin 
programme; thereafter a contrast is provided for the factors contributing to the 
variations in perfonnance of the other two programmes. 
4.4.1 Explanatory factors influencing implementation process and outcome in the 
Kisii-Merlin experience 
4.4.1.1 The innovation and its attributes in the Kisii-Merlin site 
This section considers how implementation of key hard core and soft periphery 
elements of the innovation contributed to the relative success of the Kisii-Merlin site. 
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The explanations also identify the attributes of the innovation that may have 
contributed to relative success as described in section 4.2. 
The strengths of the innovation in the Kisii-Merlin programme included the planning 
of face to face training by the resource team around a community timetable. This was 
in response to the socio-economic and cultural activities of the community such as 
farming that affected the number of PMRs who attended workshops or were available 
in their shops during follow ups. The proportion of targeted PMRs who were recruited 
into the programme was higher in the Kisii-Merlin than the other sites. This was 
attributed to the flexibility in the planning of training sessions (around a community 
timetable). This also led to follow ups resulting in timely supervision ensuring that 
knowledge gained was sustained. In contrast, there was less flexibility in the other sites 
around planning of activities, and a lower proportion of targeted PMRs were recruited. 
There were however, other factors that contributed to low recruitment, as will be 
discussed later. Overall, ability to modify the innovation to suit local needs, an 
attribute identified in section 4.2, may have been a factor that enabled implementation 
of the innovation to achieve higher impacts compared to the other sites. 
Demand creation in Kisii relied on community sensitisation and on a continuous 
process of producing and distributing a variety of IEC materials for households and 
community members. These targeted various elements of malaria control such as fever 
management at home, malaria in pregnancy and use of ITNs. The materials were 
produced in the local language to ensure easy understanding. In the course of 
implementation, the resource team also produced durable wooden posters in the local 
language to help direct customers to trained outlets, and to encourage PMRs to adhere 
to the knowledge gained. The use of local language was also used in the Bungoma- 
AMREF but not the Kwale-MoH site. However, use of durable posters was uniquc to 
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the Kisii-Merlin site. The comprehensive package of demand creation and continuous 
information flow to community members may have contributed to relative success of 
the innovation. 
A unique element of the innovation compared to other sites was record keeping using a 
pre-defined structure and kept by the PMRs. Record keeping allowed PMRs as end 
users to see the results of the innovation, which is one attribute that contribute to 
successful adoption of an innovation (Simmons and Shiffman, 2006). For example, 
record keeping allowed PMRs to monitor trends of cases they treated and enabled them 
to make informed opinions on the seasons when fevers were on the rise to allow stock 
build up. As one retailer pointed out: "It enables you to know a period when you need 
to stock more drugs from the record that you have kept". Record keeping also 
maintained some level of accountability. For the resource team, the records allowed 
them to access information for monitoring and facilitated report writing for use by both 
the funding agency and the user organisation. It also motivated PMRs to continue 
practising their new skills: "When I went through my records I realized that in the 
month ofMay we had many malaria cases. I sold up to four packets of Malaratabo a 
month... "(PMR). 
The use of specific selection criteria for programme PMRs was a feature of the Kisii- 
Merlin programme as well as being used in Kwale. A main criterion was that outlets 
must have anti-malarial medicines in stock at the time of recruitment. Selecting outlets 
stocking anti-malarial medicines aimed to maximise programme efficiency by 
targeting PMRs who were in a position to utilise the knowledge gained in training. 
This criterion was important because it was well recognised from the local operational 
research that many PMRs do not regularly stock anti-malarial medicines, but choose 
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instead to sell cheaper products with a higher turnover, such as antipyretic medicines 
(Muturi, 200 1). 
Finally, although the resource team dropped refresher training for logistical reasons, 
they instead enhanced supportive supervision. 'Ibis entailed reviewing retailer records 
with PMRs to understand the extent to which they had practised the innovation. This, 
in turn, created some level of alertness among PMRs about their practices which 
facilitated adherence to training messages. This form of support supervision was 
unique to this site. 
4.4.1.2 The resource team and its attributes in Kisii-Merlin site 
The section addresses issues around the attributes of the resource team and its power 
over implementation process and outcome. Merlin had worked in the district since 
1999 supporting epidemic management of malaria, and had been involved in the 
implementation of other programmes with the DHMT before this innovation. The 
success of the previous programmes generated a positive image among the user 
organisation enhancing Merlin's credibility and authority a feature necessary for 
successful adoption of an innovation. As was mentioned in section 4.3.3, members of 
the resource team were also residents in the district closer to the user organization. 
Physical proximity enabled frequent contacts with the user organisation where any new 
information on the innovation was easily shared building capacity and supporting the 
development of a relationship of trust. It also enabled the resource team to understand 
the user environment and recognise potential constraints of the user organisation. 
Further, provision of technical support (involving sharing roles in monitoring and 
supportive supervision) enabled implementation of the innovation and potential 
sustainability in the long term. 
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Members of the resource team had long experience in strategic thinking and 
operational research around the role of PMRs in malaria control. This means that they 
had relevant technical skills and ability to impart skills on the innovation. The project 
coordinator and a field officer were involved in the development of this approach 
during pilot studies in Kilifi district in 1998 (Marsh et al., 1999). The project 
coordinator was a member of the DoMC working group that promoted the innovation 
into a national policy. "I have been involved in the shopkeeper training programmefor 
a long time and some of the challenges I have already gone through them in other 
settings. So it was quite easy for me to have a picture of where the programme is 
going, the challenges you are likely to encounter and how we have dealt with them in 
other settings. "(Resource team member). 
The next set of paragraphs examines the organisational environment of the resource 
team. Theoretical frameworks described in section 4.2 identify organisational 
strategies as important influence over successful adoption of an innovation. 
Organisational strategies reflect on management practices of the resource team which 
have a bearing on their management skills, a necessary attribute for successful 
adoption (section 4.2). The resource team was not only well funded but worked within 
a system that had an efficient process of disbursing funds for implementation (figure 
4.8). 
Figure 4.8 Funding mechanism of the Kisii-Merlin site 
Donor funds were banked in Merlin's headquarters in the UK. During 
implementation, money was transferred to the Kenya Country off ice based on the 
monthly budgets prepared and submitted through the local finance department. A 
weekly verification of receipts ensured that all expenses were monitored. At the 
local field site, money for various activities was requested through filling in forms 
which had to be signed by the senior project officer then submitted to the project 
coordinator who authorized use of funds. In the field, allowances were paid to 
participating MoH actors. Payments were guided by an MoU drafted and agreed 
upon by Merlin and the DHMT. Retailers were paid a flat rate for transport and 
lunch and not compensated for their time in training. 
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The funding process described above shows that the resource team had some 
autonomy in decisions about how to use the available funds and had a relatively 
flexible funding process. This gave it power in implementation. This was in contrast to 
the Kwale-MoH site which had a complex funding process tied to the government 
financial management system. A flexible funding process facilitated changes in the 
implementation of some of the hard core elements of the innovation. For example, in 
response to suggestions from PMRs on the need to allow more time to understand the 
content of training, the resource team prolonged the number of training days from two 
to three. Modifying the innovation in this way promoted understanding and contributed 
to improved knowledge and PMRs practices compared to the other sites. 
Other aspects of the organisational environment were a flexible local management 
system. For example, with the introduction of new programmes focussing on 
HlV/AIDS into the local Merlin site office in Kisii, Merlin re-organised its local staff 
to set aside a core team which focussed on the PMR innovation only. This improved 
efficiency in implementing the PMR innovation and allowed the development of 
expertise in the innovation. Another example of a flexible management system was the 
establishment of an IEC department to improve efficiency in the production of IEC 
materials. This was meant to support local malaria control activities. Production was 
either done at the local site or outsourced where the latter option took advantage of 
economies of scale or when production required technology unavailable locally. The 
process of IEC production ensured continuous production of quality materials which 
took account of local needs and supported demand creation throughout the 
implementation process. The IEC department supported the development of 
communication approaches to include targeted dissemination of IEC materials through 
schools, churches and organised community groups as well as traditional public 
campaigns through community gatherings. Overall, it is likely that wide availability of 
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information contributed to the greater changes in PMRs practice seen in the Kisii- 
Merlin site compared to the other sites. 
The local management system was also characterised by an efficient mechanism of 
managing inter-organisational relationships especially with the user organisation. 
Ability to manage relationships may have enhanced the resource team's power to 
support implementation by offsetting potential opposition from actors in the user 
organisation, as well as enabling a supportive user environment described in section 
4.3.3. Relationships between the resource team and user organisation were managed by 
an MoU introduced in the initial stages of implementation by the resource team. The 
MoU was negotiated though a common meeting with the DHMT where copies were 
made available for the user organisation, who communicated the contents to their staff. 
it spelt out roles of the resource team and the user organisation, how to share resources 
(human, financial and materials) during the implementation of Merlin's programmes in 
the district. 
The MoU was important in managing financial expectations between the user 
organisation and the resource team, reducing the barriers for successful adoption of the 
innovation and increasing its support. Merlin's role was to facilitate implementation, 
since they did not have staff on the ground to support the innovation and therefore 
relied on the MoH staff to conduct activities such as monitoring. Clarifying and 
agreeing on roles for different actors enabled constructive participation in the 
innovation and resulted in completion of most hard core elements of innovation. 
Although the resource team found the process of negotiating the MoU challenging, this 
agreement facilitated implementation as quoted by a member of the resource team; 
"One thing which has been very outstanding is the Mo U, I have found it facilitating, 
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because when you link with the AfoH and you introduce things people will come to 
the officers in the ground and will complain especially in terms of thefield allowance. 
But the MoU has really made it very easy because that could have been a major 
problem. " 
Another organisational feature was the development of networks with agencies at the 
district level or outside the district mentioned in section 4.3.3. Figure 4.9 summarises 
the nature and consequences of networking developed by the resource team. The 
networks represent both ends of a continuum from intermittent collaboration to 
formalised alliances (Jones, 2007). 
Figure 4.9 Networks and its consequences in the Kisii-Merlin site 
The Merlin innovation was characterized by a well structured system of networking 
with partners. At the national level this was through formal alliances with 
KeNAAM for advocacy in the DoMC. This enabled Merlin to receive funds from 
GFTAM on top of the funding from the Government of Finland in 2006 to roll out 
retailer training to other divisions. Informal links with the provincial management 
committee developed support of implementation of the innovation through 
reporting and feedback. At the district level, formalised alliances with ICIPE, 
DHMT and intermittent temporary cooperation with other NGOs in the district 
enabled resource sharing and access to technical expertise. At the programme level, 
Merlin developed links with PSI which supplied ITNs for distribution as part of 
wider malaria control activities. Linkages with World Vision was also a temporary 
alliance driven by resource sharing (technical and financial) to avoid duplication of 
activities through curving out areas for different programme implementation. 
Collaboration with ICIPE represented a formalized alliance through a joint 
proposal. ICIPE's technical expertise in vector control research allowed Merlin to 
direct its innovation on the basis of evidence. At the community level Merlin linked 
with administrators, communities and retailers through sharing of information and 
establishment of Locational Afya committees for mobilization of communities 
strengthening grassroots support. 
At the national level, collaboration with the DoMC through KeNAAM, allowed the 
resource team to learn at an early stage about the changes in drug policy that came into 
effect in 2005 and therefore, to make prompt changes to the IEC materials. Again this 
enhanced their power to support implementation. However, some collaborative efforts 
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at the district level were counterproductive. For example, in some instances PSI 
supplied IT'Ns to Merlin for distribution through their existing infrastructure. As a 
result of these activities, some community members perceived Merlin as a well 
resourced aid agency, leading to increased financial expectations of free drugs amongst 
PMRs. 
Finally, the resource team developed monitoring and evaluation activities as part of the 
management of the innovation. The continuous and reliable nature of these activities, 
conducted by a department within the resource team, facilitated evaluation of the 
implementation progress and emerging problems to be acted upon. Emerging issues 
were communicated on time to actors both in the user organisation as well as PMRs. 
This information flow between the user organisation and the resource team helped to 
build trust and acceptance of the innovation within the user organization. 
4.4.1.3 The attributes of the user organisation in the Kisii-Merlin site 
'Me third set of factors that influenced outcomes are the attributes of the user 
organisation. Firstly, the user organisation was characteriscd by stable leadership with 
minimal transfers of actors involved in the innovation from the district compared to 
Kwale and Bungoma sites (section 4.3.3). Throughout the implementation phase the 
user organisation was led by one DMOH who supported the innovation (figure 4.4). 
This created a relatively stable environment in terms of support and expertise 
necessary for the implementation. 
The user organisation offered a supportive environment for the implementation of the 
innovation. This observation was derived from the stakeholder analyses presented in 
section 4.3.3. Table 4.1 for example shows that the roles of the DMOII and DPIlO 
were crucial in providing an enabling environment for implementation. As a result of 
232 
these roles and their positions, and the stability of their posts, the DPHO and DMOH 
wielded relatively high power which positively enabled hard core elements to be 
implemented (figure 4.3). Through their relative power they ensured smooth process of 
planning and identified cffective divisional level actors who participated in the 
implementation process. For example, the user organisation identified experienced 
PHOs for the core team who were aware of the community dynamics: "You know 
different communities have different attitudes and my longer stay here has prepared 
me well to understand the i)pe ofpeople Ideal with so that when Igo there, I know the 
type ofmechanism to put in place so that I can win them. So I think that enabled me to 
achieve a lot" (Core team member). 
As was mentioned in section 4.2, an innovation is likely to be adopted if the user 
organisation perceives a need for the innovation and how it works (Simmons and 
Shiffman, 2006). One of the positive attributes underlying this programme was its 
relevance in addressing felt problems among the user organisation, PMRs and clients. 
The user organisation supported the innovation based on their experiences on the need 
to change PMRs practices given that most community members sought care from the 
retail sector. This was enhanced by directing the innovation to areas where malaria was 
pronounced. "In Kisii Central, this programme took place in Kiamokama and 
Mosocho. These areas were facing the greatest malaria problems according to the 
ICIPE research; which was directing Merlin to areas where malaria was a big 
problem". This remark from a member of the user organisation reflects the way that 
perceptions of the relevance of the innovation generated appreciation and a supportive 
user environment. 
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4.4.1.4 Scaling up strategy in the Kisii-Merlin site 
This section presents the fourth set of factors that influenced success around the 
scaling up strategy adopted. In the Kisii-Merlin site, as in Kwale but in contrast to 
Bungoma, the actors adopted a horizontal scaling up system (Simmons & Shiffman, 
2006). 'Ibis enabled a focussed approach in implementing the innovation geared 
towards ensuring success at each stage of implementation. Ibis also allowed personal 
contacts with PMRs enhancing communication and feedback. Personal communication. 
has been identified as an attribute of the scaling up strategy that may support adoption 
of the innovation (section 4.2). For example, after each workshop, the core team 
followed up the trained sellers after a week, administered a quiz and resolved any 
problems encountered with clients while implementing the innovation. They then 
accredited PMRs through the supply of wooden mounted posters and certificates. This 
process allowed them to identify and address the loopholes in the retailer's knowledge, 
and motivated the sellers. The type of scaling up and the pace in which the innovation 
was implemented enabled adequate technical assistance to PMRs contributing to 
successful outcomes. 
4.4.1.5 Managing wider context in the Kisii-Merlin site 
The last set of factors concern the wider context and how its influence over 
implementation was managed. The contextual features of importance encountered 
included drug policy changes, socio-economic and cultural factors and the dynamics of 
the retail environment. In the Kisii-Merlin site, an attempt to work around drug policy 
changes were effected through management of inter and intra-organisational networks 
described in figure 4.10. 
234 
Figure 4.10: Managing drug policy changes in the Kisii-Merlin site ký 11ý 1ý 
Information on drug policy changes were relayed through formal 
government procedures. However due to lack of clarity on the drug of 
choice for the retail sector Merlin, through its involvement in KeNAAM, 
actively engaged in seeking official documentation on the role of 
retailers in malaria control. Merlin was also involved in advocating for 
cheaper ACT medicines and piloted ways to increase its coverage though 
the retail sector. Despite these efforts the DoMC did not provide a clear 
guideline on the status of SP which was being phased out for ACT. The 
alternative drug for treatment for uncomplicated malaria through the 
retail sector was AQ. The DoMC finally sent a circular that PMRs could 
be trained on AQ in the interim with no further guidance. On the basis of 
this information the resource team made a decision to revise all its 
materials. Implementation of the changes was easily accomplished 
because of the internal organisational arrangements such as presence of 
the IEC department. In spite of this process, actors perceived a lack of 
adequate strategic action and guidance by the DoMC on the anti-malarial 
drug policy. In addition the sudden change from SP to AQ and the short 
time SP had been in the market exacerbated lack of trust in the 
relationship between clients and retailers. 
Figure 4.10, provides an example of how effective communication between different 
partners and between actors in different departments of the resource team coupled with 
an enabling organisational. environment, contributed to a successful implementation 
process despite the problematic drug policy context. The effect of drug policy changes 
for example created challenges at the retailer-client interface. Challenges in selling 
drugs through the informal sector with minimal regulatory mechanisms, were factors 
beyond the control of the user organization or the resource team to influence. Efforts 
made in the Kisii-Merlin experience through linkages to actively access information 
for timely implementation were a good example of the resource team taking account of 
the wider context. 
Regarding economic issues, poverty was also a feature that undermined buying and 
selling of medicines across the three sites. Poverty challenged people's ability to afford 
the medicines, and PMR's difficulty in stocking the recommended medicines among 
trained PMRs. For example, in Kisii Central district, poverty indices indicate that 
235 
about 62% of people live below poverty line (chapter two table 2-4). Data from FGDs 
with clients and PMRs indicated that both sets of actors felt that that poverty was 
largely responsible for PMRs stocking anti-pyretic medicines. These medicines are 
cheap and are so often used for simple fevers. Where recommended anti-malarial were 
stocked, clients were sometimes not able to afford them, discouraging PMRs from 
practising the innovation and sometimes leading to demands for free drugs and loans 
to boost their businesses. 
This scenario is complicated by the perceptions of communities members about PMRs 
who are generally seen as having a commercial orientation and their recommendations 
would therefore be treated with some suspicion. However in the more rural areas, 
PMRs who are from the community may be related or well known to many of their 
clients and feet a sense of social responsibility towards community members. This 
relationship reportedly accentuated the difficulties that PMRs had in selling to clients 
who could not afford the recommended anti-malarial as illustrated by a PMR from 
Kisii: "We consider that our clients are mostly our kinsmen ifyou deny them credit 
and they die they will blame you and when the they will be askingfor more money to 
pay hospital or mortuary bills what you are giving now you may as well have given the 
drugs to try and help". Although on the surface kinship ties may have facilitated 
access to medicines by communities, this could in the long term undermine the 
viability of their businesses. PMRs themselves often operate under conditions of 
financial insecurity, and the level of sales and profit margins are critical for their 
livelihoods. 
Efforts to adapt the programme to socio-economic issues contributed to successful 
implementation. In the Kisii-Merlin site, knowledge of cultural activities, such as the 
timing of harvesting or important funeral gatherings, allowed Programme activities to 
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be planned for times when maximum participation was likely. The resource team also 
attempted to reduce the costs to PMRs by linking trained sellers to particular wholesale 
chemists in the urban areas to access medicines at discount rates. This was made 
possible through letters of introduction to the wholesalers by Merlin through its wider 
malaria control activities which benefited the innovation. 
To overcome the problem of high cost of medicines, trained sellers were also 
encouraged to offer credit to their clients or accepting payments in kind to improve 
financial access to recommended anti-malarial medicines. Although the credit systems 
existed before the innovation on a case by case basis, offering of credit was 
problematic for PMRs, as has already been discussed in relation to the demands of 
extended families on trained PMRs. One retailer from Kisii indicated: "Because of 
poverty, people come for credit, which makes us lose. So it makes us fear to bring 
more stock 01hers also think that we wentfor training and we are given drugsforfree 
which leads to a conflict... ". Figure 4.11 summarises the key positive factors emerging 
from this study that are likely to explain the relative implementation success in the 
Kisii-Merlin innovation. The next section examines factors that contributed to 
outcomes measured in the other two programmes. 
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4.4.2 Explanatory factors influencing implementation process and outcome in 
the Kwale-MoH and Bungoma-AMREF sites 
This section describes issues that were identified as influencing implementation 
experiences in the other two sites. These were derived from an inductive analysis of 
data as well as using relevant theoretical frameworks in the interpretative analysis of 
how the factors identified played out in each site's experience and influenced 
implementation. The section combines implementation experiences presented in 
section 4.3, and key factors that may have influenced process and outcome. By 
focusing on the key factors an in depth analytical description is provided to contrast 
with the Kisii-Merlin experience. 
4.4.2.1 The innovation in the Kwale-Moll and Bungoma-AMREF sitcs 
This section discusses how implementation of the hard core aspects of the innovation 
influenced implementation both positively and negatively in these two sites, with 
consequences for programme achievements. By doing this, the attributes of the 
innovation identified in section 4.2 as key to success are identified. The issues are: 
recruitment and selection procedures; the training approach and the need for retraining 
created by the change in drug policy given; demand creation at community level; 
monitoring and evaluation; the motivation of key community level actors and the role 
of formative research. 
The decision to select specific PMRs to be trained in the Kwale-Moll and Kisii-Merlin 
sites was based on recognition that the very large numbers of PMRs operating in 
Kenya and other similar settings (Marsh et al., 1999; Amin et al., 2003) precluded 
training all PMRs in any area. However, in practice the selection process undcn-nined 
aspects of the implementation process in the Kwale-Moll site. The main selection 
criteria included PMRs working in those outlets for at least six months and who had 
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stocks of anti-malarial medicines. In Kwale, in practice, however, the criterion of 
stocking anti-malarial medicines was often not applied. This was reportedly due to the 
low number of outlets that stocked anti-malarial medicines in one division, and 
misunderstandings about the criteria themselves among local administrators who were 
asked to support this process. Due to this problem local leaders included PMRs 
running seasonal outlets. The core team then decided themselves to select PMRs but 
also found that few shops met the minimum criteria. As a result, and given low 
awareness of the programme among local communities, the PMR workshops were 
poorly attended; generating low levels of prograrnme coverage. 
The Kwale-MoH programme trained selected PMRs through a series of skill-based 
participatory workshops, similar to the Kisii-Merlin experience. This face to face 
training approach seems likely to have been more effective in generating knowledge 
gained than that used in Bungoma, where suppliers of medicines to PMRs were trained 
to provide advice to PMRs, representing an indirect, or cascade, training strategy. 
Although the Bungoma approach was innovative, it was not based on previous 
evidence since no previous studies of this approach had been conducted with PMRs. 
This meant that the implementing team had less prior insight into implementing the 
innovation compared to the other sites. Adequate experience of an approach was 
identified as an important attribute for successful implementation of an innovation in 
section 4.2. 
The interaction between implementation of the hard core elements of tile innovation 
and context influenced ability to modify the innovation. For example, the drug policy 
change from SP to AQ in 2004 led to long delays between the centralised training of 
trainer's workshops at national level and the eventual initiation of PMR training in the 
Kwale-MoH site (January 2003 to November 2004 and January 2005). The prolonged 
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delay rendered IEC materials out of date. This led to reluctance of the user 
organisation to distribute IEC materials, contributing to gaps in the level of distribution 
of reference materials. In the Bungoma-AMREF site, meanwhile, vendors had to be re- 
trained after the AQ policy shift, as their initial training had focussed on SP. However, 
the re-training came in the period when main funding had come to an end, limiting 
implementation. 
In the Kwale-MoH programme, demand creation was intended to be achieved through 
public barazas, posters and distribution of fliers. However, in practice limited demand 
creation was carried out at community level, reportedly due to inadequacies in funding. 
In addition, there was only limited engagement with the local leaders who were 
capable of mobilizing community members. Finally, the intended involvement of 
CORPS in supporting community mobilisation and monitoring brought a number of 
challenges. First, as the KEMRI-CGMRC partner in the resource team was seen as an 
NGO (section 4.3.3), CORPS had inappropriate expectations about the level of 
allowances they would receive, and that there would be opportunities for permanent 
employment. Failure to meet these expectations de-motivated the local actors, and 
threatened continuity of these activities. 
In the Bungoma-AMREF site, the need for direct demand creation at the community 
level, later called the JKJ strategy, was identified through an interim survey conducted 
after six months of implementing the VTV component. However the stmtegy's 
introduction seems not to have been preceded by adequate community preparation, 
leading to poor understanding of it. The JKJ component appears to have created 
negative misconceptions because of its late "add on" nature, which intervicwccs 
interpreted as reflecting low strategic importance. Furthermore, it was implemented at 
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the time of the funder's decision to begin withdrawal, leading to shortage of resources 
for implementation. 
The amount of formative research conducted in the Bungoma-AMREF site to help 
design the programme led to suspicion among members of the user organisation about 
the motivations of some of those linked to the resource team. As one person said, 
"... And I think most of the things went into research than the actual programme. So 
the project design wasfaulty. Things like JKJ came in very late. They did not start with 
the project it is like somebody somewhere had realised that it is only two years or one 
year to end the project what should we do to justify the project and so they decided to 
bring this JKJ to get more impact". As a result, there was opposition (figure 4.64.7) 
and sub-optimal participation by members of the user organisation in its management; 
for example, DPHO did not participate in some planning meetings and PHOs did not 
conduct follow ups of accessed PMRs as planned. 
4.4.2.2. The attributes of the resource team in the Kwale-Moll and Bungoma 
AMREF sites 
The second set of factors that impacted on the implementation process relates to the 
attributes of the resource team: organisational features and strategic ways of 
functioning; and its relationships with user organisations and their implications. In 
contrast to the Kisii-Merlin experience, the Kwale-Molf resource team was a 
partnership between DoMC and KEMRI-CGMRC that did not have a physical base in 
the district (section 4.3.3). The Kwale-Moll implementation proccss strategically 
placed emphasis on the user organisation's role in managing the programme locally, as 
a way of strengthening sustainability. In the Bungoma-AMREF site, however, the 
resourcc team comprised a partnership between a number of different international 
agencies, with a national support agency and the user organisation. Its large size sought 
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to maximise technical support a feature that facilitates adoption of an innovation 
(section 4.2). However, although some members of the resource team, especially 
AMREF actors in Bungoma., were resident in district, members of the international 
team, in particular, were highly mobile. This element generated tensions (see 
subsequent paragraphs for details) and financial expectations leading to interpersonal 
conflicts affecting implementation process and acting as a source of opposition (figure 
4.7). 
In the Kwalc-MoH site, some technical visits by the resource team overlooked existing 
hierarchies within the user organisation, reflecting inadequate recognition by the 
resource team of the context within which scaling up should take place (section 4.2). 
For example, following a national centralised trainer's workshop, the resource team 
visited the programme sites intermittently to resolve problems but these visits were 
often planned and conducted directly with divisional level actors in the user 
organisation, overlooking the district actors above them in the bureaucratic hierarchy. 
A member of the user organisation reported that: "One thing that happened, our 
partners sometimes would come directly and go to the division and conduct an activity 
without us knowing. There was a time we told that we shall let you do things alone. Do 
not come to us at the last hour. Because they once said they were dealing with the 
divisional ojficer, which was fine but we needed to be informed". As a result the 
divisional level actors were not always free to implement the activities since their 
district bosses were unaware of the activities being implemented. However, the 
resource team's relationships with divisional level programme implementers did 
enable some level of programme implementation. 
The next set of paragraphs describes features of the organisational environment which 
had a bearing on managerial skills of the resource team. In the Kwale-Moll site the 
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resource team was not able to develop a supportive relationship with key members of 
the user organisation, resulting in conflicts amongst actors, tensions and frequent 
communication breakdown within the user organisation. This led to opposition among 
some members of the user organisation (figure 4.4-4.5). Although the resource team 
had the technical capacity to support the user organisation, working through an 
inflexible government funding system and a bureaucratic management envirom-nent 
delayed mobilisation activities and led to inadequate demand creation. 
The resource team in the Kwale-MoH site were linked with the research organisation 
(KEMRI-CGMRC) mandated to generate information on programme impact. Baseline 
surveys were initially conducted but delays in releasing funds for implementation 
meant that these baseline data could not be used to design the innovation. Inadequate 
communication by the resource team on reasons for the delay in implementation 
contributed to the user organisation's perception of low interest from the resource 
team, and generated tension between these two groups. This tension was further 
exacerbated by financial expectations (table 4.2) from the user organisation, as one of 
its members illustrated. ifI remember one time, we really argued with them about 
the package. You know civil servants are hungry (7aughs) so ifthey see a training, they 
just know today they are going home with something good But here is a small 
package; they are not transparent. So people were not really happy with them ". 
In contrast, from table 4.3, the resource team in the Bungoma-AMREF site had direct 
control of the programme funds and this facilitated timely implementation of activities 
as well as allowing a programmatic response to ground realities such as changes in 
IEC materials. Nonetheless, expectations around allowances to be paid to actors in the 
user organisation again generated tensions that affected inter-organisation 
relationships. In both sites therefore, there were urimet financial expectations within 
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user organisations and at community level. These expectations contributed to some 
level of opposition among some actors in the user organisation (figure 4.7). 
To illustrate features of organisational environment further, funding arrangements for 
the Bungoma-AMREF sites (figure 4.12) are described. In contrast, funding 
arrangements in the Kwale-MoH site are discussed under section 4.4-2.3 since 
management of funds for that innovation was primarily the user organisation's 
responsibility. 
Figure 4.12: Funding process of the Bungoma-AMREF site 
Money for all activities was disbursed to AMREF through a contractual 
agreement with USAID. Once the monthly budgets and work plans were 
presented to AMREF headquarters for approval by the board, the money 
was sent to the local AMREF office. The project coordinator who was the 
signatory withdrew money for the intended activity within seven working 
days. All the returns on expenditures were also sent to the country office for 
verification. Any expenditure on activities beyond the budgeted amount 
required justification with supportive documents and once verified this was 
reimbursed. At the programme level, the DIIMT had no role in financial 
management. Budgeting was done by the core team who decided on 
payments for field officers on the basis of distance covered and the type of 
activity. There was minimal active follow up of field officers on activities 
conducted by the core team except when an officer was noted to be less 
accountable. If an officer failed to account adequately he or she was relieved 
of duties in the programme activities. The chairperson of the core team kept 
all the returns which were submitted to the project coordinator at the end of 
each month. Lack of involvement by the DIIMT led to a perceived lack of 
transparency on AMREF's part which trickled down to the district 
development committee and the community. This perception increased the 
MoH actors' financial expectations because they perceived that the 
programme was well resourced. This was passively resolved through 
reference to the government guidelines on payments. Retailers and vendors 
were given lunch allowances in line with the budgetary allocation. 
Features of financial arrangements such as perceived level of funds available led 
illustrate power dynamics and also led to inter-organisational tensions between the 
resource team and user organisation. A member of the resource team noted: "One time, 
a DHMT member differed with CDC when he needed to be paid money like CDC 
actors because they have similar qualifications. Again, like the first year's budget, 
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people saw that there was a lot of money. Someone even told the district heads that 
we have sixty million budget every year and they were askingfor halfmillion to repair 
a lorry that had been groundedfor the last one year ". 
In addition, the user organisation was barely involved in financial management, except 
in accounting for money disbursed in the implementation of the innovation. Limited 
involvement of the user organisation in the management of funds generated negative 
perceptions. As a member of the user organisation said: "One ofthe biggest challenges 
was financial resources because people were not transparent. You see if we are 
partners and ifyou want us to have active participation then it is also good that people 
know what the inputs are. I believe in this district nobody knew even when the project 
ended. People did not know what went into this program for thefive years if they knew 
then they read about it in the final reports. I think people were in the dark This made 
people suspicious, and the credibility of the good project was damaged so people 
always feel they were being cheated'. These perceptions also contributed to middle 
support and opposition by some members of the user organisation as illustrated in 
figure 4.7. 
4.4.2.3 The attributes of the user organisation in the Kwale-Moll and Bungoma- 
AMREF sites 
This section describes the attributes of the user organisation and its organisational 
environment. The factors considered include district level leadership, relationship 
problems within the user organization drawn from stakeholder analysis and power 
relations and how this contributed to a lack of supportive environment, especially from 
key actors, and the influence of communication and bureaucracy within the 
organisational environment. 
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In both sites, user organisational. leadership was fairly unstable over the period of 
examination. In the Kwale-MoH experience the transfer of two DMOH during the 
implementation period led to delays in implementing activities. Each time, the new 
district head had little information about the innovation and so delayed releasing 
budgets for planned activities. As a member of the user organisation explained: "The 
main problem I experienced was disbursement offunds. The first phase I had a delay 
in implementing. We had organized, set the dates, mobilized the community but when 
we went to the district treasury to get these funds we were told, "Now these funds are 
not ready please re-arrange and organize the dates". "en we went again we were 
told, "No you cannot take this whole amountfor the two days pick onefor 1hefirst day 
then tomorrow come again to the treasury collect the second lot ". This was causing a 
lot of delay because you had to queue at the district headquarters to get the first lot 
then the second day again queue instead ofrushing to the field to continue training. So 
that was a bit of a handicap. But all in all we managed to get through the first phase. 
So the second phase, there was a discussion and this was resolved with the new 
DMOH" 
Similar sentiments were expressed in the Bungoma-AMREF site where turnover in 
district health managers also limited implementation continuity. This was illustrated by 
a member of the user organisation: "It is because most of the DIIMT members who 
were there then were transferred apartfrom one. The new people who came in had no 
idea about this so adapting to that was a big issue; there was no continuity after the 
changes" This experience happened towards the end of the programme contributing to 
incomplete implementation of the JKJ component. This implies that the timing and 
circumstances for this component of the innovation may not have been right. in 
addition, changes in local leadership led to a less supportive user environment, 
attributes necessary for successful adoption (section 4.2). 
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In the Kwale-MoH experience, there was also evidence of interpersonal problems 
amongst members of the user organisation which affected implementation (figure 4.4- 
4.5). For example one of the conditions of the funding by the GFTAM was that a 
DHMT meeting be convened before any money was spent. Differences amongst actors 
delayed the convening of such a meeting. The user organisation in Kwale also felt that 
the DoMC at national level did not fully support the innovation, given the delays 
experienced in implementing planned activities and poor communication regarding 
drug policy changes. As a DHMT member said: "Personally, Ifeel within the malaria 
control programme, there are others, which are given more prominence than some. 
You know for example, the issue of malaria in pregnancy there is a lot offocus in it 
and the issue of distribution of ITN". As a result, DHMT also gave little attention to 
their tasks in the programme and, for example, provided poor supervision to the PMRs, 
contributing to low outcomes. 
The selection process of the core team generated tension among the user organisation 
in the Bungoma-AMREF site (section 4.3.3). Failing to include the divisional level 
actors led to negative consequences as illustrated by a member of the user 
organisation: "Actually because it is like they involved people at the DIIAfT level. But 
the PHO were brought on board later. And I think that is what they didn't take nicely. 
We started with VTV we didn't realize that there was something like JKJ coming. I 
think that's where the main problem was. lye didn't do it wisely, the composition 
varied andyou see a player depends on where he plays. It is unfortunate that it isjust 
the DHMT that took over, and we didn't realize that at the end of it we will need other 
people who are the real stakeholders " 
The consequences of the selection process brought intra-organisational tensions within 
the user organisation and generated negative perceptions of the programme and 
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contributed to the opposition by DPHO and PHOs (figure 4.7). Some members of the 
user organisation believed that vested financial interests such as allowances influenced 
the choice of the core team. The functioning of the core team also generated problems 
which polarised relationships in the user organisation. The core team reported to the 
DHMT and AMREF in matters regarding the implementation process. Frequent 
meetings were also held with the external partners and at some point junior officers (to 
the district heads) in the core team were given an opportunity to present findings on the 
impact of programme in an international meeting. This was perceived to undermine the 
hierarchical nature of the user organisation, and contributed to tensions between user 
organisation and resource teams. 
nen some people feel that their relationship with another one is not good it affects 
the project and I thinkftom the time this project started, there were intermittent stages 
of bad relationships between the officers from the ministry and the BDMI officers. It 
started immediately when the then DMOH relationship with some members of BDMI 
were not good and these complaints went up to the ministry's head quarters, the next 
person was me when I was asked, why are you sabotaging the programme? you know 
such things are not good". This comment from a member of the user organisation 
shows how intra-organisational tensions caused inadequate participation by some 
members of the user organisation whose support would have facilitated 
implementation because of their strategic positions in the user organisation as was 
explained in section 4.3.3. 
In the Kwale-MoH site, the complex funding process represents a key feature of the 
user system that constrained implementation's (figure 4.13). The particular 
Is This was particular to Kwale and not necessarily associated with other Moll programmes operatingwithin 
the same mechanisms 
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bureaucratic environment in which the resource team in the Kwale-Moll programme 
worked caused more problems for implementation than in the Kisii-Merlin site. The 
complex funding procedures within the DoMC led to several delays and negative 
misconceptions. For example, the DMOH did not inform the divisional level actors of 
the availability of funds on time (table 4.2), paving the way for rumours that 
management wanted to divert the money to other activities. Delays in funding often led 
to activities either not being conducted on time or being inadequately implemented. 
The process of accessing funds also took a long time, and harmonisation of divisional 
level budgets with the district work plans meant that the budgetary needs for the 
division were not fully met. The inflexibility of budget procedures also prevented 
changes in the use of funds that might have covered local shortfalls or allowed 
adaptation to local settings. This led directly to inadequate demand creation and, in 
some instances, to divisional level actors focussing on some activities and leaving out 
others. A member of the user organisation indicated: "Mobilization was not extensively 
done because according to the plan, there was only a day or so for mobilizing the 
communities. Now you understand that some of areas are extensive that you can not 
cover in a day or so many of the areas were not extensively sensitised of the 
programme. " 
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Figure 4.13: Funding process of the Moll-Kwale site 
The Kwale programme was supported through the GFTAM initiative. At country 
level the GIFTAM activities were monitored by the Country Coordinating 
Mechanisms (CCM) responsible for coordinating proposals and reporting to the 
technical review panel of the GFTAM. The CCM appointed a financial consultant 
Klynveld Peat Marwick and Goerdeler (KPMG) as the principal recipient of money. 
Within the MoH, all proposals developed from divisional level were incorporated 
into the district work plans accompanied by a budget and submitted to the DoMC for 
inclusion in the national malaria business plan. Once the proposals were funded, the 
DoMC disbursed funds for specific activities to be implemented within each quarter. 
According to the GFTAM policy, any money advanced to districts required 
adherence to a number of guidelines: maintaining independent records of 
expenditures; names and addressees of participants indicating personal identification 
numbers; the nature of activity held and the period. Training was to be held in 
government institutions and it was mandatory for the DMOII to convene an 
executive meeting for the DHMT to discuss implementation plans and evidence of 
this was required during monitoring of progress. At the district level, initially there 
were unclear procedures for disbursing funds. Districts were first instructed to 
establish special accounts to avoid anticipated delays encountered in the normal 
treasury mechanisms. The first batch of funds from the DoMC was disbursed when 
the district had not opened a separate account as planned resulting to confusion. This 
process conflicted with the normal procedures where all money to the districts was 
channelled through issuance of authority to incur expenditure (AIE) to the DMOIL 
Later, all subsequent funds were channelled through the normal procedures. The 
process of accessing funds by the divisional level actors involved placing a formal 
request through an internal imprest from the district health accounts office. All 
receipts and financial returns were summarised and surrendered to the district health 
office through the same process. All payments to the Moll actors involved were 
based on government guidelines. Retailers were given a token for lunch in 
accordance with the budget. 
Networks and collaborations are important in managing any innovation (section 4.3.3). 
In the Kwale-MoH experience, the main management activities were undertaken by 
the user organisation, and the core team were perceived to be less reliant on external 
networks to create sustainability than in the other two programmes. Figure 4.14, 
describes the linkages developed in the Kwale-MoH site. 
251 
Figure 4.14: Networks and its consequences in the Kwale-MoH site 
In Kwale, there were minimal efforts made to develop partnerships with 
local organizations or institutions to support programme activities and 
support sustainability. The innovation was supported by an external team 
(KEMRI-CGMRC) who provided technical support on behalf of the 
DoMC to the user organisation while the DoMC provided strategic policy 
direction. The resource team developed direct communication with the 
divisional level actors leading to a perception that the programme was 
being popularized by a research f irrn with donor funding. These generated 
expectations such as more allowances, disregarding the normal 
government system, and provision of free drugs to retailers to make more 
profits at the community level. There were efforts made at community 
level to involve CORPS to support local monitoring and supervision but 
these linkages were not sustained due to unmet financial expectations from 
CORPS 
In the Bungoma-AMREF experience, the networks and collaborations initiated 
included both complex formalised alliances at national level between USAID and 
AMREF to informal alliances at district and community level (figure 4.15). Due to 
their position (financial and technical) USAID had high power influencing 
implementation (see figure 4.6-4.7). Since the innovation involved retail delivery 
structures, strong linkages with wholesalers and mobile vendors were important. 
However, minimal involvement of the MoH in the networks created presented a threat 
to sustainability because the intent was to incorporate the innovation into the user 
organisation. AMREF also developed informal alliances with pharmaceutical 
companies to support the vendors partly as a way of managing context and also as a 
way of ensuring continuity following donor exit. However the timing of this initiative 
coincided with the withdrawal of funds. AMREF therefore provided initial funds and 
supported vendors through linkages with social services department to form a 
community group. 
The community group was however dominated by problems of leadership and lack of 
transparency where its leaders were reported to have squandered money stalling their 
activities for a year as indicated by one vendor: "The main problem K, as ivhen the 
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chairman disappeared with the drugs and certificate of registration, AMREF helped 
us to make follow up together with the social services. They wrote letters to the 
chairman and the leaders to give us back the certificate. Even now we havejust started 
afresh ". AMREF's involvement in the registration process generated a perception 
among mobile vendors that AMREF recognised their role much more compared to the 
user organisation affecting continuity and support from the user organisation. 
Figure 4.15: Networks and its consequences in the Bungoma-AMREF site 
The innovation was characterized by a complex network with many partners 
to meet their organizational goals. At the national level, USAID developed 
linkages with AMREF through a contractual agreement, representing a 
formalized partnership between the organizations. However this partnership 
brought challenges for example, USAID's changes in the funding strategy led 
to an unexpected pull out of USAID and incomplete implementation of the 
JKJ strategy. USAID also contracted QAP and CDC to provide technical 
expertise, leading to an innovation with many external partners working 
through the government system. The role of CDC in formative research led to 
a perception of a hidden agenda by the external partners exacerbating the 
problem of lack of trust. At the district level, liaison with the DINT through 
the core team represented a less formalized structure whose operation led to 
differences between actors at DHMT level. This was associated with the 
perceptions of benefits the core team were drawing from the well resourced 
external partners. Other informal alliances at community level with 
wholesalers, retailer, vendors, pharmaceutical industries and local 
administrators were established. Overall the nature of these alliances and the 
presence of well resourced external partners destabilized relationships, 
leading to mistrust at the district and community levels. 
Another group of actors that represent linkages with the community were those 
involving local leaders. Their administrative roles were important in demand creation 
and creating support for the innovation locally. Local leaders had financial 
expectations of allowances for mobilising community in order to create demand in 
their area of jurisdiction. In both sites, minimal involvement of local leaders in 
mobilizing community members undermined direct community engagement, 
contributing to less demand and threatening sustainability of PMRs' new practices. 
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4.4.2.4 The scaling up strategy in the Kwale-MoH and Bungoma-AMREF sites 
The fourth set of factors influencing implementation is linked to the scaling up strategy 
employed. In the. Kwale-MoH site, the resource team sought to apply the horizontal 
scaling up approach of conducting implementation in phases (Simmons & Shiffman, 
2006), similar to the Kisii-Merlin experience. However, since the bulk of 
implementation was on the user organisation, other competing district level activitics 
tended to disrupt implementation process. For example, the national measles campaign 
in 2005, interrupted mobilisation by divisional level actors and led to limited demand 
creation. 
In the Bungoma-AMREF experience, the resource team's scaling up approach 
involved adding, over time, new intervention elements (JKJ), to the basic programme, 
to determine whether those intervention elements could be usefully included in similar 
programmes elsewhere, referred to as functional scaling up strategy (Simmons & 
Shiffman, 2006), therefore, reflected the different nature of the Bungoma-AMREF 
programme as compared to the other sites with consequences. The approach to scaling 
up contradicts sustainability, for example the newly added element meant that the 
programme inevitably faced the challenge of how to sustain these activities within the 
local district when its funding came to an end. As one member of the user organisation 
noted: "You see unfortunately our attitude as health workers is that when you know 
that something is beingfundedyou will do thejob ..... hut when it is lime to incorporate 
it in routine, you see resistance ". 
Implementing an exit strategy was made difficult by poor communication between 
AMREF and the funding agency: "The mistake the USAID did, they said there was a 
phase two to come but they did not put in writing to say there is no phase livo. When 
we were in the committee we were told they have now started to support the central 
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and not the district level. And to me, one of the major challenges is that this was a 
pilot programme and USAID is partly to blame, they said there would be a phase two 
but later they did not honour it or even plan the exit" (resource team member). 
The withdrawal of funding created a gap in the demand-side activities of the 
innovation, and so affected outcomes at the retailer level. This resulted to perceived 
lack of transparency between the resource team, the community members, and the user 
organisation. This led communities to feel cheated and demoralised, unden-nining their 
support of the innovation. At the same time, the unexpected changes brought confusion 
between agencies working in the district and created tension between them. As a 
member of resource team said. "Looking at AMREFs viewpoint we had prepared 
ourselves on how the exit should he done, but from the donor point of view, poor 
communication created some misconception that AMREF was supposed to hand over 
to AMKENP because it was USAID funded. I even have a colleague who told me 
"You are handing over to us, AMREF is getting out and AMKENI istogetin". ButI 
told him " nether with or without USAID, AMREF will survive ". 
Overall, poor communication characterised the relations between the resource team 
and the user organisation leading to misunderstanding of the scaling up strategy used 
in the Bungoma-AMREF site. This also contributed to opposition by some members of 
the user organization (figure 4.7). 
4.4.2.5 Managing wider context in the Kwalc-Moll and Bungoma-AMREF sites 
The last set of factors concern the wider context and how its influence over 
implementation was managed. The contextual features of importance were similar to 
those in the Kisii-Merlin site, that is, drug policy changes and socio-economic factors. 
19 AMKENI is an NGO whose name is derived from a Swahili word meaning "awakening " 
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in addition variation in the types of outlets selling anti-malarial was a relevant factor 
in the Bungoma-AMREF site, while the low availability of outlets selling anti-malarial 
medicines was important in Kwale. The drug policy change led to negative impacts on 
implementation processes in both sites. In the two sites the actors' reaction to these 
changes and its consequences were similar. Figure 4.16 and 4.17 describe these 
experiences. 
Figure 4.16: Managing drug policy changes in the Kwale-Moll site 
In the Kwale-MoH experience, information on changes in drug policy was 
relayed through formal government procedures. Decision making depended 
entirely on official. communication on the status of the drug of choice for 
the retail sector from the DoMC. Inadequate communication led to the 
user's perception of lack of government's seriousness on the involvement 
of PMRs in malaria control. The slow response from the DoMC also 
created concerns over the continuity of the innovation, delayed further 
implementation and created a time gap between capacity building and 
actual training of PMRs. Materials that had already been produced with SP 
medicines were never distributed. Revision and production of new ones in 
bulk could not be done because of budgetary constraints. However, locally 
produced materials were adapted and produced for use. DoMC 
communication on training on AQ medicines was unclear. This together 
with lack of public information attributed to budgetary constraints 
contributed the user organisation focusing only in workshops. At the 
retailer-client interface these changes made it difficult for PMRs to 
convince clients to buy the new medicines in the right dosages. The effect 
of these changes also eroded trainer's confidence and was reported to be 
expensive in terms of re-training and production of IEC materials. 
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Figure 4.17: Managing drug policy changes in the Bungoma-AMREF site 
Response to drug policy changes in the Bungoma-AMREF experience 
was characterised by concern over cost implications of developing new 
materials and undoing the emphasis made on SP medicines through the 
JKJ strategy. Although AMREF was a member of KeNAAM, its 
approach in seeking clarification on the drug of choice for the retail 
sector was not active as that of Merlin. AMREF relied on official 
communication from the DoMC regarding the changes which they then 
used to seek funding for production of new materials. The changes 
coincided with the time when the funding from USAID was coming to 
an end and therefore AMREF sought funding from Rotary Club and 
European Union to produce new materials. Production of these new 
materials was conducted centrally in line with AMREF procedures 
although this process was slow given the immediate changes required. 
The new changes eroded the confidence of trainers especially since the 
programme emphasised five messages on SP medicines. In addition the 
process was perceived to be expensive in terms of re-training and 
production of JEC materials. It challenged the authenticity of 
information passed to clients affecting delivery of the intervention. 
Perceived lack of a firm regulatory structure on multiple brands of drugs 
such as SP and AQ and the marketing strategies of pharmaceutical 
companies led to the perception that these changes were likely to be 
spearheaded by drug firms to make profits. 
The two experiences indicate that the resource team and the user organisation in both 
sites employed a fairly passive management style in seeking information on the drug 
policy changes than in the Kisii-Merlin site. This led to them being more affected by 
the delays and uncertainties that arose as a result of protracted change. In the Kwale- 
MoH site, inadequate communication between the national office and the funding 
process meant that new materials on AQ could not be produced on time. In the 
Bungoma-AMREF site, despite delays related to communication problems, the 
resource team was able to mobilise resources from other donors to reprint the 
materials. Across all sites however, the user organisation and the resource team 
perceived drug policy changes as expensive because of re-training PMRs and 
production of new materials. 
In addition, changes in drug policy increased the perception of unrcliability of PMRS 
as sources of health care and created a dilemma for trained sellers as indicated by a 
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remark from a PMR in Bungoma. "In connection to drugs there have heen several 
drugs in the market, when Igo for more drugs Ifind a new one. They also make us to 
look for new ways of convincing clients every now and then, because today I may 
recommend such and such a drug to the client, the next day, I have to change my 
tactics and recommend another one, this makes the clients doubt us". The change in 
drug policy also created a dilemma for trained PMR as one of them from Kwale said: 
"The problem that I have experienced most is on the drugs that are no longer in the 
market. For those who have been trained on drugs and you took large quantity of 
drugs, when you come to realize that they are no longer recommended you really get 
disturbed Because you are selling knowing well that they are no longer in the market 
so it really bothers you. Ifyou are not trained then you won't worry much but now 
since you know selling the drugs to someone becomes a bit problematic it really affects 
you to 
The resource team in the Bungoma-AMREF site also argued that the sudden changes 
in drug policies eroded their confidence "The sudden change oftrealmentfrom SP to 
AQ was bad, infact I had withdrawnfrom doing community education. I told my boss 
that we should choose other people because you look odd, the other month you were 
just telling them that SP is the best drug infact we had taken 3-4 weeks to come up 
with 5 key SP messages. You see after marketing those then after 3-4 monthsyou are 
told change that. No sooner had this been put in place than it was stopped, we were 
now goingfor A CT, which people cannot afford ". 
It was reported that the occurrence, delays and lack of clarity associated with the drug 
policy change heightened existing confusions generated by the large number of anti. 
malarial brands in the market. As one DIIMT member in Bungoma pointed. "People 
hadi ust gotten the concept of SP and thereafter they were told it is being phased out. 
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Manufactures had written on their package that AQ is a single dose treatment. So 
consumers took it as the truth since it had come from a manufacturer. This message 
has been ingrained in our communities that this is a single dose treatment. So it has 
cost us a lot to convince these people to change ". 
As described earlier, poverty and low affordability of anti-malarial medicines are 
important challenges to PMR programmes. Poverty indices indicate that Bungoma 
district had the least proportion of community members living below poverty line 
(57%) compared to Kwale (63%) (chapter two table 2.4). Overall, levels of poverty 
may have played a role in sale of recommended medicines. To overcome this, 
adaptation to socio-economic issues varied in the two sites. In the Bungoma-AMREF 
site, there was an attempt by the resource team to manage problems of high cost of 
medicines by establishing links with pharmaceutical industries and setting an 
agreement to supply vendors with drugs at affordable prices, providing temporary 
motivation until competition from chemist shops forced many out of business. This 
may have facilitated continuation of the programme for a while but this was not 
sustained. 
One feature of the context observed only in Bungoma, was the number of informal 
chemist shops. This was largely associated with the weak regulatory framework in the 
wider health system. Many retired health workers or those working within government 
facilities opened chemist shops as a source of income. Most of the chemist shops were 
not registered; people manning them were unqualified as one DIIMT members said: 
"Like the nurse aides they get a photocopy somewhere and use it. Afayhe the owner is 
unaware. But you willfind that when you want to trace these medical personnel whose 
documents are available at the chemists, you can never get him. I can assure You". 
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Presence of drug shops in almost every market centre was reported by general 
retailers to create competition in the sale of anti-malarial medicines. This is because 
they sold medicines at relatively cheaper prices compared to general retailers because 
they buy in bulk and sell loose tablets repackaged in plain envelopes instead of the 
original package. In addition, although drug shops may not be manned by trained 
professionals, they were perceived by community members as offering professional 
services denying trained PMRs opportunities to practice the innovation. Figure 4.18 
and 4.19 summarises all the factors that may have influenced implementation and 
outcomes in the Kwale-MoH and Bungoma-AMREF sites. 
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4.5 Summary 
This section presents a summary of key factors which facilitated successful 
implementation and outcomes as experienced in the Kisii-Merlin site compared to the 
other sites. It also outlines the limitations of qualitative study and the policy analysis 
approach used. The main limitation was that the study was not designed to test 
theoretical propositions derived from the analytical frameworks used, limiting the 
explanatory power of the analysis presented. Given the range of influencing factors it 
was, for example, difficult to identify priority influences among those identified. The 
second limitation is that this analysis did not consider the diffusion of innovation 
beyond the district level implementers. This means that the study did not focus on how 
the innovation may have been taken up by PMR or clients. Although this would have 
been important, it was beyond the scope of this analysis. Yet despite these limitations, 
the use of an inductive approach to analysis guided by relevant theoretical frameworks 
helped to clarify how the factors identified played out in each site's experience and 
influenced implementation. This analysis of implementation processes took account of 
differences in settings including actors, and the use of stakeholder analysis allowed 
better understanding of actors involvement in implementation, dynamics in 
interactions and how that influenced process and outcome. Ibe study therefore 
provides useful lessons for implementation practice both for specific PMR 
interventions and generic lessons for general public health implementation practice. 
Figure 4.20 provides an overview of the key lessons drawn from across all sites about 
how to manage innovations to enhance programme performance and coverage. 
The study identifies several factors specific to managing PMRs interventions that 
facilitated successful implementation of the innovation. A resource team with a good 
relationship with the user organisation and a flexible management system allows a 
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localised decision making process to respond to immediate contextual features and 
supports effective implementation. In addition, ability to manage relationships between 
organisations and actors involved, including organisational environments and 
perceptions of the user organisation about the innovation and implementation process, 
are critical for successful implementation and outcome. Use of an MoU for example 
may enhance communication and contain unrealistic actor expectations of financial 
gains. This may be possible if the resource team possess attributes such as the ability to 
modify the innovation to suit local needs, credibility, authority, understanding of the 
user environment and relevant skills. The selection and functioning of the core team 
also requires adequate consultation for effective implementation. This may help avoid 
expectations that may polarise relationships within the user organisation. Stability and 
effective leadership in the user organisation coupled with transparent and flexible 
management system may also facilitate implementation process. 
The scaling up strategies employed should provide an opportunity for learning, 
allowing actors to gain experience in the intervention which should feedback into the 
implementation process. Finally, challenges of balancing the relationship at the client- 
retailer interface require that strategies to manage external context such as socio- 
economic factors should be taken into consideration to facilitate creation of an 
enabling environment. However, the interplay of such factors illustrates that there are 
challenges in the wider context such as poverty and drug policy shifts that are beyond 
the ability of the implementing team to overcome limiting the success of the 
innovation. In summary, in these districts these data highlight the difficulties of 
working with and through the user organisations for service delivery innovations 
involving the retail sector. They point to the complexity of implementing innovation in 
a bureaucratic environment constrained by resources as well as many competing 
interests of other conventionally accepted innovations. 
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Chapter 5: 
Policy Implications and Conclusions 
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5.1 Introduction 
Prompt and presumptive treatment of fever continues to be one of the main strategies 
for malaria control. Literature on care seeking studies in SSA shows that the retail 
sector plays an important role in fever and malaria management. However, treatments 
obtained from the retail sector are often inappropriate. Due to their popularity and 
physical accessibility, it is recognised that PMRs can have a role in increasing 
coverage of appropriate malaria treatment. This recognition led to the WHO 
advocating for strategies to improve HMM with PMRs interventions as one potential 
channel to provide prompt and effective treatment of malaria in children under five 
(chapter one). 
This study aimed primarily at understanding the benefits and challenges of different 
approaches of working with PMRs through a comparison of three programmes 
implemented in Kenya. At the outset of the study, it had been anticipated that the 
findings would provide clarification on the effectiveness of particular approaches to 
working with PMRs, a gap outlined by the Goodman review (Goodman ct al., 2007a). 
Over the duration of the study, the main focus of interest shifted from a comparative 
evaluation towards an in-depth understanding of the strengths and challenges of each 
approach evaluated. Findings relating to the relative strengths and weaknesses of 
programme design and its implementation provide useful lessons on the factors to 
consider when managing implementation of PMR programmes. Primarily, this shift 
has been as a result of an emerging understanding that each programme represents a 
complex set of activities, implemented in different contexts and involving difTercnt 
sets of actors; therefore, implementation and impact inevitably played out differently 
in each site (both from what was planned and from each other). Secondarily, 
methodological challenges experienced in evaluating the programmes led to limitations 
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in interpreting data, discussed in chapter three section 3.5.2 and chapter four section 
4.5. Comparability was further made difficult by lack of cost data for potential cost- 
effectiveness assessment, although this was initially part of the study, lack of quality 
data made it difficult to estimate the cost of implementing the programmes thus the 
costing component was dropped. 
Regardless of the challenges described, the overall evaluation approach had several 
strengths. First, the study utilised a pragmatic design in two sites (Kisii and Bungoma 
districts) and random allocation of intervention and control areas prior to 
implementation of the intervention (Kwale district). Use of contemporaneous controls 
made this evaluation relatively stronger than previous PMR assessments (Goodman et 
al., 2007a). Secondly, indicators used for quantitative assessment for site comparisons 
were common across all sites, allowing for uniformity in the evaluation. This approach 
is supported by lessons from IMCI multi-country evaluations where use of a common 
conceptual framework and uniform indicators and tools ensured a coherent set of 
studies with outputs for policy implications (Bryce and Victora, 2005). 'I'lle third 
strength relates to the use of a series of inter-related studies with mixed methodologies 
to measure the performance and outcome of different PMR programmes and to 
understand how implementation experiences may have influenced their performance. 
This evaluation drew from the public health evaluation and policy analysis literature. 
Policy analysis is of relevance in this regard, as implementation is one area of inquiry 
within this broader field of work. Indeed, innovation theory, which draws on concepts 
from policy analysis and wider organisational management theory, is particularly 
relevant to this study as it investigated the early stages of implementation and scaling 
up of a public health innovation. A review of the published literature on the application 
of health policy analysis in empirical inquiry indicates gaps and weaknesses in this 
field in LMICs. Instead, the dominant focus of many analyses concentrates on 
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considering "what happened" rather than investigating "what explains what 
happened". The review suggests the need for more studies that are carefully designed 
and use relevant theory to guide systematic investigation of implementation 
experiences (Gilson and Raphaely, 2008). 
Through policy analysis, the study highlights that successfully introducing innovations 
like these (and indeed other public health innovations) requires that attention be paid 
not just to the overarching programme design but also to the process of managing the 
intervention's implementation. In addition, the study also addressed several research 
gaps identified in chapter I from a review of PMR interventions. These gaps include 
information on the impact of implementation of PMR programmes within the scaling 
up context, evidence on the impact of PMR programme in different geographic 
locations, and capturing potential variations in effectiveness across cpidemiologic and 
health system settings and with different types of sellers (Goodman et al., 2007a). 
This chapter discusses the policy implications of the outcomes and experiences 
described in chapters three and four and situating these findings in the wider literature 
reviewed in chapter one. It is structured around six sections. Section 5.2 summariscs 
key findings and the strengths and weaknesses of the interventions. Section 5.3 
addresses the contribution of the study to the existing knowledge on the impact of 
PMR interventions. Section 5.4 presents insights for the future implementation of 
PMR programmes and for the introduction, and scaling up, of public health 
innovations more generally. Section 5.5 outlines implications for future PMR and 
broader public health evaluation research. The study conclusions are presented in 
section 5.6. 
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5.2 Summary of key findings 
The main findings are presented in table 5.1. The first set of findings is linked to the 
impact of programmes on population coverage and utilisation of the interventions. This 
evaluation indicates that PMR interventions can increase coverage of appropriate 
treatment. The NGO-led participatory-based training in the Kisii-Merlin programme 
had the highest coverage and was most effective in reaching the target outlets. 
Programmes in the other two sites, Kwale-MoH and Bungoma-AMREF, had relatively 
low coverage, although the Bungoma-AMREF site was more successful in covering 
target outlets. Of importance to note is the low coverage in the Bungoma-AMREF site 
given that it was a social marketing programme targeting outlets across the district. 
MoH guidelines suggest that trained outlets should be within a walking distance of 2 
krn to community members (Moll, 2003). The spatial analysis using thiessen polygon 
technique undertaken in this study indicates that all programmes attained this target. 
For example, community members were likely to walk an average distance of 1.30Km 
to access a trained PMR in the Kisii-Merlin site. This was followed by the social 
marketing approach in the Bungoma-AMREF site (1.40 km) and the Kwalc-Mol I site 
(1.86 km). 
Despite low coverage of outlets and the highest physical distance to access a trained 
PMR, the Kwale-Mol-I site demonstrated a relatively high potential utilisation of target 
group compared to the other sites (table 5.1), and this was primarily achieved in the 
most remote and sparsely populated division. It seems likely, therefore, that the long 
distances to formal health providers, the clustered nature of homes and the wide 
separation of such clusters from each other could support the existence and use of local 
retail outlets selling patent medicines alongside general provisions. This is important 
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since PMR programmes are premised on the need to improve the physical 
accessibility of fever and malaria treatment in remote rural populations. Reaching large 
numbers of users indicates the feasibility and potential success of working through 
PMRs in remote rural areas. However, an important limitation for these PMRs in this 
type of setting concerns the type of drugs normally stocked (section 5.3.3). 
The second set of findings show that PMR programmes implemented in different 
geographical settings can have an impact on PMR knowledge and practice in selling 
anti-malarial medicines. There was evidence for a significant impact on PMR 
knowledge and practice at six months with an NGO-led participatory training approach 
in the Kisii-Merlin programme. 60.5% of trained PMRs sold AQ medicines with 
appropriate advice compared to 2.8% among the untrained ones (OR; 53.5: 95% Cl 
6.7,428.3). However, the study was unable to consider whether this impact would be 
sustained over time. There was also some evidence of a limited impact at six months 
for the MoH-led participatory training approach in the Kwale-Mol I programme, where 
18.8% of trained PMRs sold AQ medicines with appropriate advice compared to 2.3% 
of control PMRs (OR; 9.4: 95% CI 1.1,83.7). This programme was, however, marked 
by implementation challenges and the study was also unable to consider whether the 
impact would be sustained. Finally, this study was unable to show evidence of impact 
from the social marketing approach used in the Bungoma-AMREF programme. No 
(0%) intervention PMRs sold AQ medicines adequately compared to 7.1% in the 
control areas (OR; 0.5: 95%CI 0.1-5.5). 
As part of the qualitative analysis, the implementation strengths and weaknesses for 
each programme are outlined in table 5.1. A central theme that cuts across all the three 
sites is the importance of relationships between actors at various levels and the need 
for management strategies that support building of good relationships. While 
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introducing an innovation like this to a district level setting, an underlying issue is the 
importance of a strong and experienced resource team that is flexible and transparent, 
which responds to immediate contextual features and enhances good relationship with 
the user organisation. In addition, a user organisation with stable, effective, transparent 
and flexible management system may allow adaptation of the innovation to local 
settings. 
Finally, in order to assess overall performance of programmes, putting together data on 
utilisation and quality of care in the three districts is infort-native. For coverage to be 
effective, quality of services is important (Shengelia et al., 2005; Thiede et al., 2007). 
For example, since 60.5% of trained PMRs in the Kisii-Mcrlin site sold AQ medicines 
in adequate doses, this would translate to about 18,074 children who would potentially 
receive adequate treatment if their care givers sought care from trained PMRs. In 
comparison, in the Kwale-MoH site with 18.8% of trained PMRs offering adequate 
treatment, 8994 under fives would receive adequate treatment. Although the impact in 
the Bungoma-AMREF site was difficult to attribute to the programme, (chapter three 
section 3.5.2), the quality of services offered at the time of the evaluation means that 
1179 under fives would potentially receive adequate treatment. Overall, as discussed in 
the introduction, this comparative analysis could not establish a single "best approacw' 
for working with PMRs, but it provides important implementation lessons around all 
three programmes evaluated as summarised in subsequent sections. 
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5.3 Contribution to knowledge on retail sector interventions 
This section outlines the contributions the study has made to existing knowledge on 
working with PMRs to improve malaria treatment. 
5.3.1 Impact of PMR programmes 
The study confirms that PMR programmes can impact positively on PMR knowledge and 
practices. As described in chapter one, previous reports indicate that difTercnt PMR 
interventions have improved rates of appropriate treatment and PMR knowledge and 
practices in small scale studies. However, there is insufficient evidence on the impact of 
PMR interventions on their knowledge and practice at larger scale (Goodman ct aL, 
2007a). This study supports not only previous evidence that such interventions can 
improve PMR knowledge and practices but that the impacts are achievable within a 
moderately large (divisional) scaling up context. This was also the case for all the sites in 
the MoH DDP programme (PMR interventions were implemented in fivc initial districts 
in Kenya as part of scaling up) which included Kwale-Moll site (annex 1). The study also 
provides evidence of the potential to operationalise such programmes through an NGO 
and the MoH. 
53.2 Insights on the importance of management processes in implementing 
innovative PMR programmes 
A key finding in this study has been the critical nature of the implementation process in 
determining the impact of PMR programmes. This section examines speciric insights the 
study has provided on this issue, and relates them to wider evidence. However, as was 
alluded to in chapter one, there are relatively few studies in LMICs that have examined 
implementation process using policy analysis that this study can draw from. 
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By nature an innovation requires a resource team to champion it. Therefore the 
characteristics and management of the innovation by the resource team is key to its 
success. In all the three sites, there were many actors involved in implementation, ranging 
from representatives of the funding agencies to the resource team external to the district 
health system, the DHMT and the core team. The composition of the resource team (with 
good credibility, adequate management skills and relevant expertise) had an important 
influence over the implementation process. This team has a particularly important role to 
play in managing actors' interests and the power relations among them, as described in 
chapter four section 4.3.3 and 4.3.4. Management of actors is further compounded by the 
number of actors involved, their roles and the differences in the organisational 
arrangements of the different agencies they represent, as was illustrated by the Bungoma. 
AMREF site with actors drawn from CDC, USAID, QAP, AMREF and the DINT. The 
interactions between actors may change the intervention and undermine plans, Icading to 
implementation gaps. This strongly supports the observation that managing relationships 
between key actors involved is key to successful implementation and the outcome of any 
policy (Thomas and Gilson, 2004; Simmons and Shiffman, 2006). 
The need to develop and maintain a good relationship between the resource team and 
district health managers is important in generating a supportive user environment 
(Gladwin et al., 2003). This study provides further evidence to illustrate that such 
relationships are built over time and require deliberate efforts to manage conflicts. This 
was illustrated in the Kisii-Merlin site where these relationships were successfully 
managed. A memorandum of understanding spelt out the roles and responsibilities of all 
involved and the incentives for implementing PMR activities which acted as reference 
document within which to manage actors linked to the innovation. This enhanced 
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transparency, improved communication and minimised conflicts (especially around 
financial expectations and expectations of the logistical support available from the NGO) 
Managing relationships between the resource teams working at district level and their 
funding agencies is also important. This was clearly an influence in the Bungoma- 
AMREF site. Although the funding agencies were represented on the ground through 
actors in the resource team, the contractual agreements between AMREF and USAID was 
characterised by inadequate communication on the funding cycle, undermining the 
implementation of activities linked to demand creation and generating the perception ofa 
lack of transparency by the district health system and community members. The overall 
result was some opposition to the implementation by the user organisation. Although there 
was no specific contractual agreement between the resource team and the funding agency 
in the Kwale-MoH site, relationships between district level actors and the DoMC were 
also characterised by inadequate communication about the release of funds for programme 
implementation. Again, this resulted in inadequate implementation of the intervention. 
The characteristics of the user organisation and the management environment are equally 
important for successful implementation, including management of inter-personal 
relationships between actors within the district health system to minimise internal 
conflicts, and obtain strategic support important for implementation and continuity of 
intervention activities. 
The influence of actors over processes of policy change, including introducing public 
health innovations and the consequent need to manage them, is supported by a range of 
empirical work. A study in South Africa indicates that policy reformers have to take active 
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steps to manage actors to avoid opposition to new policies preventing moves towards 
implementation (Thomas and Gilson, 2004). In Kenya, the influence of actors in the 
introduction of Malaroneg donation programme showed the political and bargaining 
influence of national, regional or international actors on the development and 
implementation of the programme (Shretta et al., 2001). Other studies have shown actors' 
views and values lead front line providers to implement policies in difTerent ways from 
what was intended, often undermining effective implementation (Seidel et al., 2000; Kalcr 
and Watkins, 200 1; Walker and Gilson, 2004). 
A stable district leadership in the user organisation is instrumental for effective 
implementation of any intervention. This is important regardless of the underlying PMR 
approach used. In Bungoma, transfer of the actors who had been inducted into the 
programme led to a leadership gap which slowed implementation of activities during the 
phase when funding was being withdrawn. In Kwale, frequent transfers of district health 
managers coupled with ineffective internal communication of district health activities 
interrupted implementation. Importantly, these problems were not experienced in the Kisii 
site. 
The broad influence over implementation of leadership changes in local health systems 
has been illustrated elsewhere. In Brazil, staff changes in the implementation sites aflcr 
every election process stalled implementation activities threatening the sustainability of 
reproductive services (Diaz et al., 2006). In Zambia, health care reforms led to insecurity 
amongst providers which saw high turn over of staff during the implementation of new 
reproductive services. During the pilot phase for example, a third of 20 trained stafTwerc 
still active at the end of the second year undermining the study's implementation strategy 
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(Skibiak et al., 2006). Overall, high turn over of health workers to the private sector is 
observed to drain the public sector of its bloodline for effective implementation of 
programmes (Berer, 2002). 
For both the resource team and the user organisation, there is need for transparent and 
flexible management systems which allow local managers (from the resource team and the 
district health system) to adapt interventions to local contexts, and so enhance community 
acceptability of the intervention. As experience in the Kisii-Merlin site demonstrates, such 
systems include a budget system that allows local decisions and an efficicrit 
communication channel between actors. However, as shown in Kwale, the often 
centralised bureaucratic procedures of government systems undermine local decision- 
making flexibility and so present challenges to the implementation of innovations 
(Simmons and Shiffman, 2006). Across all sites, one strategy adopted by the resource 
teams to deal with this problem was to ignore or seek to work round the existing 
hierarchical structures by direct communication to implementing actors at divisional level 
(within districts). However, this strategy sometimes generated its own opposition from 
district level actors with negative consequences for implementation and 
institutional isation of the intervention. 
The process of selecting a core team to spearhead the implementation process as policy 
champions is also vital (Simmons and Shiffman, 2006). A core working group is 
recommended as essential in any HMM strategy for effective implementation (W110, 
2007). Based on evidence from the three programmes examined, this study shows the 
need for a consultative process in selecting the core team to enhance cohesiveness and 
support implementation. This may involve actors from the user organisation and the 
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resource team. This process may be facilitated by a good understanding of the 
management system of both the resource team and the district health system for ease of 
selection. However, where core team members are drawn from a range of organisations, 
this study shows that the roles and responsibilities of the core team need to be clearly spclt 
out. 
For successful implementation this study indicates that it will be necessary to adapt the 
intervention to local realities. The resource teams and district health managers will need to 
respond flexibly to changing features of context. A good example in this study was the 
response needed to the changing drug policy as was observed in Kisii where activc 
engagement between the implementing team and national malaria control actors provided 
information necessary for action reducing the potential knowledge gaps and hindrances to 
successful implementation process at district level. The transition phase of drug policy 
changes requires a well instituted communication mechanism between the district level 
and the national level actors. This may allow effective response to changes of JE-C 
materials and curriculum for PMR training to reduce potential chances of confusion 
among end users. 
The importance of adapting the intervention to local realities is supported by several 
studies. In Ghana the community based health programme showed an improvement of 
family planning and safe motherhood indicators after the experimental trial was adapted to 
the resource constrained district level settings (Awoonor-Williams ct al., 2004; Nyonator 
ct al., 2006). Adaptation was also a key element of organisational management of tile 
broad-based initiative for expanding contraceptive choices in the Copper Belt region in 
Ghana (Skibiak ct al., 2006). Similarly in Bangladesh some structural features of the 
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reproductive project were not scaled up but substantial operational changes were 
instituted for different settings (Phillips et al., 2006). 
This study provided particular insights on the issue of the sustainability and 
institutional isation of PMR programmes, as the three programmes were evaluated at 
different stages of implementation. Evidence of the lack of sustainability is examined at 
two levels; the organisational level (continuity within the district health system) and the 
end user level (PMR practising the intervention) (chapter 1). 
At the organisational level there was evidence to suggest a lack of sustained cffort to 
maintain the intervention activities within the local district health system. At the time of 
this evaluation in the Bungoma-AMREF and Kwale-MoH sites, activities such as training, 
distribution of job aids, on going supportive supervision and public information activities 
were not being conducted. These programmes had relatively lower impact compared to tile 
Kisii-Merlin site. As discussed in chapter four, in the Bungoma-AMREF experience 
AMREF and the funders failed to develop an exit strategy that allowed for the hand over 
of responsibility to the local DHMT. Thus the intervention was not sustained beyond the 
lifetime of the project and its funding. In the Kwale-Moll site, the strength of the 
intervention, as outlined in table 5.1, was to ensure that the intervention became part of the 
routine practice of DHMT operations. To achieve this, the implementation approach tried 
to minimise the role of the resource team to strengthen sustainability and promote 
institutional isation. However, since the intervention was new, it may have required more 
external support for effective implementation. Thus at the time of study, there were signs 
of a lack of continuity of intervention activities, in contrast to tile Kisii-Mcrlin site with a 
very active resource team. 
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Although not unique to these programmes, the PMR programmes do seem to reflect 
wider experience of the problems of institutional ising new and innovative programmes in 
district health systems in SSA (Simmons and Shiffman, 2006). This is the case especially 
when the new programme being popularised does not seem to match the user's 
organisational practices. A ten year study in Bangladesh that sought to operationalise a 
family planning project within a district health system showed that new policies that 
disrupt long-standing power relationships and organizational culture take considerable 
effort to implement (Haaga and Maru, 1996). Experience in Zambia, meanwhile, shows 
how important it is to integrate new interventions within the public health system through 
a slow transfer of management responsibility to the district team which allows learning 
(Skibiak et al., 2006). A study in Uganda illustrates the importance of understanding the 
district level system by the implementing team where power relations led to opposition to 
a newly introduced information management programme (Gladwin ct al., 2003). Future 
PMR interventions could borrow these lessons to enhance sustainability. 
At the end user level, lack of sustainability is illustrated by the Bungoma-AMREF 
experience. For example, although a community group of PMRs was established to 
support continuity after exit of donor funding through a revolving fund and supply of 
drugs, management problems and drop outs led to discontinuation of the programme. A 
study in Nigeria has shown that retailer associations can support quality care ofCcred 
through inspection of their services by peers from the organisation (Oshiname and 
Brieger, 1992). However, lack of adequate management skills in the organised community 
group in the current study points out that such organisation may rcquire managerial skills 
in its leadership. For PMR approaches that utilisc community level actors for continuity or 
programme activities, there are likely to be challenges of sustaining programme activities 
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at end user level due to problems of incentives as was seen where CORPS were involved 
in Kwale and the Locational Afya Committees in Kisii. Therefore careful consideration 
need to be given to which actors should be involved to enhance sustainability of PMR 
interventions to support continuity at this level. 
Finally, the type of scaling up strategy used is critical for success. As mentioned in 
chapter four, functional scaling up may limit sustainability, especially in donor funded 
programmes with limited timelines as was seen in Bungoma. The scaling up strategies 
employed in implementing an innovation should, instead, provide an opportunity for 
Icarning, allowing actors to gain experience in the intervention which is then fcd back into 
the implementation process (example-Kisii and Kwale). 
5.3.3 Importance of context on implementation process 
This section examines how this study provides greater understanding of the dynamic 
influences of context over implementation processes and the cffectivcncss of PMR 
programmes. In this way the study has contributed to understanding the cffcctivcness of 
PMR interventions in different epiderniologic contexts and health systems and with 
different types of sellers (Goodman et al., 2007a). Lessons learnt are grouped into three 
areas: effects of poverty on the delivery of intervention, the challenges of involving 
different types of PMRs and the influence of malaria epidemiology. 
This study expands the knowledge on how the complex dynamics of client-l"MIJ 
relationship is affected by the wider socio-economic context making it difficult for trained 
PMRs to balance their commercial role with advising clients to buy the right medicines. 
As was described in chapter four, the PMR-client relationship is often charactcrised by 
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mutual suspicion. For example, there was a general perception that PMRs are 
commercially oriented, and their recommendations are treated with some suspicion. This 
observation is supported by wider literature where PMRs are described as popular in part 
because they often sell anti-pyretics which are cheaper compared to anti-malarials, for 
treating fevers or malaria, they are physically closer to communities, and often sell 
medicines according to clients demand (Goodman et al., 2007a). Given their commercial 
orientation, PMRs' attempts to convince clients to buy expensive anti-malarial medicines 
are a cause for suspicion to many clients, limiting their ability to promote appropriate 
practices. 
Due to socio-economic challenges, PMRs found it difficult to stock expensive anti- 
malarial medicines, especially in remote settings. This is informed by their client's 
inability to afford them, particularly in the right doses as recommended by the 
intervention. Thus, discussions with implementing actors indicated that most remote 
outlets in the rural areas were unlikely to stock anti-malarial medicines due to their cost as 
well as overall low stock turn over. A complication to this description of the PMR-clicnt 
relationship is that remote settings are also often characterised by strong social relations 
between clients and PMRs. In these settings, high costs of anti-malarial medicines 
increased clients' expectations of credit from PMRs, given that clients often knew or were 
related to their local PMR. This situation tends to destabilize remote outlets where these 
pre-existing social "obligations" were most likely to occur. They experience additional 
pressure to provide credit facilities, but may not be able to rc-stock anti-malarial 
medicines. The above challenges illustrate the difficultics trained PMRs experience in 
convincing clients to buy full courses of anti-malarial medicines, and the need for 
effective public information and affordable pricing to support such interventions. 
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involving different types of PMRs introduces several challenges. For example in 
Bungoma, involvement of the chemist shops as well as general retail shops into tile 
programme hampered sales of recommended anti-malarial medicines among general 
retailers. Chemist shops were likely to stock a variety of anti-malarial medicines compared 
to general retail shops since they buy their drugs in bulk and sell loose tablets often at 
lower prices than general retail outlets. This generated competition and pushed general 
retail shops out of business of selling anti-malarial medicines, limiting the coverage of 
PMR services and undermining the aim of the intervention. Although chemist shops are 
generally perceived by community members to offer high quality care, there were reports 
of considerable level of regulatory infringement with some settings having chemist shops 
being manned by unqualified staff or stocking unregistered anti-malarial medicines 
(Goodman et aL, 2007b). 
In terms of effectiveness of PMR programmes in different geographic settings, this study 
illustrates that different settings did not appear to influence the outcomes measured at 
PMR level. However, different geographic settings required adaptation of the intervention 
to these settings for effective delivery as was described in section 5.3.2. In addition, 
through use of GIS data, it was observed that there are differences between population 
distribution in relation to the geographic location of PMR services. For example, despite 
low coverage in the Kwale-MoH site (table 5.1), more under fives were likely to be 
reached even in remote settings as observed in Kinango division. This is likely to increase 
prompt and effective treatment of fevers in these settings. I lowcvcr, further work on how 
GIS can be used to assess the potential to reach different socio-economic groups as well as 
confirming the current observation is needed. 
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T1 
5.4 Recommendations on strengthening the introduction and 
implementation of PMR programmes 
5.4.1 General recommendations 
This section draws out the implications of this study for the future implementation of 
PMR programmes, building on policy implications from a review of PMR studies, WHO 
guidelines and experiences of implementing other elements of HMM interventions (WHO, 
2004a; Goodman et al., 2007a; WHO, 2007). The main issues discussed in this section 
focus on recommendations around the need for institutional isation, conducting a 
situational analysis, selection procedures of PMRs, using a combination of activities, 
establishment of partnerships, and understanding the wider context for implementation. 
In implementing public health interventions, a recommendation widely rccognised is the 
need to plan for institutional isation and exit strategies before initiating implementation 
(Mona et al., 1998; Olsen, 1998; Shed iac-Rizkal lah and Bone, 1998). This is especially 
the case where scaling up the intervention is being supported by external agencies such as 
NGOs. In the context of PMRs, sustainability needs to be built at two levels. One is at the 
individual level involving PMRs and community members. For example, by maintaining 
knowledge gained through updates, supportive supervision and public information 
activities to enhance practices and create demand to sustain the benefits of the 
intervention. For continuity of programme activities there is a potential for using support 
groups of PMRs but however, this requires strengthening of their management skills. The 
second level is at the district, requiring strategies to generate the support of district level 
actors and ensure that the intervention is part of annual district plans with mechanisms for 
implementation. There may be some value in outsourcing certain elements of the 
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intervention to NGOs when the programmes go to scale for continuity until the district 
health team institutional ises it. This has not been demonstrated in participatory training 
approaches involving PMRs. However, projects which utilised franchising principles have 
demonstrated the potential to outsource training and supportive supervision to NGOs or 
commercial companies (Mensah, 2005; Ombogo, 2005; PSI, 2005). 
The importance of a comprehensive situational analysis has been suggested for such 
programmes. WHO guidelines for scaling up HMM recognise the need to collect 
information on quality and cost of drugs, distribution and availability of private sector 
providers, health seeking behaviour patterns and access to anti-malarial treatment (WHO, 
2004a). A review of PMR interventions suggested that a comprehensive situational 
analysis should also cover the legal framework in which PMRs operate, rates of closures 
and new start ups (Goodman et al., 2007a). Through the application of policy analysis, 
regardless of the PMR approach to be implemented, this study suggests additional 
information necessary to include when conducting a situational analysis. Given the 
innovative nature of these interventions, a comprehensive situational analysis in the set up 
phase should also include characterisation of the management system to enable an 
understanding of different organisational systems and actors involved and ways of 
managing their expectations and interests. This is important especially when 
implementation is supported by an external technical team to the local district health 
system. One key result from such analyses is the identification of a mechanism for 
clarifying responsibilities and sharing resources (financial and human) among the different 
partners involved. The example of the Kisii-Merlin MoU supported management of 
expectations and smooth implementation which enabled adaptation of the intervention to 
local realities. 
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Selection of PMRs is considered important especially since there are many PMRs in 
most settings necessitating a selection process to involve PMRs who are potentially able 
to practice the intervention thus improve programme efficiency. This study provides 
further insights on how the selection process of PMRs requires a balance between wide 
coverage to increase access to adequate treatment and ensuring provision of quality of care 
(for example, through supportive supervision and follow up). One criterion for including 
retail outlets in the participatory training approaches was existing availability of anti- 
malarial medicines. Although it was an important criterion for the success of the 
intervention, using this criterion tended to include many outlets which were located in 
large market centres and were probably well established financially. Conversely, the most 
remote outlets were often those least likely to stock anti-malarial medicines. This raises 
the question of what mechanisms can be instituted to support inclusion of outlets that arc 
less likely to be financially able to stock anti-malarial medicines yet they are in remote 
settings where such services may be most needed? It is likely that a selection process 
based on a criterion of existing anti-malarial medicine stock would undermine the aim and 
the fundamental basis for the intervention. 
Previous PMR interventions suggest that a combination of approaches involving both 
short term training of PMRs and community infon-nation are likely to lead to ciTectivc 
outcomes (Goodman et al., 2007a). This study confirms that lack of a combination of 
approaches may have negatively impacted outcomes. For example, public inrormation 
activities were not well implemented in the Kwale-Moll and Bungoma-AMREF sites, 
both of which had limited impact on key outcomes also supported qualitatively. Public 
information activities have been reported as a strong determinant of outcome for 
interventions which focus on provider performance especially in cases where drugs are 
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brought from a commercial-oriented providers such as a PMRs (Marsh et al., 2004). This 
study confirms that community information to generate appropriate demand for PMR 
services should be conducted continuously and should take account of the immediate 
contexts to support the delivery of the intervention at end user level. Community 
awareness through public infon-nation activities have been reported to increase carcgivcr 
knowledge (Kaona and Tuba, 2003; CORE Group, 2004), which may translate to 
sustained benefits of the intervention at community level. 
Monitoring and supervision are widely recommended as a way of improving compliance 
and appropriateness to treatment (WHO, 2004a; Goodman et al., 2007a; WHO, 2007). 
Experiences from interventions on distribution of pre-packaged anti-malarial suggest that 
monitoring and supervision offers additional work load for health workers. This means 
they may be unable to conduct the activities frequently. The alternative is to use 
community research assistants, but associated increased costs may make this approach less 
sustainable. Self completed monitoring forms have been recommended (WHO, 2007). 
One potential way of enhancing monitoring and supervision was illustrated in the Kisii- 
Merlin site where record keeping was utilised as a source of information for monitoring. 
This may be adopted for future PMR programme, however, in places where literacy levels 
among PMRs are low; there may be difficulties in utilising this approach. 
This study illustrates the importance of building partnerships as part of innovation 
management (Simmons and Shiffman, 2006). As part of the set up phase, the WHO 
guidelines recommend developing an advocacy plan, building partnerships and mobilising 
resources for the HMM intervention (WHO, 2004a). Experiences from previous PMR 
interventions recommend the involvement of a range of actors such as public health 
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officials and community representatives in curriculum development, training and 
supervision as likely to contribute to acceptability and effectiveness (Goodman et al., 
2007a). Experience of other HMM interventions also suggests that to enhance chances of 
acceptability, the community entry process should involve key figures from social, 
political, and religious groups and should sustain the interactive nature of consultation and 
negotiation with stakeholders (WHO, 2007). While the study supports recommendations 
to involve a wide spectrum of actors in planning and development, it also highlights the 
challenge that involvement of many actors from different organisations requires careful 
management and effective communication channels. Through the use of stakeholder 
analysis, the study demonstrates the influence of power relations among actors within the 
district health system over the implementation process. 
Finally the study highlights the importance of understanding the context-intervcntion 
interaction and its influence over the implementation process. The study provides 
evidence of the way that recognition of a changing context and adapting the intervention 
to local contexts may strengthen implementation processes. For example in the Bungoma- 
AMREF programme, the set up phase emphasised use of SP which was mainly sourced 
from wholesalers. Later changes to AQ saw chemists becoming important suppliers over 
time, indicating the need for involving them as key channels of delivery as opposed to 
pervious use of mobile vendors. Another observation was the unwillingness of PMRs to 
sell anti-malarial medicines for children under five. This was probably associated with tile 
current manufacturers' package instructions which indicate that only children over five 
years should be treated with OTC anti-malarials, highlighting the need for better 
coordination between malaria control programmes and pharmaceutical industry over 
packaging instruction. 
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Overall the study shows that provision of technical support and adequate resources for 
successful adoption is vital but not enough. Capacity building should include adequate 
managerial skills of the user organisation in addition to the content of the intervention. 
This means that the setting up of such interventions may require time before positive 
outcomes are realised. 
5.4.2 Recommendations on the challenges of new drug policy for PMR interventions 
The final sets of recommendations are derived from broader drug policy influences over 
implementation of PMR interventions. These recommendations also draw from insights 
on the interplay of factors around PMR-client interactions which may influence the 
delivery of future PMR interventions. 
The transition to ACT medicines as a first line drug for malaria treatment is a critical 
element but also challenges malaria control activities (Bosman and Mendis, 2007). Some 
studies have shown that use of ACT is cost effective compared to SP medicines (Coleman 
et al., 2004; Chanda et al., 2007). However, as was alluded to in chapter one, key 
challenges around the use of ACT in the public sector are deployment, access, 
implementing costs and rational use of the drug (Depoorterc ct al., 2004; Fogg et al., 
2004; Malenga et al., 2005; Zurovac et al., 2005; Bosman and Mendis, 2007; Gitonga ct 
al., 2008; Njau et al., 2008; Wasunna et al., 2008; Zurovac et al., 2008). 
ACT medicines have been advocated for use in I-IMM (WHO, 2001), although there are 
challenges of implementing IIMM using ACT medicines. For example, indiscriminate 
distribution ofACTs is likely to disproportionably increasethe costof IIMM interventions 
because ACT are costly compared to AQ or SP medicines uscd in the past (D'Alcssandro 
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et al., 2005; Hopkins et al., 2007). Malaria is also a difficult disease to diagnose. it is 
estimated that clinical diagnosis of malaria by health professional overestimates malaria 
by about 61% (Amexo et al., 2004). With such high rates of errors by trained 
professionals, over diagnosis is likely to be greater when mothers or community based 
drug distributors are involved. In addition, chances of increased parasite resistance, 
especially under indiscriminate use of ACTs, and potential shortages in supply are likely 
to be key challenges for using ACTs in the HMM (D'Alessandro, 2005). Other challenges 
are around the unregulated markets which might provide opportunities for counterfeits and 
high use of anti-malarial medicines by adults with low risk of malaria increasing the cost 
of treating malaria (Charlwood, 2004; Abuya et al., 2007). 
With such a background, this study offers practical insights drawn from the PMR-client 
interactions that may have implications for introducing ACT in the retail sector. From the 
discussion around the influence of context (section 5.3.3), alTordability and tile 
relationships of mutual suspicion between PMRs and clients is likely to be an important 
set back to practising the intervention. The key challenge for costly ACT medicines for the 
retail sector is around ability of PMRs to stock the medicines as well as their clients, 
ability to afford them. It is therefore recognised that subsidies will play an important role 
in achieving high levels of ACT use (Affordable Medicines-Facility Malaria, 2007). 
However, the amount of subsidy that would be needed to support adequate uptake of OTC 
ACTs is currently unknown. 
Early experiences from pilot programmes of global subsidy in some SSA countrics OfTcr 
promising results. This is largely under the current global ACT subsidy known as the 
Affordable Medicines Facility-malaria (institute of Medicine, 2004). The strategy is undcr 
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development with consideration by the governing board of the Global Fund and may be 
launched in a initial set of countries in 2009 (GFTAM, 2008). The pilot project 
programme in Tanzania is centered on distribution of ACTs to private outlets at highly 
subsidized prices. The Clinton foundation procures ACTs and sells them to a national 
pharmaceutical wholesaler at 88% below the manufacturer's price ($0.12 overage 
compared to $1 normally). The wholesaler then uses existing distribution channels, 
including sale to regional distributors, to deliver the ACTs to accredited shops in the two 
intervention districts. The proportion of consumers seeking treatment for children under 
five in the intervention areas using subsidized ACTs rose from 40%to 62% three months 
after implementation (Sabot et al., 2008). The main challenge of the subsidy was that the 
adult course sold more than paediatric courses (Samarasekera, 2008b), similar to an 
observation also made for other OTC anti-malarials in Kenya (Abuya ct al., 2007). In 
Kenya, efforts to increase access to ACTs, was launched in 2007 through franchised shops 
referred to as CFW Tm. AL is distributed to CFW Tm from the government central medical 
stores and administered free of charge to patients with uncomplicated malaria after 
confirmation by a rapid test. Patients pay $0.65 for a consultation and rapid test before 
receiving AL for confirmed malaria. Evaluation showed that the distribution contributed 
to less than 10% of the increase in total ACT coverage after 15 months among CFW TM 
target clinics (Sabot et al., 2008). Building on such experiences and the ongoing pilot 
work in Ethiopia and Uganda may help determine effective ways in which PMR 
interventions could reach the target group. 
The main question around ACT subsidy is the level of subsidies to bc sct for diiTercnt 
settings. This study sheds some light on these issues. For example, since a relatively high 
proportion of PMRs in remote rural areas of Kwale stocked AQ prior to the intervention, 
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this suggests that these were affordable at their current retail prices (if supply is assumed 
to reflect demand). Although fewer outlets stocked AQ in Kisii, a less remote area, this 
different pattern of supply could reflect easier access to free anti-malarials at government 
health clinics. It could therefore mean that ACTs subsidised to the level of existing OTC 
anti-malarial prices would be affordable. However, treatment seeking behaviour does not 
necessarily reflect true affordability, and the costs of these may impose severe, or even 
catastrophic, costs on families (Chuma et al., 2007). 
5.5. Implications for future evaluations 
This section addresses the implications of the study for future public health evaluation 
research. They are grouped into three categories: the importance of prospective studies in 
evaluating pubic health interventions especially for social marketing programmes, the 
value of systematic assessment of the implementation process and the use of GIS tools in 
evaluating coverage and potential utilisation of PMR programmes. 
The choice of the evaluation design of any intervention is critical to the interpretation of 
outcomes (Kirkwood et al., 1997; Habicht et al., 1999; Rosi et al., 1999). Pragmatic 
designs which are planned prospectively provide an opportunity to maximise the 
likelihood of constructing comparisons groups similar to the intervention group. Such 
designs also provide an opportunity to examine previous evaluation in rclcvant 
programme area and include variables useful for statistical adjustments (Rosi ct al., 1999). 
This study has illustrated the difliculty of evaluating social marketing interventions 
retrospectively. This is because there are challenges of selecting contemporaneous control 
outlets making the intervention difficult to evaluate compared to tile participatory training 
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approaches. This is linked to both the risk of contamination, since the approaches 
encompass wide dissemination of infon-nation, and to the difficulty in establishing 
whether exposure has taken place. Given these challenges in selecting comparable 
controls, the interpretation of outcomes is also difficult. The alternative way is to design a 
prospective study at the time of implementation to allow a before and after assessment 
using longitudinal controls (Habicht et al., 1999), to strengthen future evaluation of social 
marketing programmes. 
The study illustrates the value of systematic assessment of the implementation process 
using policy analysis approaches. These include the application of stakeholder analysis to 
examine actor's role, behaviour, power balances and its influence on implementation 
process and outcome. In applying these frameworks, future work could address the current 
paucity of data on the role of implementation in evaluation work, which has 
predominantly focussed on epidemiological and descriptive research (Sanders and I laines, 
2006). 
Although there are other studies that have utilised GPS techniques for assessing covcragc 
of other public health programmes (chapter one), this is the first study to utilisc this 
technique to examining access of PMR programmes. It has provided a provisional 
benchmark for threshold distances for PMR use, and calls for studies in different settings 
to establish gencralisability. Use of GPS techniques has also illustrated that potential 
utilisation was higher in remote rural settings than expected which, as explained in section 
5.2 may plausibly have been related to population distribution. Therefore programmes 
utilising PMR as distribution channel for anti-malarial medicines are likely to continue to 
remain a potential way of improving access. 
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Finally, in the course of this evaluation, the study supports the need for further research 
around: 
* The need to examine the sustained impact on PMR behaviour and the capacity of the 
national malaria control programmes to support such innovative initiatives in the long 
term and at large scale, especially in the context of a rapidly changing drug policies. 
This should include assessment of impact on health, as well as costs and cost 
effectiveness (Goodman et al., 2007a). 
9 The potential for outsourcing certain elements of the participatory based PMR training 
programmes to local NGOs when they are implemented at scale within government 
bureaucracies (Goodman ct al., 2007a). 
9 With powerful tools such as GIS, further studies may provide useful insights on the 
extent in which PMR interventions reach different socio-economic groups (Goodman 
et al., 2007a). 
5.6 Conclusions 
This thesis addressed three broad areas: the impact of different programmes on PMR 
knowledge and practices; the geographic population coverage and utilisation of different 
PMR programmes; and the role of implementation processes and underlying factors in 
influencing outcomes observed. 
Despite the limitations of the evaluation approach, use of multiple methods has generated 
lessons for future evaluation and practice of both PMR and wider public health 
interventions. The study has made several contributions to knowledge specific to PMR 
interventions and wider public health interventions. The evaluation shows that PMR 
training interventions operationalised through various institutions in the district level 
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settings at moderate scale are likely to impact on PMR knowledge and practices and lead 
to increased coverage of target populations by appropriate treatment. This can occur in 
diverse geographic and epidemiological settings with varied outcomes, often depending 
on implementation practice. The changing socio-economic and anti-malarial drug policy 
landscape and the dynamic retail sector indicate the need for adapting interventions to 
local realities including flexibility in design, and responsiveness to contextual features. 
Overall, deliberate and careful management of the implementation including actors is key 
to successful uptake and impact at retailer level. This may include a strong and transparent 
management system for PMR interventions; managing financial resources and 
relationships between implementing actors; stable district leadership; and a consultative 
selection process for the core team. These factors are likely to improve coordination and 
support of implementation process. Finally, the study supports the need to assess 
implementation processes during the evaluation of public health programmes in addition 
to impact on behaviour or health. Use of policy analysis techniques may provide useful 
insights on such evaluations with informative policy implications. 
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Annex 11: Guide for coding adequateness 
Adequate (AD) is defined as within the limits given by standard treatment guidelines for 
age. Evaluation of adequateness is based on the dosage charts used for the training, adapted 
from the National Guidelines for diagnosis, treatment and prevention of malaria for health 
workers, MoH, Kenya, January 1998. 
For SP medicines: 
High dose: (HD)-If the total amount of drug given is high (higher than recommended 
amount for age) coded as high dose. 
Adequate dose-If the total amount given corresponds with the recommended amount for 
age then this will be coded as adequate dose. However, we will code SP use as adequate 
where the recommended amount is given within a 24-hour period. For example, this can 
mean the total recommended dose was divided within the same day or between an evening 
dose and a dose the following morning. 
Low dose: (LD)-If the total amount of drug given is low, the treatment should be coded as 
low dose, regardless of how many days it was given over. 
For AQ medicines: 
High dose: (HD)-If the amount given overall corresponds to that recommended, but this is 
given in I or 2 days only, the regime should be coded as a high dose since the child will 
have received over the recommended daily dose on the days when the drug was 
administered. Overall, if the total amount of drug given is high, the treatment should be 
coded as a high dose regardless of how many days it was given 
Adequate dose-If the total amount corresponds to that recommended, and the course of 
treatment has lasted 3 days. 
Low dose- If the total amount of drug given is low, the treatment should be coded as low 
dose, regardless of how many days it was given over. 
These codes will be followed by subsequent codes as shown in the table below. 
Table 1: Additional codes describing the number of days drugs were taken 
Codes Description 
Al Adequate dose taken over I day (24 hour period) 
A3 Adequate dose taken over 3 days continuously or with a break in 
between (for multi dose d 
H2 High dose taken over 2 days. 
HI High dose taken over I day 
H3 High dose taken over 3 days continuously or with I day break in 
between 
H4 High dose taken over 4 days continuously or with a break in between 
LI Low dose taken over I day 
L2 Low dose taken over 2 days 
L3 Low dose taken over 3 days continuously or with a single day's break in 
be een K 
L: dose ý__, akcn over 4 da 
ýnuousl ý®r wiýtha breýaktn betwccný ::: ýý s contiý 
Note: this pattern may include drugs taken for several days upto 7 days or a week after, in 
which specific description will be given. 
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Figure: Schematic framework for assessing adequateness 
or 
N 
or 
Low/fligh I 
Dose 
H I, f 12, H2 etc 
or LI, L2, L3 etc 
Note: Al and A3- Will be considered the "gold" standard of adequateness for single (SP) 
and multi dose drugs (AQ) respectively. 
AMODIAQUINE TABS AND SYRUP 
I tab--200 mg amodiaquine base 
5 ml = 50 mg amodiaqine base 
Table 2: Dosage guide for AQ drugs 
Age Days given Total no Total in mg Total no sp- oo ss rup 
over tabs tsp (5m]) tbs 0 Oml) 
< 6m 3 3 /4- 1 150-200 3 -4 Y2 IS -2 6-11m 3 1 '/4 -I Y4 250-350 5 -7 V2 2Y2-31/2 
12 - 47m (3y I Im) 3 2-2V4 400-450 7 
V2 
-9Y2 4-5 
48 - 71m (5y I Im) 3 2V2 - 31/2 500-700 10- 14 
V2 5-7 
Is- 15Y Ilm 3 
16+ 3 
SP TABS AND SYRUP 
I tab--500mg sulphadoxine, 25 mg pyrimethamine 
5 ml = 250 mg sulphadoxine, 12.5mg pyrimethamine 
Table 3: Dosage guide for SP drugs 
Age Days given Total no Total in Total no sp ons syrup 
- - over tabs mg* tsp(5ml) tbs(lOmj) : ý, Im I V2 
-% 250 - 3T5- . I- IY2 Y2 .% 
12 - 59 (4y I Im) I I-1 
'/4 500-625 2- 2 Y2 1-1 1/4 
5-8 years 1 1 V2 _1 3/4 750-875 - 
9-14 years 1 2-2% 1000-1375 
15+ 1 3 1500 
ror suipna cumponenE 
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CQ TABS AND SYRUP 
I tab--150mg base chloroquine, 5 ml=50mg chloroquine 
Table 4: Dosage guide for CQ drugs 
Age Days given 
over 
Total no 
tabs 
Total in mg* Total no spoons syrup 
tsp (5ml) bs (I Oml) 
< 6m 3 1 'A -13 /4 187.5-262.5 3 V2-4V2 1%-21/4 
6-11m 3 2-21/4 300-337.5 5-7 2 V2-31/2 
12 - 47m (3y II m) 3 2 V2-3 375-450 7 V2-9 3 -/4-4V2 
48 - 95 (7y I Im) 3 31/4-6 487.5-900 - - 
48 - 71 (5y I lm) 3 - - 9-12 4 Y2-6 
15y- 15Y Ilm 3 81/2-9V2 1275 -1425 
16+y 3 10 1 1500 
*Note that this is the total amount in 24 hrs, and will normally be given in 4 doses in a day e. g. 
tsp x4 per day -> total of 4 tsp/day 
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Annex III 
Part 1: Quantitative Tools 
KEM RI/WelleomeTrust / DoMCSurrogate Client Stin ey 
District: 1 11 1 Division: lilt/ ('0111: Rcplacciiient Y/ N 
Date ot'visit I (clcl/nini) /2006 Date of visit 
Decoy name Decoy codc: 
Shop name 011110 Code 1 11 
Location Village /Markct Ccntrc 
Shop status C/0: visit II 
--- 
I visit 211 Sex ol'SK: F/M II 'I raMcd Y/N II 
Ask if has ni a laria dru (Is. I l'yes, ask 11or ma I ariii d rugs I'm- it chi Id (If as ked q ties I it) its, gi%e respon%es ill 
guide) 
1. Did the SK ask about any ofthe 1`611owing, '? I'Mer ) NIV R ill 
Fever j__j Age No. ofdays Fits Pre\ioustreatment 
Weaknessl___1 Vomiting II Diarrhoea II D11,11cultv In hi-ciltlillig 
NoSigns: 
2. Wcrc any drugs sold during this visit'? .............. ...... ..... 
Y/N 
3. If no drugs sold, givc SK's reasons: 
I- no drugs in stock-, 2- no AM drugs in stock, 3 no sintable drug's in stock-. .1 
rellerred to clinic/chen-list 5- other. 1.1'nof suilable or o1her, I 
Were AM drugs visible in shop? Y/N. 
brand ............................................ 
Note: fftioAM drugs are available OR visib1c, riplact, mithv ..................... C()(]C 
IJSK savs no suitable AM drugs available, or stivs n, )., IAI (h-ugs hay"it can. vtv ihem o, Nl,,, A, 1, ý 
replace oullel. Discuss vvilh supervisor tit reviov. 
(Go lo 06 ýfno drugs sold) -4 
Where drugs were sold 
121 
Recommended ý Druu I I lk I Drul, 3 
A rvi 1: 
AN12-, 
All: 
ANI 1: 
AM 2: 
AM 1: 
AM2: 
AM 1: 
AN12 
5. Type ofdrugs recommended and tile way used 
AM I dose[ 11 1[ 1.1 1 ing days AM2 dose 
days [___I AM dosedays: 1 11 
_1 
6.11'advised you to go clinic, what advicc did the retailer give'! 
go to clinic ij'signs persist: 2- go to clitiic now (drugs sold): 3- go to clinic plols. (j), ) (h-jjg. v. %o/jI) 
4- other, specýlj . ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... .. - ý/ / 
Description of lite outlet 
Name 
oulside ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..... ... ... ... ... .... ... ... ... ... ... ... ... . ..... ... ... .... 
('olour qfwall ..................................................................................................................... 
Poslers otiftoni . ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... . Roofmaterial ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..... 13julding on righl ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... .... 
On 
... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... 
('onunents (record an ,r 
dijjic"Ifies infindingsholp, howSK Ireated. rou, ý/ymi thought the %-ij% %u%1, j, ýi, )j, % 
ofyou and why, any inhlitional information given or discus. %ioll with SA) 
- ... ... ... ... .Iý... ... ...... .... I. ... .-... -.. ... .I....... ... ... ... ... I ..... ... ... .. Iý. 
... ... ... ... ... ... ... ... ... ... ... ... .I.... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... - ... ... ... .. I...... . 
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KEMRI/Wellcome'Frust / DoMC: Retail 0utlet Survey 
To be completed lor all outlets visited 
1. District [B][G I ..................... 2. Division 
3. Outlet name and ID................................................................. 
4. Today's date (dd/nini) ................................................................ 
Type ofoutlet 
I- chernist owned and run, 2- chemist owned, run by other, -3 - N(IO/niis,, ion drug, shop: 
4- community drup shop, 5- general shop, 6- other, specify ............................ 
6.1, ocation ...................................................... 
7. Market centre/ Village ................................... 
8. Situation: 
in large market centi-c; 2- small niarkct ccnlrc*, 3 single outlet. not hased in 1winesicad. - L- 
4- single outlet in liornestead ........................................................ 
Outlet status: 
I- open/sellIng malaria drugs-, 2- open, no nialaria drugs-. 3 tcinporarilý closcd, 
4- permanently closed; 6-no drugs at all; 7- refusal, 8- other 
spec i 1-y ................................................................................................. 
litterview the main swller 
Name of niain seller ............................. 
/ 
............................. 
I 1.1'rained'? Y/N 
.................................................................................. ...... 
Place and date oftraining ................................................... 
1-14-11-1 
Age ol'inam retailer (yrs) ............................................................................... 
Sex: F/M .................................................................................................. 
FIducation: .................. l'ypc j__j I --- 844; 2 old sys(cin 
Yrs 
....... 
Maximum number oflwoplc that ever serve cusionters in this shop at the sanic 
17 Types ofdruos avallable lor sale today: ('Ircic Y/N 
Ma laria Y/NI 'ever/licadac lie Y/N Oiarrhoca ............ Y/N 
Cough1cold Y/N Wornis Y/N )I lieu NN 
Specify Other I )ther 2 
To be completed lor all outlets sellino AM medicines. II'llierc are no AM drup-, iclini, 1ý11L. inicl N lk-ý% 
18. Fvpes ofinalaria drups currently in shop. - 
a. Brand name 1: 1 'IbIct/syrul) 1. \ 
b. Where dru- obtained: Gcncral %kholesaler, Clicimst. While vcndor, Othcr, sl)ccil'% 
Ncarby market. T -nearby town ccnIre, A distant lown centre ............................ 
c. WhoIcsalc price/unit: KS per 
I-- 
- -- 
I 
........ 
I 
d. Retail pricc/unit: KS per 
e. Storage conditions: I -stored awaY firom (III-ect Sunlight, '-- (11-\ placc -')- c1can placc..... 1'. liidicatekklictlierexpir-yditeoii packages is\kidmi 1111"(1,11c ..................... Y/N 
a. Brand name 1: [__ ___ -- ----- 
TahICI/SN rilp Clicillical tNpcý 
b. Wherc drug, obtamcd: t, 
Gcncral wholesaler. Chemist. Mobile vendor, Othcr. spccik ............................. 
Ncarby market. T --nearby town ccntre, A distant lom) ............ 
c. Wholesale price/unit: KS PCr 
d. Retail pricc/unit: KS Per 
c. Storage conditions: I -stored away from (fircct sunlight, 2- drý place 3- c1can 
place ................. [I 
1'. Indicatc Nflicther expiry date oil packages is within Ilil. " (late ........................... Y/N 
a. Brand name 1: [_ 
- __ -I 
Tablet/syrup Chemical 1ýpc: 
b. Where dru- obtained: 
Cencral wholesaler, Chemist, Mobile vendor. Other, spccifý ............... ............ 
Nearby market, T- nearby town ccntrc, A distant (o%,, n cclitrc ................... . .. 
c. Wholesalc pricc/unit: KS per 
d. Retail price/unit: KS1 11 11 1.1 11 1 per 
c. Storage conditions: I-stored aNvaý from direct sunlight, 2- drN place 3- Clean placc.. 1 
1'. Indicate whether expiry date on packages is vvithin this date ....... ..... I ........ 
VIN 
19. List the brand names oficvcr/headache drugs curroitly in shop 
1.1- 
--- ---- 
1 
3. I . 1.1 
20.11'a customer asked you what medic I ncs to huN f0r a 5-Ncar-o Id cI ii I (I ý% it IIaIII gi II c%cl. I),,, 
other symptoms, what would you recommend? Prohe (Ilwgs of. ollit. l. 
Rec-drug: I AMO, 2 AMP,. ) AMX, 4 AllO, ýs 
AP\. 6 0111, 
............................................ .II 
Illec 
- 
type: I SP, -) AQ, ') CQ, 4 SP/AQ, SM AM. 0 AS, 7 PA-N 
BR. 10 other drug, II- otheradvice ................................................ ... 
2 1. What would you rccommend IfIlle CIIII(I did 1101 gcI bCtjcl- kl'ICI. " days oil tills (re. 111TICIII. hill 
was not worsc? Probefin- iypes t? /*, /,., T. v, ()I. 
I I.. 
Rec-drug: I- AMOý 2- AMP, AMX, 4 -- APO, 5 APX, 6 0111,7-adN icc 
.............................. **********, *[ 
I 
We 
- 
type: I-SP, 2-AQ, ')--CQ, 4---Sl'/AQ, 5 OTAM, 6 AS. 7 I'A. 8 B0.9 
13 It, 10 ---other drug, II- other advice ........................................................ II 
22. Use of currently slocked drugs: How wolihl, voll advist, a cl/s/o/ner to 11m, III(II(Whi 
_vousiock. 
fin- a 5-year old chil(I" 
Note: if more than one brand of SP or AQ drijus itt outlet, asA ahow brand inov 
commonly sold 
For SP drugs stocked: enter brand name ............ 
I 
I low many days to take'? .................................................................. .II 
How much each day? Day I 
Amount to take at a time (specify tab, tsp 
or tbs) 
No oftimes per day 
Day 21D. IN 3 
Total dose LA-IL-1.1-1 llig Sullullary (lose 1 11 1 I)osc &1\'ý 1 11 1 
For AQ drugls stocked: entcr brand name 
I low many days to take'? ................................................................ ý, 
II 
46h day? Day I Day 2 How much each D-ký 3 
Amount to take at a tinie (specify tab, tsp 
or tbs) 
Týo oftimes per daN 
Total dose Summary (lose Dose davs 
Did seller use aiiy rellcmice charts flor drug dosiges? Y/N) ................. I.. I 
Iff, what type'. ) I- Prognuimic chart-, 2- DoMC calewhir-, 3- NImul', unirer clI. Irt: 
4 Other specify .................................................................................... 
25. Referral: Are Mere un 1,, v ilm Ilions where vou lhiiik i child wil/I It'verShould he I'A'. 11 I(, 
heallh worker and not treated at home wilh. vhoj) bough1drugs? N' N 
26. IFY describe the situatim 
.......... I .......................................................................................... 
27. Other shop products for malaria: Indicate ifilic ing, arc prc. sciii totla) 
Programme matcrials: (codcs 1'61- a-c: I- casllý -, ccill 2 not ca... 'lly secil, 3 not a%allahlk-) 
a. Drug chart ............................................................................. . ..... II b. RelCrral chart ....................................................................................... 
c.. Posters ............................................................................................. . d. 1, callcts (YN) ................................................................................. ..... 
cAlooklets (Y/N) .......................................... ............................. F. Bed ncts (Y/N) ........................ II l1r; III(I ll; llllc ... ................... 
gAnscclicides I'Or bed nets (Y/N) II III-and nallic ..................... ......... li. Acrosol insecticides (Y/N) ......... i. Coik N /N ...... ............... 
Mosquito repellent body gels/creams (YN) .................................................... F1 
28. Training programme involved: I- VTV Programme with SP; 2- VTV programme 
SP+ AQ 3-MOH training programme; 4- MOH and VTV SP; 5 MOII and VTV SP+ AQ 
6; None 7; Other specify 
.................................................................................................... 
L-1 
Description of the outlet 
Name outside ................................................................................................................. 
Colour of wall .................................................................................................................. 
Posters on front . ............................................................................................................. 
Roof material .................................................................................................................. 
Building on right ........................................ On left .............................................................. 
Comments (record any difficulties in finding shop, how SK treated you, If you thought &/he was 
suspicious of you and why, any additional information given or discussion with SK) 
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KEMRI[Wellcome Trust & Division of Malaria Control: Locating retail outlets 
1. District [B]G] ....................... 2. Division FI 
3. Location ............................. r 
4. Market CentreNillage ............ FI 
5. Outlet name ........................ ..................................................... 
6. Shop owner ............................................................. 
7. Date located (dd/mm) ..................................................... r1 4- 1 2006 
8. Trained.. Y/N ... r I... 
if Yes Date trained (dd/mm ) ............. rI -LJ-J. L-LJ 
9. Type of outlet 
I- chemist; 2- NGO/mission. drug shop; 3- community drug shop; 4- Kiosk, 5- general 
shop; 6- other, specify ............................................................................... [--] 
10. Are there any anti malarial drugs in your shop today Y/N ............................ L-J 
I I. Maximum number of people that ever serve customers in this shop at the same time. 
.......................................................................................... 
12. Position: 
Reading I Reading 2 Rcading 3 
Latitud L---I-r I- rMI- Li-f I 
e 
Longitu 
de 
-Li-Li 
I Li-i I-Li IIIIII 
Comments: 
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Part 11: Qualitative Tools 
FGDs guide for clients: Demographic data capture sheet 
Date of discussion Moderator 
Venue Note-taker 
Time start No. Participants at start 
Time stop No. Participants at stop 
ke hreaker ..... tell me ahout a little your general life experiences within this area 
Understanding retailer-client interaction 
Since you all come from around .......... which is in ...... division, may be we should start by discussing how do retailers in this area sell medicines? 
(Seek their viewsfirst, and then probe and digfor issues that might be relevant eg: 
Type of drugs retailers sells often why? 
Cost of drugs 
Process of interaction-how retailers behave while selling medicines 
Perceived role of retailers as sources of care 
Anyproblems encountered while buying medicines 
Role of religious beliefs in sale of OTC medicines 
Role ofthemists: quacks, women empowerment, vendors 
Perceived impact of programme on retailer practices 
Have you noticed any changes in retailer practices recently? (if yes ... what changes? ) Do they ask questions 
Do they refuse to sel1lonly certain drugs with information 
Attitudes 
Perceived impact on death rates 
What do you think about these changes- problemsladvantages 
What do they attribute these changes to-if they say programme and why 
If mixed reactions explore reasons whyfocus on: perceived causes of changes, why they think so if 
programme is not mentioned ... go on to ask ..... 
Views regarding programme activities and ownership 
Arc you aware of any training activities that involve retailers in this area? ffcns-are ask: 
"at activities are they (elements of the programme) 
no is running the activities 
no is involved in these activities and what are their roles 
What are their roles 
How did they hearlbecome aware of these activities 
Erplore their views1perceplion and knowledge ofprogramme activities 
Perceived success orfailure ofthese activities 
Reasons behind these problems1success 
Single out materials andlorpublic information activities: 
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Perceived role of materials/public information and appropriateness in local context 
Have you come across materials used in this programme? 
(Carry samples but show them after they have discussed it) 
How did they come across them 
"at materials? 
Are they suitable, 
Other communication or channels used, 
Views about these materials 
Programme goals and appropriateness in local context 
What do you think in general about this programme in comparisons with other approaches to 
treating/control ling malaria eg bed net, hospital care? 
Is it a good idea? 
Why do you say so? 
What makes this such as goodprogramme 
If unaware. explain what the programme is all about and ask their opinion on whether it is a good 
idea 
For both negative andpositive responses ask questions on problems and benefits 
If negative response 
Costs and benefits of programme 
Are there specific problems that you haven't mentioned about tile programmc that makcs you say 
so? What are they and why? 
Costs associated with programme 
Problems with retailers 
Programme managers, others 
Potential harriers to success 
Ifposilive response 
What are the main benefits that are associated with the programme? 
Successes as they view it? 
Reasons hehind success -why they think so, what contrihules to it? 
What in your view are the main barriers of success of such a programme? 
Lack ofpuhlic information 
Costs of drug 
Practices of retailers1clients 
Others 
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FGDs guide for PMRs 
Ice breaker.. tell me about the general lifestyle in this area: what people do, business activities etc 
Understanding client-retailer interaction and coping mechanisms 
Can you tell me more about your experiences while selling medicines to clients? 
Problems with client's preferences in terms of type of drugs and reasons 
Cost of drugs in relation to regime, other, access to drugs through vendors role ofpolicy change in 
stocking patterns 
Role of religious beliefs in OTC sale, drugs shops, free health care 
How do you deal with it? 
what do you do -credit, advice, other, 
Reason behind all these mechanisms 
Views regarding programme activities and perceived adequateness 
What do you think about the training workshop, which you participated? 
no was organising it 
How do youfeel about it was it adequate? 
Were your expectations met, why and how? 
What materials were used, how useful?, why? 
other communication channel used in training, how, their view on this channen 
How did you get involved in this programme? 
Knowledge, 
Recognition 
Monetary gain or other reasons 
Has your involvement achievedyour expectations? 
Are you aware of other programme activities? Ifaware: 
Specific elements- public information, monitoring and supervision 
How didyou know ofthem? 
no was involved? 
Their views ofwhether a success orfailure 
ff bylany problems 
If unaware: Ask their views on the supportive environmentlactivilies that will make this 
programme a success and why 
perceived impact of programme on their practices 
Has the training influenced your daily practices? 
How? -are main sellers same as trained sellers? 
In what wiDI-refuse to sell medicines to young children why? 
"y do you say so? 
Programme goals and appropriateness in local context 
What do you think in general about this programme in comparisons with othcr approaclics to 
treating/controlling malaria eg bed net, hospital care 
Is it a good idea 
why do you say so? 
nat makes this such as goodprogramme? 
Costs and benefits of programme 
Ask the question on prohlems and benefusfor both negative andpositive respontses 
If negative response 
Can you tell me about the problems you have experienced with the programme in gcnertil? 
(Seek their views first, and then probe and dig for issues that might be relevant) 
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Barriers to practices -cost of drugs, profit motive 
If any of these comes up then askfor more details why they think it is a problem 
Their views on this or any other issue that comes up 
Ifpositive response. 
Are there any benefits that are associated with the programme -successes as they view it? 
Why they think so 
What contributes to it 
To whom does it benefit most)? 
Closing debate a summaryfrom above discussions: Overall, do they think this programme is a 
success or notfor and against, reasons 
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FGD guide for mobile vendors: 
Ice breaker.. tell me about the history ofdrug vending in this area: how it started, how it was 
before and after the active phase ofprogramme, reasonfor such a number of vendors etc 
Understanding initial programme activities involving vendors 
Can you tell us more about the activities that you were involved in the VTV programme? 
How were you involved- coerced, Knowledge, Recognition, Monetary gain or other reasons 
no was organising it 
Has your involvement achievedyour expectations? Why and how? 
How were the activities organised: links with drug company, common drug store supporting 
structuresftom AMREF, MOH, reftesher courses 
Views regarding programme activities and perceived adequateness 
What do you think about these programme activities which you participated? 
How do youfeel about it was it adequate? 
What materials were used, how useful?, why? 
Oiher communication channel used in training, how, their view on this channen 
Was this programme a success: - any evidence for success orfailure? 
Are you aware of other programme activities? Ifaware: 
Specific elements- public information, monitoring and supervision 
How didyou know ofthem? 
no was involved? 
Their views ofwhether a success orfailure 
Whylanyproblems 
Understanding Vendor -retailer interaction and coping mechanisms 
Can you tell me more about your experiences while selling medicines to mailers? 
Problem with rctai ler's preferences in terms of type of drugs and reasons 
Cost of drugs in relation to regime, otherproblems? 
Role ofthemists and the impact oftheir business 
Current activities that vendors are involved in 
How do you deal with it? 
"at do you do -credit, advice, other, 
Reason hehind all these mechanisms 
Perceived impact of programme on retailer practices 
Has this programme influenced retailer practices? 
How? - refuse to sell medicines to young children, stocking patterns, failure to pass information 1() 
retailers 
How information can he sustained? 
Programme goals and appropriateness in local context 
What do you think in general about this programme in comparisons with odicr approaclics to 
treating/control ling malaria eg bed net, hospital care 
Is it a good or a had idea ? 
why do you say so? 
nat makes this such as goodlhadprogramme? 
Costs and benefits of programme 
, 4sk the question on prohlenis and benefillsfor 
both negative andposilive responses 
If negative response 
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Can you tell me about the problems you have experienced with the programme in general? 
(Seek their views first, and then probe and dig for issues that might be relevant) 
Barriers to practices -cost of drugs, profit motive 
If any of these comes up then askfor more details why they think it is a problem 
Their views on this or any other issue that comes up 
Ifposilive response. 
Are there any benefits that are associated with the programme -succcsses as they view it? 
ny they think so 
"at contributes to it 
To whom does it benefit most)? 
Views regarding the CBO formation and it prospects 
Can you tell us briefly more about the CBO that you have formed? 
How did the idea come about? 
no are the members: criteriafor membership, mechanism ofoperation, why othersfell out? 
What is the role of the CBO? 
"at was the process ofregistration 
How about sustainability? How doyouperceive thatyou will maintain goals? 
Role of, 4AP? EF1MOH in this process 
Why have didn't the MOH take up the supportive role and continue with programme activities 
How do you perceive thefuture ofthis programme? 
Closing debate a summaryfrom above discussions: Overall; do they think this programme is a 
success or notfor and against, reasons 
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In depth guide for trainers and co-trainers 
ke hreaker.. tell me ahout your experiences in this division perhaps in terms ofyour role in 
various activities that you heen involved in 
Ifmaintrainer: tell me ahout your experiences in this division how long have you worked here, you 
like it ........ why 
Role of actor in implementation of training programme 
I understand that you are a co-trainer/trainer in the retailer training in this district. What was/is your 
role as a co-trainer/trainer? 
How do youfeel about it? 
Have yo u experienced any problems in juYlIling this role-what and why? 
97iat has helpedyoufuffil these roles? 
How did you got involved in this programme 
"y you in particular? 
For what reasons-part ofyourjob, recognition, monetary gain, other 
Has your involvement achievedyour expectations? 
Can you tell us about your induction into the programme? 
How were you trained -workshopslon thejob 
Was it relevant to programme? 
What other activities have you been involved in, in this programme? 
Was itpart ofyour roles or was it additional?, why and how didyou get involved, 
Have you experienced any constrains in these activities -what and why . ..... i(not. 
9,1hat has helpedyou conduct them successfully? 
Who else have been involved with the programme in this district? 
ff7hat was their role in specific activities? 
How did they get involved, why? 
Besides the training programme, do you have other roles, which involves interaction with Mailers? 
97hat do you think about these roles? 
Do they hinder your interaction with them in this programme? How and wily? 
How do you manage programme activities with other district roles? 
Views about programme activities and materials used 
Tell me more about mobilisation activities prior to the training ofretailer 
How was it done? 
Who was involved? 
What do you think about the train ing/programme activities that you conducted with retailcrs 
"at style of teaching, why, 
Own views on effectiveness, 
Anyproblems? 
Means of invitation, 
Selection process? 
Can you share with us your experience with materials which you used in the training1programme? 
"at do you think about them? 
nose role was it to produce, distribute them 
"en and how were they distributed? 
Were they suitable? 
, 4nyproblems with materials? "y- show samples: 
drug chart, referralcliart booklet, poster) 
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Support andsupervisory activities 
Have you ever received supervision/guidance in the programme activities? if yes 
no supervised them? when, for what, how, your views about it, was it helpful, how why do you 
say so? 
Mere there any problems associated with this supervision? Which ones If not why, whose role is 
it? ) 
Have you been involved in any supervisory activities/monitoring of retailers? if ycs 
"en, how -didyou use any tools, your views about it-any problems associated with ill any 
success if not -why whose role is it? ) 
Ifrelevant: if they don't mention any of the following (retailers and co-trainers induction, public 
information, monitoring and supervision- ask whether it happened in their context (details-if did 
not happen- why it didn't happen, whose role was it? ) 
Understanding ofprogramme goals 
What do you think in general about this programme in comparisons with other approaches to 
treating malaria -is it a good idea? why do you say so? 
Mix are your views on programme goals and relevance) 
Ask the question ofproblems and beneflisfor both negative andposilive responses 
If negative response 
Factors affecting implementation process 
What sorts of problems did you and others in the district experience in implementing this 
programme? (Seek their views first, and then probe and dig for issues that might be relevant such 
as: Financial-arrangement, returns, Incentives1remuneration; Retailers-attitudes and behavior) if 
any of these comes up then ask for more details why they think that happcncd-thcir views on this or 
any other issue that comes up and any other problems they have faced) 
If, positive response 
What are the main successes of programme as you see it? What makes this such as good 
programme (probe and dig-why they think so, what contributes to it, are there w(Vs this could be 
improved? ) 
Process of implementation 
Ilow would you describe bow this programme was implemented? 
Weakness, 
Chronology of activities? 
Activities planned and not implemented? 
Would you kindly take us through the organizational structure of this programme? 
"at is your view on the organizational structurefor this programme? 
Is it a good arrangement? My? 
Tell us about the financial arrangement of this programme? 
How does this compare with otherprograms? why 
if you were given a chance again how you implement this programme? 
Ask if differentfrom what they did why was it different and thc advantages of this approach 
Does this programme link up with other district programmes/departmcnts/organizations within 
district? How? any success and failures with such linkages? 
"at challenges you have experienced in coordinating this programme, 
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Resources used 
Changes required 
What is the role of TOTs in the integration of this programme within the MOll? 
Linkages and activities ofAMREF 
What is the future of this programme in he light of the changing drug polices? 
Who were the main partners in this BDMI and what were their roles? 
What are the current programme activities in the AMREF programme? 
Otherfollow up questions 
According to the reports the collaborating agencies had the challenge of implementing the activitics 
and keeping in touch with schedules of activities? 
Why is it that MOH/DHMT has not been able to sustain and take up by the approach as kcy in the 
district? 
What is the role of operational research in the programme? 
What are the other organisations that are in Bungoma district and what are their activities? 
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Interview guide for Managers 
Ice breaker ... tell me about a little your experience in the district 
I understand that you have overall responsibility in co-ordinating district/AMREF programme 
activities in Bungoma. What are some of the success and weaknesses of this programme? 
Broader achievements ofprogrammes andfailures 
Any concrete evidencelexperiences 
What was/is your role in this programme? 
Managin&finance, supervision, training, induction, core team member 
Have you experienced anyprohlems injuYlilling these roles-what and why? 
What are thefacilitatingfactors that have helped achieve these roles -why? ) 
Tell me about the financial arrangement of this programme? Is it different with other programmes? 
How much money was obligated why? Not all 
What was the process of releasing 1hefund? 
Who are the main partners in this programme and what was their role? 
What were the roles ofcollaborating agencies: challenges of implementing programme activities, 
control ofprogramme activities 
Role of research activities at baseline? Number and expensive etc 
ff, 'hat are the current AAlREFprogrammes 
Who else was involved and what was their role in this programme 
"at activities were they involved in? - Production of materials, retailers and co-trainers 
induction, training, public information, monitoring and supervision. 
Did they experience anyproblems in carrying out these activities? 
Are there anyfactors that enabled them cany out their roles with ease? why and how, 
, 4ny major issues encountered that were brought to you attention?. 
Ifrelevant: if they don't mention any of the above activities; ask whether it happened in their 
context (if did not happen- why it didn't happen, whose role was it, anyfuture plans regarding 
these activities? ) 
Could you kindly tell me about activities that were planned for the VTV/rctailcr-training 
programme? 
"at was planned? 
nat activities were implemented and which ones were not? Reasons? 
Single out planning training/materials - core elements ofprogramme; 
ff, rhat do you think aho ut these aspects of the programme? 
Were youfully involved in planning? If no why how do youfeel about it? 
ny was there sudden shift offocus to workshop approach 
Who was involved in actual training of retailers? Can you tell me more about this activity 
what was his role, what materials were used, 
JVhatprohlems were experienced? 
Has this training changed retailer's practices-how? 
Have you been involved in any supervisory activities of programme activities? 
What was your actual role? 
How didyoufind it? 
, 4nyprohlems you experienced, were there anyfacilitatingfactors? 
In understand you play crucial role in coordination of programme activities cithcr within or outside 
district? 
Withinloutside: what was Your actual role? How didyoufind it? 
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Any prohlems you experienced, what enahledyou coordinate with ease? 
Were there any unrealistic expectationsfrom various people in the programme? 
Any other people involved in coordination? 
What was their role: checkfor mechanisms ofcommunication with trainers, national ofJI'ce. 
Handing over the programme to CBO 
I understand the vendors have set up a CBO: When did this start and reasons for this? 
What are the mechanism of operation number at handing over and why others fell out 
How does this model differ from other experiences? 
Why is that the MOH/DHMT has not been able to sustain and take up by the approach as key in the 
district. 
AMREF functioning and its impacts 
How does AMREF carry out its functions within local contexts? 
Do you think there is something in the functioning of this district management bcfore/during and/or 
after AMREF withdrawal that helps explain lack of sustainabil ity? 
What factors would you cite that may have influenced implementation and sustainability or the 
programme? 
What do you think in general about this programme in comparisons with other approaches to 
treating/controlling malaria eg bed net, hospital care (is it a good idea? why do you say so? 
Do you think it is relevant in this setting? ). 
Ask the question ofproblems and beneflisfor both negative andpositive responses 
If negative response 
Are there specific problems that you haven't mentioned in implementing this programme that 
makes you say so? For each of the problems: 
How didyou became aware ofihem, 
no was involved, how was it resolved -Seek their viewsfirst, ifthey haven't mentioned then: 
before, probe and digfor issues that might be relevant eg. financialprohlems- access, adequacy, 
process, rem uneration, other partners , national officeldonors, staff changes, adjuv Iments all d 
expectations 
ifany ofthese comes up then askfor more details why they think that happened-their views on this 
or any other issue that comes up. 
IfPositive response 
What are the main successes of programme as you see it? What makes this such as good 
programme (probe and dig-why they think so, what contributes to it-checkfor Lvsues above, is-ho is 
the greatest beneficiary of this programme -What sort of benefits why? and any other). 
Could you tell us about the organisational structure of the programme? (Is it good arrangement? 
JVhy is it so? Give a chance to implement this how would implement it? ) 
in you view do you think this programme has been a success or failure? 
Reasons to hack responses 
What are the potential barriers to the success of such a programme? 
Do you think that AMREF/ MERLIN/DIIMT plans to continue with this programme? 
"y how? Is it aprogramme that isfitIfeasible within the district level activities and among donors 
andotherpartners 
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flow would you explain the relationship between the district/AMREF/ MERLIN and national level 
office? 
Have you received supportfrom the national office? 
Ifno why do you think so? 
Ifyes what kind of support? 
Does this programme link up with other district programmes/departments/organizations within 
district? 
What is the nature of linkages? 
Resources, coordination, technical, other? 
For what reasons were these linkages estahlished 
What are the henefus andfailures of such linkages? 
Could you tell me how you perceive the future of this programme within the AMREF/MERLIN 
programme? 
Nature of integration with the M011programmes 
Sustainability and the relationship with MOH-co-trainers 
What are your views regarding the strategic policy direction in the role of retail sector in malaria 
control I the light of ACT? 
Finally, could you describe the chronology of events that have implemented in the rctailcr-training 
programme? 
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PART III: Consent forms: Retail Audit information sheet 
Introduction 
My name is .............................................. and I work for KEMRI GGMRC 
in Kilifi. 
KEMRI is carrying out surveys in shops that sell medicines in several districts in Kenya to collect 
information about medicines sold over-the-counter. This information is being used to develop 
programmes to help retailers and their customers get better information on commonly uscd over- 
the-countcr medicines. 
Who is heing asked tojoin in the survey? 
A few shopkeepers have been trained in and we are asking the main 
seller/trained seller from each of these shops to participate in the survey. 
What are we requestingfrom you? 
If you agree to participate, i would like to interview you on medicines commonly stocked and sold 
over the counter. This interview will take approximately 20-30 minutes, however, each time a 
customer comes, you will attend to hiffL/her first. I will also like to let you know that participation 
in this survey is voluntary. 
Are there any risks or benefits of being involved in the study? 
Apart from the time spent now, there are no disadvantages or direct bcnef its to you from 
participating in this survey. However, the information we collect will help medicine retailers and 
people living in Bungoma in developing and strengthening MOH and AMREF programmes on sale 
of over the counter anti malarial medicines. 
Confidentiality 
Once we have interviewed you, the information collected in this form will be storcd in a locked 
off ice until it is entered into a computer in Kilifi. The computer files will only accessible to people 
working for KEMRI in Kilifi who are involved in this survey. Once the survey is ended, we will 
compile a report for the MOII in Bungoma and Nairobi. This report will not contain any names or 
specific locations of people or of shops included, except the divisions involved in the survey. The 
information will not be used in any way that could threaten your business. 
Do you have any questions or concerns regarding the information I have given you? 
Do you agree to participate in this survey? Y/N 
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GPS survey information sheet 
Introduction 
My name is .............................................. and 
I am working for KEMRI GGMRC in Kilifi. 
KEMR1 is carrying out a survey in this division, which will attempt to locate all shops and collect 
information about their geographical position. This information is being used to estimate coverage 
of a ministry of health programme that involves training of retailers in this division. 
Who is being asked tojoin in the survey? 
We are visiting all outlets in this division whether trained or not and we are requesting all retailers 
who sell in these shops to participate in the survey. 
What are we requestingfrom you? 
If you agree to participate, i would like to ask you a few questions regarding ownership of tlic shop, 
whether you have attended any training on anti malarial medicines and whether you have any anti 
malarial drugs in stock. This interview will take approximately 10 minutes, however, each timc a 
customer comes, you will attend to him/her first. I will also take readings of the position of this 
outlet using this hand held machine. Finally I would like you to know that participation in this 
survey is voluntary. 
Are there any risks or henefils of heing involved in the study? 
Apart from the time spent now, there are no disadvantages or direct benefits to you from 
participating in this survey. However, the information we collect will help the ministry of health 
strengthen the programme and estimate coverage. 
Confidentiality 
Once we have interviewed you, the information collected in this form will be stored in a lockcd 
office until it is entered into a computer in Kilif L The computer files will only accessible to people 
working for KEMRI in Kilift who are involved in this survey. Once the survey is ended, we will 
compile a report for the MOH in this district and Nairobi. The information will not be used in any 
way to harm your business. 
Do you have any questions or concerns regarding the information I have given you? 
Do you agree to participate in this survey? Y/N 
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Community member's information sheet and consent form for FGDs 
Introduction 
Welcome, my name is and I work for KEMRI CGMRC in Kilifi. KEMR1 is holding 
interviews and discussions with community members in several districts in Kenya on medicines 
sold over-the-counter. This infon-nation is being used to develop programmes to help retailers and 
their customers get better information on commonly used over-the-counter medicines. 
Who is being askedtojoin in the discussions? 
We have decided to hold discussions with different members of the community based on gendcr, 
level of education and age. 
Wh at are we req uestingfrom yo u? 
If you agree to participate, the discussion will take one to one and a half hours. During the 
discussion, one of us will ask questions as the other takes notes. We will also record the discussion 
so that we do not miss out on anything we have talked about today. At the end of the discussion, we 
will record your age and years of education. It is upon you to choose whethcr you want to 
participate in the discussion or not. You should also feel free to withdraw from the discussion at 
any point. Everyone's participation is very important and I would like you all to fccl comfortable to 
give your opinions throughout the discussion. Please remember, there are no right or wrong 
answers. 
Are there any risks or benefits of being involved in lite sludy? 
Apart from the time spent now, there are no disadvantages to you for participating in the 
discussion. However, the information we collect will help medicine retailers and people living in 
Makueni generally in future through MOH programmes to get better information to rctailcrs and 
their customers on shop-bought drugs. 
Confidentiality 
We will not record participant's names during note taking and will instead assign numbers to 
individuals that will be matched against their responses. Notes from the discussion will be storcd in 
a locked office and later entered into a computer. The computer files will only be accessible, to 
people working for KEMRI in Kilifi who are involved in this study. At tile end of the discussions, 
we will compile a report for the MOH in Makueni and Nairobi. This report will not contain any 
names or specific locations of people but only the divisions in which the discussions were 
conducted. 
Group consent 
Are you willing to participate in this discussion as a group? Y/N 
If you agree to participate, you are requested on behalf of the group, to sign in the space below as a 
sign of having understood the purpose and content of the discussion. 
I have signed on behalf of the group to conf inn that sufflicicnt infortnation 
regarding the discussion has been given and that we have willingly accepted to take part in this 
discussion. 
Signature Date: Name of witness Signature 
Date: 
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PMRs FGDs consent form 
Introduction 
My name is and I work for KEMRI GGMRC in Kilifi. KEMRI is carrying 
out interviews in several districts in Kenya in shops that sell medicines and were involved in the 
shopkeeper training. We intend to collect information about medicines sold over-the-counter, and 
your views on the training and the shopkeepers' programme as a whole. 
Who is being asked tojoin in the interviews? 
We have chosen the names of 9 shops from a list of all those selling medicines in Makucni district. 
The main sellers in these shops have been chosen based on gender, age and level of education and 
requested to participate in the interviews. 
What are we requestingfromyou? 
If you agree to participate, the interview will take approximately one hour. It is your choice to 
participate or not to. 
Are there any risks or benefits of being involved in the study? 
Apart from the time spent now, there are no disadvantages or direct benefits to you for participating 
in this interview. However, the information we collect will help medicine retailers and people 
living in Makueni generally in the future through MOH programmes to get better information to 
retailers and their customers on shop-bought drugs. 
Confidentiality 
Notes from the interview will be stored in a locked office and later entered into a computer. The 
computer files will only be accessible to people working for KEMRI in Kilifi who arc involved in 
this study. At the end of the interview, we will compile a report for the MOI I in Makucni and 
Nairobi. This report will not contain any names or specific locations of people or shops involved in 
the interview, but only the divisions in which the shops involved are located. The information will 
not be used in any way that could endanger your business. 
Group consent 
Are you willing to participate in this discussion? Y/N 
If you agree to participate, you are requested on behalf of the group, to sign in the space bclow as a 
sign of having understood the purpose and content of the discussion. 
1 have signed on behalf of the group to confinn that 
sufficient information regarding the discussion has been given and that we have willingly acceptcd 
to take part in this discussion. 
Signature Date: 
Name of witness Signature 
Date: 
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Trainers' /Managers interview information sheet ft 
Introduction 
My name is and I work for KEMRI GGMRC in Kilirt. KEMR1 is carrying 
out interviews in several districts in Kenya in shops that sell medicines and were involved in the 
shopkeeper training. We intend to collect information about medicines sold ovcr-thc-countcr, and 
your views on the training and the shopkeepers' programme as a whole. 
Who is being asked tojoin in the interviews? 
We are holding discussions with community members, trained retailers, trainers like you and 
programme managers to find out their perceptions about the retailer training and other aspects of 
the programme. 
What are we requestingfromyou? 
If you agee to participate, the interview will take approximately one hour. It is your choicc to 
participate or not to. 
Are th ere any risks or benefits of being involved in the study? 
Apart from the time spent now, there are no disadvantages or direct bencrits to you for participating 
in this interview. However, the information we collect will help medicine retailers and people 
living in his area generally in the future through MOH programmes to get bcttcr information to 
retailers and their customers on shop-bought drugs. 
Confidentiality 
Notes from the interview will be stored in a locked off-ice and later entered into a computer. I'lic 
computer files will only be accessible to people working for KEMRI in Kilirt who are involved in 
this study. At the end of the interview, we will compile a report for the MOI I in tile districts and 
Nairobi. This report will not contain any names or specific locations of people or shops involved in 
the interview, but only the divisions in which the shops involved are located. The information will 
not be used in any way that could endanger your business. 
Individual consent 
Are you willing to participate in this discussion? YIN 
If you agree to participate, you are requested to sign in the space below as a sign of having 
understood the purpose and content of the discussion. 
I have hereby signed to conrinn that sufflcicnt 
information regarding the discussion has been given and that I have willingly acccptcd to take part 
in this interview. 
Signature Date: 
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